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ABSTRACT
Throughout history, people speculated that an 
association existed between nutrition and disease 
prevention. Recently, studies have examined the influence of 
single nutrients on immunological mechanisms, but with 
limited focus on marginal deficiencies.
This project investigated the effects of severe, 
marginal, and adequate levels of dietary magnesium and 
copper on immune function. Three experiments were conducted, 
with 100 gm male rats consuming one treatment diet for 
three, four or eight weeks. Mineral levels used were:
1) magnesium - 50 ug/gm, 160 ug/gm, 280 ug/gm, 400 ug/gm;
2) copper - 0.5 ug/gm, 2.0 ug/gm, 3.5 ug/gm, 5.0 ug/gm; or
3) a combination of the severely deficient and marginal 
levels of magnesium and copper.
Results showed that within two weeks, plasma magnesium 
and copper levels reflected the amount of mineral in the 
diets. Ceruloplasmin paralleled plasma copper 
concentrations.
IgM and IgG concentrations correlated with plasma 
magnesium levels. Only the severely copper deficient rats 
had lower IgM. The gamma globulins were dramatically reduced 
with the combined magnesium and copper severe deficiency.
Lymphocyte proliferation following mitogen stimulation 
was not altered in magnesium deficient rats. Stimulation
indexes were lower with the severe copper deficient 
treatment. Proliferation rates after ConA stimulation for 
marginally copper deficient rats were higher, but the 
differences were not statistically significant. Antibody 
response to heterologous red blood cells tended to be lower 
in severely magnesium or copper deficient rats, and higher 
in marginally copper deficient rats.
The combined severe deficiency and combined marginal 
deficiencies with 2.0 ug copper/gm had higher proliferation 
rates with ConA and significantly lower rates with PWM. Mean 
specific antibody response tended to be lower in severely 
deficient rats.
Neutrophil function was not altered by magnesium or 
copper deficiencies. However, a greater percentage of 
neutrophils from severely magnesium and copper deficient 
rats ingested bacteria, but bactericidal activity was 
similar to neutrophils from control animals. Neutrophil 
myeloperoxidase activity was higher in rats with the 
combined severe deficiency.
The results from these experiments indicated a tendency 
toward altered immune function with severely deficient 
magnesium or copper diets, while marginal deficiencies did 
not always appear to have an effect.
Chapter 1 
INTRODUCTION
In the beginning, man, as a hunter-gatherer, ate a 
variety of meats and plants. Through trial and error, he 
identified those foods that presumably resulted in good 
nutrition and resistance to diseases. Thus, it had been 
speculated by investigators, including Hippocrates, that the 
association of nutrition and disease prevention existed 
throughout history (Stinnett, 1983).
As man moved to farming and with the growth of cities, 
people became more dependent on single food sources.
However, failure of crops and a limited availability of 
foods rendered the populations more susceptible to plagues 
throughout European history. The relationship between 
malnutrition and disease was becoming apparent.
Additional evidence of the association between 
malnutrition and disease could be found in the history of 
warfare. During early wars, when destroyed crops resulted in 
famine, the starving populations became victims to 
pestilence. That sequence continued through the Napoleonic 
Wars, the American Civil War, and World War I, Significant 
improvements in nutrition helped to control illnesses by the 
start of World War II.
While the information provided by famine and wartime 
experiences led to the hypothesis of an interaction between
1
2nutritional intake and resistance to disease, much 
documentation was provided by field studies of malnourished 
individuals in developing countries. Widespread incidence of 
infectious disease and high infant mortality rates were 
common in those populations. It had been recognized that 
persons who were malnourished were more susceptible to 
disease (Gershwin, et a l ., 1985; Gross and Newberne, 1980; 
Stinnett, 1983).
Those field studies, along with clinical observations 
and experimental studies provided evidence in the 1960’s for 
the direct and causal interrelationships between infection 
and malnutrition (Scrimshaw, et a l ., 1968). Two patterns of 
interactions were described: 1) malnutrition may alter host 
resistance to infectious disease, or 2) infectious disease 
may have a deleterious effect on the nutritional status of 
the host.
The primary target of early clinical and experimental 
studies of nutritional effects on immune mechanisms was 
during protein-calorie malnutrition (PCM). With the 
complexity of deficiencies present in general malnutrition, 
many physical and biochemical changes occur. Moreover, 
immunological functions are altered in many ways.
The size, weight, and cellular structure of the 
lymphoid organs are significantly altered by malnutrition 
(Gross and Newberne, 1980; Stinnett, 1983). Cell-mediated 
immunity, the humoral response, phagocytosis and the
3complement system also were found to be affected by 
nutrition.
Cell-mediated immunity (CMI) is depressed during severe 
PCM (Gershwin, et a l., 1985; Chandra, 1980; Stinnett, 1983). 
This also happens during mild or moderate malnutrition 
(McMurray, et a l ., 1981), and the depression of CMI appears 
to be in proportion to the severity of the malnutrition 
(Neumann, et a l ., 1975).
During PCM there is impaired differentiation of T-cell 
precursors with decreases in the number of circulating T- 
lymphocytes and an increased proportion of "null" cells. 
Lymphocyte response to mitogens and antigens generally is 
reduced, perhaps due to impairment in antigen processing or 
recognition. Cutaneous delayed hypersensitivity reactions 
also are diminished in malnourished individuals (Schlesinger 
and Stekel, 1974).
While alterations occur with T-lymphocytes in PCM, the 
number of circulating B-lymphocytes remains normal 
(Gershwin, et a l ., 1985; Gross and Newberne, 1980; Stinnett, 
1983). However, the number may be increased at times when 
infections are present. Immunoglobulin levels usually are 
normal during PCM (Suskind, et a l ., 1976) or may be elevated 
with concurrent infections (Stiehm, 1980). Serum IgE 
significantly increases due to the prevalent incidence of 
intestinal parasitic infestations in malnourished 
ind ividuals. Specific antibody responses have been found to 
vary depending on the severity of malnutrition, which
4perhaps results from a lack of T-cell regulation (Neumann, 
et a l ., 1975) .
Neutrophilia frequently is observed in malnourished 
individuals (Gershwin, et a l ., 1985; Gross and Newberne, 
1980; Stinnett, 1983). But, variable results have been 
obtained and reported concerning the functions of the 
phagocytes during PCM. In general, chemotaxis and 
phagocytosis are normal, while the bacterial-killing 
capacity is impaired. Much of the variation might be 
explained by biochemical alterations of the phagocyte 
enzymes involved in the oxygen-dependent bactericidal system 
(Salimonu, et a l ., 1982).
The depression of immunocompetence that has been 
reported in malnourished individuals from developing 
countries similarly occurs in hospital patients in the 
United States (Dowd and Heatley, 1984). Nearly half of 
patients with chronic liver disease or chronic renal failure 
are affected with undernutrition and depression of cellular 
immunity. Undernourished surgical patients generally have 
increased incidence and severity of postoperative and 
terminal infections. Cancer patients are frequently 
undernourished, which results in decreased immunocompetence 
and a high risk to fatal infections. Nutritional 
supplementation has been beneficial in improving the immune 
function of malnourished hospitalized patients.
Alterations of the immune response in the elderly also 
may be ascribed to nutritional deficiencies (Chandra, et
5a l ., 1982; Effros and Walford, 1987). Preliminary 
observations of malnourished individuals more than 60 years 
of age have shown impaired CMI with reduced T-cell numbers, 
decreased lymphocyte proliferation responses, and impaired 
delayed hypersensitivity skin reactions. Those immune 
responses improved after nutritional supplementation.
Dietary deficiencies also have been implicated in 
veterinary medicine as contributing to serious diseases in 
animals (Chandra and Newberne, 1977). Studies during the 
1940’s indicated that in animals, an adequate supply of 
protein discouraged intestinal parasites, and vitamin 
deficiencies decreased resistence to infection in varying 
degrees (Chandler, 1951).
In the 1960’s, dietary deficiencies of California beef 
cattle were found to be closely related to high incidences 
of abortion caused by infectious bovine rhinotracheitis 
(Crane, 1965). Feed supplementation with phosphorus, vitamin 
A, protein and energy, in addition to vaccinations, 
increased the weaned calf crop from 73 to 94 percent.
Clinical observations of dogs in the 1960’s found that 
malnutrition contributed to immunization problems (Sheffy,
1966). In malnourished dogs antibody production was lower 
than in healthy dogs after distemper and infectious canine 
hepatitis vaccination. Nutritional therapy with simultaneous 
immunization was found to facilitate a maximal immune 
response. Hospitalized dogs suffering from anorexia were 
found to be at greater risk to contracting infectious
6diseases (Morris and Collins, 1967). The presence of 
anorexia was reported to affect drug therapy, wound repair 
or surgical intervention.
Food deprivation in small companion animals alters 
host-defense mechanisms much like PCM in humans (Lewis, et 
a l ., 1987). A reduction of T-lymphocytes depresses CMI 
responses, and humoral immunity also is impaired with low 
synthesis of antibodies. Leukocyte motility is decreased 
along with the bactericidal activity of the leukocytes. 
Likewise, similar changes in the immune response of small 
animals may occur with injury or disease when food intake is 
inadequate. Proper nutritional support is required for 
recovery and improved immunocompetence.
Today, the nutritional care of hospitalized companion 
animals receives attention to optimize recovery of 
critically ill or injured animals (Allen, 1986; Crowe,
1985). Supplemental diets or parenteral and enteral 
hyperalimentation methods are available to provide adequate 
nutrition for animals requiring nutritional support.
In addition to small companion animals, the nutritional 
status of livestock has been a concern (Miller, 1975).
Modern feeding conditions of high animal density create 
favorable environments for the spread of infectious disease. 
Proper nutrition is now considered to reduce the incidence 
and severity of infections.
Overall, it has been shown that malnutrition impairs 
immunocompetence, and increases susceptibility to infection.
7Thus, nutritional deficiencies such as those that occur with 
PCM can cause infections to become more severe. But this 
synergistic relationship between diet and infectious disease 
is bidirectional. Infections can have a detrimental 
influence on the nutritional state of an individual or 
animal through biochemical, metabolic, and hormonal 
responses (Beisel, 1977, 1980; Lewis, et a l ., 1987).
The nutritional consequences of infection are largely 
the result of catabolic events associated with fever and 
anorexia (Beisel, 1977, 1980). Changes occur in nitrogen and 
protein metabolism when amino acids are utilized for 
gluconeogenesis. The demand for amino acids also increases 
during the synthesis of proteins required for host defenses. 
Thus, negative nitrogen balance results. This is accompanied 
by altered production and utilization of carbohydrates and 
lipids. A depletion of body nutrient stores occurs during 
the hypermetabolic state of fever with changes in mineral 
and vitamin metabolism. Electrolyte imbalance occurs with 
water losses from diarrhea.
The studies showing the relationship of malnutrition 
and immunity involved multiple nutrient deficiencies. The 
many effects of PCM on immune function suggested that 
individual nutrients altered the immune response in some 
way. However, the causal relationship between single 
nutrients and immunologic functions could not be explained 
from previous studies. Therefore, the interrelationship of 
single nutrients and immunocompetence recently has received
8more attention (Beisel, 1982; Beisel, et a l ., 1981; Chandra 
and Dayton, 1982; Nauss and Newberne, 1981).
Individual nutrient interactions with the immune system 
may be through direct or indirect mechanisms (Cunningham- 
Rundles, 1982; Gershwin, et a l , 1985). Nutritional factors 
with primary activity within the lymphoid system may be 
classified as direct regulatory effects. Such effects may 
include those on cells of the immune system. The capacity of 
the cells to recognize foreign stimuli may be changed or 
antigen presentation may be modified. Phagocytic cells may 
become defective in the uptake or killing of organisms.
Nutrients required for other organ or cellular systems 
which then regulate the immune response interact indirectly. 
Metabolic, neurologic or endocrine alterations may 
ultimately influence immunologic mechanisms. For example, a 
deficiency of nutrients required for the synthesis of 
proteins may limit the production of immunoglobulins or 
lymphokines.
Various components of cellular and humoral immunity 
have been found to be altered by single nutrient 
deficiencies (Chandra, 1988). In general, protein and amino 
acid deficiencies reduce immunocompetence. Current research 
has shown that with protein malnutrition, functional 
activities of lymphokines and monokines are altered, and 
lymphocyte responsiveness is depressed.
Vitamin A deficiencies are associated with 
immunosuppression. Immunity also may be impaired with
9deficiencies of the B vitamins which serve as cofactors in 
many metabolic pathways. Data on the roles of trace elements 
such as iron, zinc and copper, suggest the importance of 
those and other minerals in maintaining immunocompetence.
An animal's response to infections will be determined 
by its nutritional status (Chandra and Newberne, 1977). 
Animals consuming diets insufficient in the water-soluble 
vitamins generally have decreased resistance. Viral 
infections are more severe in animals consuming diets 
deficient in vitamin A. An inadequate protein intake impairs 
phagocytosis which depresses resistance to bacterial 
infections. Therefore, a balance of protein and energy is 
required for optimum immunocompetence, and proper nutrients 
must be provided for the animal to respond to the stress of 
a bacterial or viral challange.
The data obtained concerning single nutrient 
deficiencies with respect to immunocompetence may find 
practical application as more of those types of deficiencies 
are recognized. People on self-restricted diets or those 
receiving parenteral feedings may be deficient in a single 
nutrient (Beisel, et a l ., 1981). The elderly with limited 
incomes, low-birth-weight infants, or children with growth 
retardation may be "at risk." Single nutrient deficiencies 
also may occur in individuals or animals with chronic renal 
or liver disease.
In addition, marginal nutrient deficiencies are more 
common in industrialized nations rather than the severe
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deficiencies that are associated with PCM (Fletcher, et a l ., 
1988). This may be due to the consumption of highly refined 
and heavily processed foods that may have reduced contents 
of trace elements and/or vitamins. Marginal trace element 
status also may be found during periods of increased need 
for the nutrient such as growth and development, pregnancy, 
lactation, or during illness.
In the field of veterinary medicine, marginal or single 
nutrient deficiencies may occur in livestock consuming a 
limited variety of feeds, or primarily reared on home-grown 
forages and grains (Sheffy and Williams, 1982). The feeds 
may be low in a nutrient due to soil mineral deficiencies, 
or the nutrient may be lost during curing or storage.
Severe environmental conditions or prolonged winter seasons 
may contribute to marginal total feed supplies.
Seasonal changes of some minerals in forages common to 
the Southeastern United States were found to be significant 
(Kappel, et a l ., 1985). Among those, magnesium and copper 
were found to be marginally deficient in relation to the 
requirements of lactating dairy cows at different■times of 
the year.
Immunocompetence may be altered in various ways as a 
result of single nutrient or marginal deficiencies due to 
the multiple roles of nutrients and the complexity of the 
immune system itself. More information is needed about 
nutrient involvement in the immune system to provide a 
better understanding concerning the importance of nutrition
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in host defense and resistance to disease. In addition, 
information concerning the physiological function of trace 
elements is so relatively new that little knowledge exists 
on the mechanisms by which trace elements affect the immune 
system (Gross and Newberne, 1980).
To contribute to the information concerning single 
nutrient and marginal nutrient deficiencies on 
immunocompetence, the two minerals, magnesium and copper, 
were selected for this study. The objectives were:
1. To determine the effects of adequate, marginal and 
deficient levels of dietary magnesium on immune function.
2. To determine the effects of adequate, marginal, and 
deficient levels of dietary copper on immune function.
3. To determine the effects on immune function when 
adequate, marginal, and deficient levels of dietary 
magnesium and copper are fed simultaneously.
The immune function was assessed by measuring activities of 
the cell-mediated and humoral immune systems, and phagocytic 
responses.
Plan of Development
In this chapter, the relationship between malnutrition 
and immunocompetence was discussed. The need for more 
research concerning single nutrient and marginal 
deficiencies was noted, and provided the basis for the three 
objectives and experiments of this research. The next 
chapter will summarize studies conducted on the effects of
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magnesium and copper on immune function, while the third 
chapter will outline the procedures and analytic methods 
followed for each experiment. The results from each 
experiment will be provided in the fourth chapter. A summary 
of this research, a discussion for each experiment, and the 
conclusions will be presented in the fifth chapter.
Chapter 2 
REVIEW OF LITERATURE
Early studies on the effects of nutrition on immunity 
looked at malnourished individuals and their lack of 
resistance to disease. Recently, individual nutrients have 
been examined as to their involvement in the immune system. 
Research on the two minerals selected for this study, 
magnesium and copper, will be reviewed.
Magnesium
Of the total body content of magnesium, 60 percent is 
in the bone, 1 percent is extracellular, while the remaining 
is distributed between muscle and other soft tissues. 
Magnesium is the second most abundant extra- and 
intracellular divalent ion. Magnesium homeostasis is 
maintained primarily by the kidney. A specific magnesium- 
regulating hormone has not been found. During magnesium 
deficiency, especially during youth, the bone provides a 
magnesium reserve and equilibrates the magnesium between the 
plasma and bone. In ruminants, however, the magnesium in the 
bone and soft tissue is not readily available. (Aikawa,
1981; Wester, 1987).
Most of the extracellular magnesium is ionized and 
biologically active, while approximately one-third is bound 
to serum proteins (Kroll and Elin, 1985). Of the protein-
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bound magnesium, three-fourths is bound to albumin and the 
remaining one-fourth to the globulins. At high and low 
albumin concentrations, serum magnesium is linearly related 
to the albumin content. At the physiologic levels of 
albumin, magnesium concentration is independent of the 
albumin concentration.
Physiological Roles of Magnesium 
During the process of biological evolution, magnesium 
was of primary importance for effective energy utilization. 
It was utilized for photosynthesis and then for oxidative 
phosphorylation. Magnesium is involved in metabolic 
processes including glucose utilization, muscle contraction 
and membrane transport systems (Aikawa, 1981; Wester, 1987).
The magnesium cation is complexed with many enzymes 
including those that catalyze the transfer of phosphate 
groups. Enzymes utilizing ATP have an absolute requirement 
for magnesium, with the magnesium ion bound to the phosphate 
moiety of ATP to form a stable complex. Thus, magnesium is 
involved in numerous reactions which are essential to life 
(Aikawa, 1981; Wester, 1987).
Magnesium also is important in all stages of protein 
metabolism (Aikawa, 1981). The concentration of 
intracellular magnesium must be optimal to maintain the 
structural integrity of the ribosomes for RNA synthesis. The 
transfer of amino acids in RNA translation requires 
magnesium, and peptide bond synthesis is dependent on
15
magnesium. During the synthesis of nucleic acids, magnesium, 
as well as ATP, are required. In addition, the DNA helix is 
stabilized by magnesium.
Magnesium Deficiencies 
Magnesium deficiencies in man were largely unrecognized 
until recently. The importance of magnesium deficiency is 
associated with the major cardiovascular diseases, including 
hypertension, congenital heart failure and arrhythmias 
(Whang, 1987) . Among the causes of clinical hypomagnesemia 
are gastrointestinal factors such as alcoholism, diarrhea, 
or malabsorption, renal losses with diuretics, or endocrine 
disorders including diabetes. Concurrent potassium depletion 
increases the risk of cardiac rhythm disturbances.
The daily magnesium intake may be suboptimal when 
compared to the U.S. Recommended Dietary Allowance (Wester, 
1987). It has been reported that 25 percent of surveyed 
individuals had adequate dietary intakes. The refining of 
flour, rice, and sugar results in a loss of greater than 80 
percent of the magnesium content. Boiling vegetables may 
diminish magnesium by half. Magnesium absorption may be 
decreased by excess calcium, phosphate, phytate, and 
protein. Lowered absorption increases the dietary 
requirement for magnesium.
In animals, magnesium was first demonstrated to be an 
essential nutrient in 1926. A deficiency in rats retards 
growth and causes peripheral vasodilation, anorexia,
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hyperirritability, muscular incoordination, convulsions, 
coma, and death. Experimental animals that are deficient 
also have shown excessive calcification of bone, 
disturbances in calcium and phosphorus metabolism, depressed 
protein synthesis, and a high incidence of fetus resorption. 
Symptoms of magnesium deficiency in poultry include poor 
feathering, ataxia, and palpable tremors (Sell and Fontenot, 
1980).
The National Research Council (1978) requirement of 
magnesium for the growing laboratory rat, based on an 
estimated feed intake of 15 gm/day, is 400 ug/gm. This 
amount also is adequate to maintain normal levels of blood 
and bone magnesium. The optimal level of magnesium for mice 
has not been established, but 400 ug/gm has been 
recommended. The American Institute of Nutrition’s AIN-76 
mouse diet includes 500 ug magnesium/gm diet.
The level of magnesium in common feed ingredients for 
most animals is high in relation to the dietary requirement. 
Therefore, deficiencies are uncommon, and are induced by 
experimental purified diets. Ruminants, however, qre 
susceptible to hypomagnesemia or grass tetany, which is 
associated with a metabolic deficiency of magnesium. The 
deficiency may be the result of a simple dietary deficiency, 
or may be caused by an impairment of magnesium absorption or 
utilization by the animal (Sell and Fontenot, 1980).
Immunologic impairment due to magnesium deficiency has 
not been reported in humans. However, for many animals, the
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immune system is affected by magnesium deficiencies (Beisel, 
1982). It is believed that the roles of magnesium in DNA and 
protein synthesis influence the immune system. However, 
little is known about the specific biochemical interactions 
of magnesium in immunologic processes. More is known about 
the physiologic changes of the immune system in response to 
a magnesium deficiency.
Leukocytic Effects
Magnesium deficiencies in rats consuming diets with 30 
to 60 ug magnesium/gm consistently produced leukocytosis and 
myeloid hyperplasia (Battifora, et a l ., 1968; Hass, et a l ., 
1980). The increase in total leukocyte count was primarily 
due to a two- to threefold increase in the number of 
circulating neutrophils. Eosinophilia also was common in 
animals during the acute stage of deficiency. After two to 
three weeks, the leukocyte count declined. Feeding diets 
with adequate levels of magnesium, 650 ug/gm, rapidly 
returned leukocyte counts to normal in most rats. Extending 
the deficiency to 60 weeks by reducing the magnesium content 
of the diet, sustained the leukocytosis (McCreary, et a l .,
1967) .
Battifora, et al. (1968) found with persistant and 
severe leukocytosis, myelogenous leukemia followed. 
Additionally, cells from leukemic rats were successively 
transplanted to newborn rats who then developed leukemia. In 
subsequent studies, malignant lymphomas appeared within 24
18
hours in younger rats fed magnesium deficient diets 
containing 30 to 50 ug roagnesium/gm (McCreary, et a l .,
1973). When live lymphoma cells were injected into other 
rats, the deficient rats were more susceptible to 
transmission of lymphomas than normal control rats.
Normal and deficient rats then were immunized with sub-
tumorigenic doses of viable lymphoma cells (Hass, et a l ., 
1978). The rats were challenged with a tumorigenic dose of
lymphoma cells, and 104 of 110 deficient rats died of
lymphoma, while only 5 of 101 normal rats died. Two 
subgroups from the control rats then were subsequently 
challenged, after consuming a normal or a deficient diet for 
eight weeks. Normal rats survived the challenge. However, 90 
percent of the newly deficient rats died of lymphoma 
indicating a loss of a previously established immunity to 
lymphoma.
Extensive mast cell degranulation, an increased release 
of histamine resulting in histaminuria, and hyperemic 
dermatitis have been found to occur with magnesium 
deficiency (Hass, et a l ., 1980). An abnormal distribution of 
mast cells with decreased granularity of the mast cells, but 
without increased urinary histamine also have been reported 
(Bois, 1963). Peripheral vasodilation was observed after 10 
days of magnesium deficiency and peripheral hyperemia within 
20 days. The hyperemia was replaced by white edema with 
chronic magnesium deficiency lasting 60 days.
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The changes in mast cell activity and histamine levels 
were further studied in magnesium deficient rats (Kraeuter 
and Schwartz, 1980). Widespread degranulation of the mast 
cells occurred early during magnesium depletion with a 50 ug 
magnesium/gm diet. Subsequently, degranulation subsided, but 
the number of submucosal mast cells increased and were 
smaller in size than those from control rats consuming 
1,000 ug magnesium/gm.
Blood histamine levels in the magnesium deficient rats 
peaked within 12 to 16 days which correlated with maximal 
degranulation. Although submucosal mast cells increased 
later, blood histamine levels declined. Peritoneal mast 
cells contained significantly more histamine within five 
days of magnesium deficiency, then dropped to one-third the 
amount in cells collected from control rats. The authors 
concluded that the immature cells at later stages of 
magnesium depletion were deficient in their capacity to 
secrete histamine.
Lymphoid Organs
Thymic hyperplasia has been observed in rats during 
magnesium deficiency (Alcock, et a l ., 1973). In various 
experiments, rats consumed diets with a magnesium content of 
10 ug/gm. Enlarged thymuses were observed between the 38th 
and 60th day of deficiency in 18 to 52 percent of the 
deficient rats. The incidence of enlarged thymuses was twice 
as great in young rats than among older animals. The normal
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cellular structure of the thymus was replaced by cells that 
resembled transformed lymphocytes. The change was 
hyperplastic rather than neoplastic. Splenomegaly also was 
observed in the deficient rats.
In an attempt to help explain the changes occurring in 
the lymphoid organs during magnesium deficiency, the 
synthesis of tissue proteins and nucleic acids was measured 
(Zieve, et a l ., 1977). Rats were fed a diet containing 50 ug 
magnesium/gm for 4.5 months before isotope incorporation 
studies were conducted. The rats were injected 
intraperitoneally with [3H]leucine for protein 
incorporation, [3H]thymidine for DNA incorporation, or 
[14C]orotic acid for RNA incorporation. The average increase 
in thymic weight was not significant, but the spleens were 
twice the weight of those from pair-fed control rats and 
were congested with lymphocytes.
Uptake of [14C]orotic acid in the spleen and thymus 
significantly increased, but its incorporation into RNA did 
not change. [3HjThymidine incorporation into splenic and 
thymic DNA dramatically increased. The increase in DNA 
synthesis was believed to represent early
lymphoproliferative processes leading to leukocytosis and 
the development of neoplasia. On the contrary, protein 
synthesis appeared to be inhibited in magnesium deficient 
rats, because [3H]leucine incorporation was significantly 
lowered in the spleen and thymus. The reduction in protein
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synthesis may have been responsible for impaired immune 
response during magnesium deficiency.
Immunoglobulins
With the changes that occur in the lymphoid organs 
during magnesium depletion, and with the requirement of 
magnesium for protein synthesis, the effects of magnesium 
deficiencies on immunoglobulin synthesis and secretion have 
been of interest (Alcock and Shils, 1974; Elin, 1975; McCoy 
and Kenney, 1975). Rats fed a magnesium deficient diet for 
two, four or six weeks had lower levels of serum IgG than 
animals fed a control diet. Animals repleted with injections 
of magnesium and fed adequate diets showed after 24 hours an 
increase of serum IgG. IgG levels then were similar to or 
greater than control values. The marked depression and rapid 
recovery of serum IgG in response to magnesium intake 
suggested a direct role for the mineral in the synthesis or 
metabolism of the immunoglobulin (Alcock and Shils, 1974).
Elin (1975) evaluated four serum immunoglobulin 
concentrations in mice fed 35 ug magnesium/gm. Levels of 
IgGi , IgG2 , IgA, and IgM significantly decreased after six 
days of the dietary deficiency. After 12 days, the IgG2 and 
IgA concentrations increased, and the IgGi concentration was 
near control values. The partial recoveries were explained 
by protein catabolism which might have provided endogenous 
magnesium that could have been reutilized.
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The mice also were immunized with sheep red blood 
cells, and after four days the number of splenic plaque- 
forming cells (PFC) were determined. The spleens from 
magnesium depleted mice were similar in weight to those from 
control mice, but the deficient mice were unable to gain 
total body weight. Although splenic weights were not 
significantly different, magnesium deficient mice had a 
significant decrease in the total number of PFCs per spleen.
The splenocytes also demonstrated a reduced ability to 
respond to an antigenic stimulus and synthesize IgM specific 
for the antigen, as indicated by lowered serum IgM 
concentrations. Therefore, the process of antigen 
recognition and processing with subsequent antibody 
synthesis was impeded with magnesium deficiency.
In an analysis of the production of specific antibody, 
serum gamma globulin levels of young and older magnesium 
deficient rats were measured, in addition to agglutinin and 
hemolysin activities (McCoy and Kenney, 1975). Weanling rats 
were fed a diet with 10 ug magnesium/gm for eight days and 
then 142 ug magnesium/gm. The rats were immunized.after 36 
days with sheep red blood cells. Older, 200 gram rats were 
fed 10 ug magnesium/gm, and immunized after 29 days.
Spleens, when expressed as percentages of body weights, 
were heavier in the magnesium deficient young and older rats 
than in control rats. The young magnesium deficient rats had 
higher concentrations of gamma globulins than controls, but 
agglutinin and hemolysin titers were lower. Older deficient
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rats had lowered concentrations of gamma globulin in 
addition to lower agglutinin and hemolysin titers.
The low antibody titers associated with magnesium 
deficiency might have occurred due to a failure to 
synthesize antibody. This was reflected in the older animals 
that had lower concentrations of gamma globulins. However, 
the effect of magnesium was believed to be primarily on 
reduced activity of specific antibodies, especially in 
younger animals. The authors believed the lack of dietary 
magnesium influenced cellular metabolism in such a way as to 
depress serum antibody titers.
In contrast to the general decrease seen in the 
production of most immunoglobulins, the level of circulating 
IgE increases (Larvor, 1980). Three- to fourfold increases 
in serum IgE have been observed in experiments with 
magnesium deficient mice. Several factors were thought to be 
responsible for the increase. Usually, increased IgG 
inhibits IgE production. Therefore, the decrease in IgG 
levels during magnesium deficiency may stimulate IgE 
production. In addition, thymic alterations in magnesium 
deficiency may decrease the control of IgE synthesis.
Recently, the effect of magnesium on the in vitro 
binding of IgE by human basophils has been studied 
(Pruzansky and Patterson, 1988). Optimal binding of 
[125I]IgE to basophils occurred when suspended in medium 
without Mg2* and Ca2+. Binding to basophils incubated in 
medium containing Mg2+ and Ca2* was significantly reduced.
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The cations seemed to decrease the number of membrane-bound 
receptors available for IgE binding. When 10 percent fetal 
calf serum was added to the leukocytes, binding 
significantly increased. The authors suggested that a Ca2 + 
and Mg2+ energy-requiring process shed basophil membrane- 
bound IgE receptors, and factors present in fetal calf serum 
were response for reexpression of the receptors.
Lymphocyte Proliferation
The process of antibody formation includes the 
transformation of lymphocytes to lymphoblasts. Therefore, 
the effects of magnesium deficiencies on lymphocyte 
stimulation have been studied (Gunther and Averdunk, 1979). 
Spleen and thymus cells from chronically magnesium deficient 
rats had [3H ]thymidine incorporation rates which were half 
the control values. DNA and protein contents of the cells 
were 25 percent lower than in cells from normal rats. When 
stimulated by phytohemagglutinin (PHA), lipopolysaccharide 
(LPS), or concanavalin A (Con A), the cells from normal rats 
had response rates that were 1.5 times higher than the cells 
from the magnesium deficient rats.
The spleen and thymus cells also were incubated in 
medium with a low magnesium concentration. The DNA synthesis 
rates and the responsiveness to lectins were lower for cells 
from both the magnesium deficient rats and the normal rats 
when compared to cells incubated in medium with a higher 
magnesium content. The authors proposed that the magnesium
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deficiency altered cell permeability causing changes in 
electrolyte concentrations. Increased intracellular sodium 
and calcium would inhibit DNA and protein synthesis, 
decreasing cell proliferation.
In a series of experiments on the effects of magnesium 
on DNA synthesis, depletion of Mg2 + in growth medium 
decreased DNA synthesis in chicken embryo fibroblasts and 
mouse BALB/c 3T3 cells (Sanui and Rubin, 1982). Cellular 
cation content changed with a dramatic increase in 
intracellular calcium content. The effects of reduced 
extracellular magnesium on cell membrane permeability and 
the cellular Ca2+ pump appeared to be responsible for the 
reduction in DNA synthesis.
After measuring levels of intracellular magnesium in 
mouse BALB/c 3T3 cells, Sanui and Rubin (1982) found a 
positive correlation between intracellular Mg2+ levels and 
DNA synthesis. As the rate of [3H]thymidine incorporation 
increased, intracellular magnesium had an overall increase 
of 15 percent. In addition, a slight change in intracellular 
magnesium corresponded with a substantial change in the 
incorporation rate of [3H]thymidine. It therefore was 
suggested that intracellular magnesium was primary to the 
physiological regulation of cell metabolism and growth.
A study to quantify lymphocyte proliferation 
requirements for magnesium, in addition to calcium, employed 
a serum-free iri vitro culture system (Abboud, et a l ., 1985). 
DNA synthesis in lymphocytes from healthy human donors was
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measured by the incorporation of [3H]thymidine into the 
lymphocytes after exposure to phytohemagglutinin (PHA) and 
concanavalin A (Con A). The cells were suspended in a serum- 
free modified Dulbecco’s medium without added calcium and 
magnesium. The inherent calcium concentration was 25 uM and 
the magnesium concentration was 7 uM. Magnesium and calcium 
then were added at concentrations ranging from 0 to 1 mM.
The addition of either 1 mM magnesium or 1 mM calcium 
increased thymidine incorporation into DNA in the presence 
of PHA or Con A. When both magnesium and calcium were added 
to the medium, thymidine incorporation greatly increased, 
indicating a synergistic effect. In medium that contained 
1 mM calcium, maximal DNA synthesis occurred with the 
addition of magnesium, while 70 percent of the maximal 
response was observed without added magnesium.
The authors concluded that the lower requirement for 
external magnesium than for calcium may be due to the manner 
in which the lymphocytes maintain the concentrations of the 
cations. Intracellular magnesium concentrations are similar 
to external concentrations, while cytoplasmic calcium is 
actively removed. Magnesium-dependent enzymes for lymphocyte 
DNA synthesis may have a greater retention of magnesium when 
the external concentration is low.
Results from experiments on the role of magnesium ions 
in the proliferation and differentiation of human 
promyelocytic leukemia HL-60 cells also confirmed the 
requirement of magnesium (Okazaki, et a l . , 1987). HL-60 cell
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proliferation peaked in standard medium containing 0.4 mM 
magnesium, while in magnesium deficient medium, 
proliferation was inhibited. After two days, cells were 
resuspended in standard medium, and cell proliferation was 
restored.
Cell differentiation was induced by the addition of 
1 alpha, 25 dihydroxyvitamin D 3 . Maximum differentiation was 
observed in cells incubated in standard medium. For cells 
incubated in magnesium deficient medium, differentiation was 
inhibited, but when transferred to the standard medium after 
two days, the cells differentiated.
In contrast, cells from standard medium that were 
resuspended after two days in a magnesium deficient medium, 
showed no further increase in differentiation. The authors 
suggested that the expression of differentiation-related 
phenotypes required magnesium, but magnesium was not 
required for the commitment to differentiate. Additional 
experiments found that the mechanism inhibited by magnesium 
deprivation was during protein synthesis. A reduction of 
extracellular magnesium decreased intracellular magnesium to 
61 percent of the control values after three days, and 
protein synthesis was decreased.
Neutrophil Function
The production and function of polymorphonuclear 
neutrophils (PMN) require extracellular magnesium (Brennan, 
et a l ., 1980). The neutrophil arises from a colony forming
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unit precursor that requires magnesium and calcium for 
optimum proliferation. Depletion of either cation in 
cultured cells, resulted in reduced proliferation, and the 
absence of both severely restricted colony growth. However, 
in vivo deficiencies produce neutrophilic leukocytosis, 
suggesting that sufficient cation content may exist to 
release leukocyte production from inhibition.
Neutrophil adhesion and aggregation requires magnesium, 
but not calcium. Extracellular magnesium also is needed for 
chemotaxis and spontaneous movement of the neutrophil. 
Optimum chemotaxis was observed when calcium was present, 
although either cation supported chemotaxis. Magnesium, 
however, was more potent.
Similar results have been observed for phagocytosis 
(Stossel, 1973). Optimum ingestion by human neutrophils of 
serum-opsonized oil particles was observed when magnesium 
and calcium were present in the incubation medium. When 
unopsonized particles were used, higher concentrations of 
magnesium or calcium were required for ingestion. In both 
situations, magnesium was more effective than calcium.
During phagocytic ingestion of microorganisms, oxygen 
is consumed and rapidly converted to the superoxide anion, 
hydrogen peroxide and the hydroxyl radical, which are used 
for microbicidal activity. The enzyme system involved in the 
respiratory burst is NADPH oxidase. The role of magnesium 
and calcium ions in NADPH oxidase activity have been 
examined (Johnston, et a l ., 1985).
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Kinetic studies of the NADPH oxidase from membrane 
preparations of human neutrophils were performed with the 
addition of various cations in the reaction mixture. The 
production of the superoxide anion was enhanced by either 
Mg2♦ or Ca2 + . EDTA inhibited NADPH oxidase activity, but was 
overcome by the addition of excess Mg2 + or Ca2 + . Saturation 
studies suggested that the magnesium ion was required to 
convert the enzyme to its active form, but had no effect on 
the binding of the substrate.
In a discussion of the results, the authors considered 
possible mechanisms of the magnesium ions in NADPH oxidase 
activity (Suzuki, el a l ., 1985). The membrane fraction might 
have contained other components that modulated the catalytic 
activity. Binding of the Mg2+ with catalytic or regulatory 
components of the oxidase might have enhanced oxidase 
activity.
C opper
Total body copper content exists primarily in the 
liver, heart, kidneys, spleen, and brain (Davis and Mertz, 
1987). The distribution varies according to age, copper 
status, and species of animal. Of the copper present in 
blood, half is found in the erythrocytes with smaller 
amounts in the white blood cells and platelets. Sixty 
percent of the erythrocyte copper is complexed with the 
enzyme, superoxide dismutase (SOD), while the remaining 
exists as a labile pool complexed with amino acids.
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In the plasma, 90 to 93 percent of the copper is firmly 
bound to ceruloplasmin (Cp). The remaining is less firmly 
bound with albumin (Davis and Mertz, 1987). In rats, less 
copper is bound to Cp, and in dogs, 30 to 35 percent of 
serum copper is bound with proteins and amino acids (Brewer, 
1987 ) .
Copper homeostasis is primarily maintained by the liver 
which is the principle storage organ for copper (Suttle, 
1987). Plasma and tissue enzymes also comprise the copper 
pool. When copper intake is inadequate, species variations 
exist. Rats first increase the amount of copper absorbed 
from the diet, which then is retained in the liver.
Ruminants typically have a high capacity for hepatic storage 
so, from the beginning, will mobilize copper from the 
reserves.
Physiological Roles of Copper
Copper is a multifunctional element, and is involved in 
many metabolic pathways (Suttle, 1987). Much of its 
involvement is related to its activity in metalloenzymes. 
Copper is required for heme synthesis through the iron 
mobilization activity of the enzyme Cp. During copper 
deficiency, anemia develops and iron accumulates in the 
liver. The structural integrity of connective tissue and the 
cardiovascular system is dependent on copper. The formation 
of elastin and collagen cross linkages is catalyzed by the 
copper-containing enzyme, lysyl oxidase. The mineralization
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of collagen for bone growth also is dependent on copper, as 
well as the myelination of the central nervous system.
A reduction in plasma copper follows a fall in plasma 
Cp (Frieden and Hsieh, 1976). The multifunctional enzyme is 
involved in iron mobilization from storage sites to the 
plasma through its ferroxidase activity. Characteristic 
signs of copper deficiency in rats include anemia and 
hypoceruloplasminemia (Prohaska, et a l ., 1983). The copper 
transport function of Cp had been doubted, but there is 
evidence that Cp provides copper for copper-dependent 
enzymes, including cytochrome C oxidase, lysyl oxidase, and 
hepatic SOD (Camakaris, 1987). Cp does not appear to be 
required for copper uptake by lymphocytes, but further 
evaluations are required.
The relationship between dietary copper and another 
copper-containing enzyme, SOD, has been investigated within 
the last 15 years. Changes in erythrocyte SOD activity have 
been compared with changes in the copper status of various 
animals. Reduced SOD activity was demonstrated with a 
decrease in dietary intake of copper in swine (Williams, et 
a l . , 1975), cattle (Paynter and Allen, 1981) and lambs 
(Andrewartha and Caple, 1980). When the deficient lambs were 
fed diets adequate in copper, SOD activity increased within 
90 days.
Similar results were reported by Suttle (1983) in 
steers, lambs, and ewes. During dietary copper depletion, a 
decline in SOD activity began later and was slower than the
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decline in plasma copper. SOD activity began to increase 
after plasma copper repletion, and continued more slowly.
The magnitude of change in SOD activity was found to be 
tissue specific in the rat (Paynter, et al., 1979) and in 
mice (Prohaska, 1983; Prohaska, et a l ., 1983). Liver SOD 
activity was greatly reduced during dietary copper 
deficiency, and was repleted with copper supplementation.
SOD activities of spleen and thymus tissues also were 
lowered with copper deficient diets.
The significance of SOD in immunocompetence is thought 
to be related to its function as a scavenger of superoxide 
which is formed and released by phagocytosing neutrophils. 
Superoxide damages cells unless dismutated to hydrogen 
peroxide and O 2 . SOD catalyzes this reaction, protecting the 
phagocytes and surrounding tissues (Fridovich, 1983).
Copper Deficiencies 
Copper deficiency is rare in humans (Turnlund, 1988). 
Hypocupremia was first observed in the 1950’s and was 
reported in 1964. Most deficiencies have been noted in 
patients on long-term total parenteral nutrition without 
copper or in premature infants fed cow’s milk. Low serum 
copper and ceruloplasmin due to defects in copper metabolism 
are found in individuals with Menke’s kinky hair syndrome or 
Wilson’s disease. Most diets generally adequate in other 
nutrients contain sufficient copper. There is no RDA for 
copper, but a recommended intake range has been established.
33
On the other hand, copper deficiency is common in 
livestock (Brewer, 1987). It may be due to genetic factors, 
low copper content of feed or water, an excess of 
antagonistic minerals, or ingestion of some plant poisons. 
Food sources have great variations in copper content 
according to soil conditions, seasonal variations, weather, 
and processing procedures (Davis and Mertz, 1987).
Calcium, iron and zinc are antagonistic to copper 
absorption. Ascorbic acid depresses the bioavailability of 
copper through the reduction of the copper ion, or by the 
formation of stable complexes, similar to those that are 
formed with phytates. Minimum copper requirements exist 
depending on the presence of influencing factors. A greater 
understanding of the etiology of copper deficiency in 
grazing ruminants recently has led to improved diagnosis of 
hypocuprosis (Suttle, 1986).
In 1928 it was recognized that copper, in addition to 
iron, was required to alleviate the anemia which developed 
in rats on a milk diet. Since that time, the involvement of 
copper in a variety of metabolic processes became evident, 
but many of the biochemical functions of copper associated 
with specific deficiency symptoms are not completely 
understood (Davis and Mertz, 1987).
The satisfactory dietary copper content for the 
laboratory rat has been set at 5 ug/gm by the National 
Research Council (1978). This amount has been established 
for adequate growth and for the maintenance of maximal
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hemoglobin concentration with a recommended iron allowance 
of 35 ug/gm. Together, the levels of copper and iron prevent 
hypochromic microcytic anemia.
No studies on the copper requirement of the mouse have 
been reported, but mouse requirements have been assumed to 
be similar to the rat (National Research Council, 1978). 
Adequate purified diets contain at least 4.5 ug copper/gm, 
and the AIN-76 mouse diet contains 5 ug copper/gm.
Characteristics of copper deficiency include anemia, 
neonatal ataxia, skeletal abnormalities, achromotrichia, 
impaired keratinization, cardiovascular disorders, and 
reproductive failure. Nutritional copper deficiency also may 
adversely affect the immune system (Davis and Mertz, 1987). 
The physiological and biochemical processes responsible for 
reduced immunocompetence caused by a lack of copper 
currently are being examined.
Bacterial Challenge 
Several studies have reported a decreased resistance of 
copper deficient experimental animals to bacterial 
infections. Newberne and coworkers (Newberne, et a l ., 1968; 
Newberne, 1977; Gross and Newberne, 1980; Nauss and 
Newberne, 1981) found that copper deficiency resulted in 
high mortality of rats infected with Salmonella typhimurium. 
There was a significant reduction in both the average time 
of survival and the number of survivors of infected copper 
depleted rats when compared to infected control rats.
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The spleens of the copper deficient animals failed to 
enlarge in response to the infection, unlike those from 
infected control rats. The livers also showed no tissue 
hyperplasia. In addition, total serum protein levels were 
lower, there was no increase in the serum gamma globulin 
content, and lymphocytes of copper deficient rats exhibited 
less mitogenic stimulation than those of supplemented 
controls. Because of these results, it was hypothesized that 
copper deficiency in rats prevented the reticuloendothelial 
system (RES) from responding appropriately to infection.
Jones and Suttle (1983) also found a higher incidence 
of mortality in subclinically copper deficient mice 
following intraperitoneal injection of Pasteurella 
haemolytica. Mice were fed diets with less than 0.001 ug 
copper/gm for 8 or 12 weeks before bacterial challenge. No 
clinical signs of copper deficiency were observed. Total 
body weight, spleen and liver weights, and whole blood 
hemoglobin concentrations did not significantly differ from 
control animals. However, plasma copper decreased 6 8  percent 
and blood cell SOD activity decreased 26 percent.
Copper deficient mice that survived bacterial challenge 
had significantly enlarged spleens with a concomitant drop 
in body temperature when compared to uninfected animals. 
Several possibilities for the enhanced susceptibility of 
copper deficient mice to bacterial infection were discussed. 
Adverse effects on the RES were disputed due to a 
discrepancy in the results concerning enhanced splenic
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response after challenge with the reported failure of 
response by Newberne et a l . (see above). Impaired lymphocyte 
proliferation, T- and B-cell cooperation, and/or antibody 
production were suggested as possible explanations for the 
decreased resistance to infection.
Lymphoid Organs 
The biochemical and morphological features of the 
spleen and thymus were found to be altered by chronic 
dietary copper deficiency (Prohaska, et a l ., 1983). Thymus 
glands were small in 6 -week-old mice fed diets containing 
0.6 ug copper/gm, while spleens were enlarged. Lymphoid 
tissue morphology showed abnormal mitochondria and misshapen 
nuclei. The copper deficient mice were anemic and had 
hypoceruloplasminemia. Biochemical changes observed were 
diminished activities of the cuproenzymes cytochrome oxidase 
and SOD in liver, spleen, and thymus tissues. These effects 
of copper deficiency on lymphoid tissue were suggested as 
responsible for impaired immunocompetence.
Antibody Response 
Prohaska and Lukasewycz (1981) found humoral-mediated 
immunity to be impaired in copper deficient mice. Young mice 
were fed diets containing 0.5 ug copper/gm for four to six 
weeks. Response to the diets was variable so the mice were 
divided into two groups based on ceruloplasmin activity. 
Severely deficient mice had a 97 percent or greater decrease
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in Cp, while those with a smaller decrease (69 percent) were 
considered marginally deficient.
Body weight, hemoglobin, liver copper, and antibody- 
producing cells significantly decreased in both groups of 
mice, with the largest changes seen in the severely 
deficient mice. Spleen weight increased only in mice 
considered severely deficient.
Serum ceruloplasmin activity was highly correlated with 
the number of antibody-producing cells, assayed in 
splenocytes after the mice were injected with sheep red 
blood cells. Also, the reduction in hemoglobin and liver 
copper followed the magnitude of immune response. Thus, the 
degree of immune function impairment was related to the 
severity of copper deficiency. The results suggested that a 
clinically marginal copper deficiency would impair the 
humoral-mediated response (Lukasewycz and Prohaska, 1981).
Antibody production, natural killer (NK) cell 
cytotoxicity, and delayed-type hypersensitivity (DTH) 
responses were assessed in copper deficient rats (Koller, et 
a l . , 1987). Rats were fed copper depleted (0 ug/gm), copper 
deficient (2 ug/gm) or copper adequate (6 ug/gm) diets for 
eight weeks. At six weeks, the rats were immunized and 
boosted eight days later with keyhole limpet hemocyanin 
(KLH).
Reductions in the DTH reactions were observed in rats 
consuming the copper depleted diets, but the changes were 
not significant. Rats in that group had a significant
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decrease in NK cytotoxic activity, while rats on the 2 ug/gm 
diet had responses similar to control animals.
Antibody titers to KLH were ranked, and comparisons 
were made on the mean ranks for males and females on each 
diet. Male rats from the 0 ug/gm and 2 ug/gm diet groups, 
and female rats from the 0 ug/gm diet group, had reduced 
antibody responses. The decreases in antibody production and 
NK cytotoxicity were postulated to be caused by changes in 
copper dependent enzymes.
Lymphocyte Proliferation 
Previous studies found copper deficient animals had 
lower resistance to infection. This in turn, led to 
speculations that cell-mediated immunity may be altered in 
some way. Lukasewycz and Prohaska (1983) determined the 
effects of dietary copper deficiencies in mice on T- and B- 
cell reactivity to mitogens. Splenocytes from mice 
maintained on a 0 . 6  ug copper/gm diet were stimulated with 
Con A, LPS, PHA, and pokeweed mitogen (PWM).
Stimulation indexes were variable, but the responses of 
the splenocytes from the copper deficient mice were 
consistently lower than those from adequate control mice.
The mean stimulation indexes were less than 50 percent of 
the controls. Additionally, the decrease in responsiveness 
appeared to follow the decrease in ceruloplasmin activity.
Additional studies to evaluate the functional 
responsiveness of splenocytes from copper deficient mice
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recently were conducted by Lukasewycz, et a l . (1987). Two 
experimental designs were used to compare mixed lymphocyte 
reactions of splenocytes from copper deficient and control 
mice. Two strains of mice, C58 and C57BL, were used. First, 
splenocytes were stimulated by mitomycin-treated spleen 
cells from normal mice. Second, splenocytes from normal mice 
were stimulated by copper deficient or copper adequate 
mitomycin-treated spleen cells.
For the first experiment, the mean response of the 
splenocytes from copper deficient C58 mice was 49 percent of 
that for control mice. Similar trends were observed in C57BL 
mice, but mean comparisons were not significant. The copper 
deficient C57BL mice had hematocrits similar to controls so 
were considered marginally deficient. In the second set of 
experiments, splenocytes from the copper deficient mice of 
both strains stimulated less than splenocytes from control 
mice.
The reduction of immunocompetence appeared to be 
proportional to the degree of copper deficiency. Moreover, 
it was postulated that the deficiency altered lymphocyte 
membranes in such a way as to change the components 
necessary for stimulating mixed lymphocyte reactions.
Reduced lymphocyte proliferation during copper 
deficiency was found to differ according to tissue source of 
the lymphoid cells (Davis, et al., 1987). Spleen lymphoid 
cells and cervical lymph node cells from rats consuming 
copper deficient diets (0.6 ug/gm) for 14 to 70 days were
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stimulated with Con A. Proliferation rates were influenced 
by the dietary deficiency. Spleen cells from the deficient 
rats had significantly lower proliferation rates than those 
from rats consuming adequate diets. In contrast, the 
proliferation of cervical lymph node cells from deficient 
rats was higher than controls.
Additionally, proliferation rates of non-adherent 
spleen cells were found to be equivalent to those from the 
spleen lymphoid cells of deficient and control rats. The 
phagocytic activity of spleen lymphoid cells from the 
deficient rats was lower than those from controls, while no 
differences were found for non-adherent spleen cells. The 
authors suggested that copper deficiency may reduce 
lymphocyte proliferation due to an impaired macrophage 
enhancer function for lymphocyte proliferation.
Neutrophil Function
The increased susceptibility to infection during copper 
deficiency had raised questions as to whether phagocytic 
activity was altered, especially through the copper- 
containing enzyme, SOD. The relationship between plasma 
copper concentrations, leukocyte SOD and phagocytic function 
has been investigated (Jones and Suttle, 1981). Peripheral 
blood leukocytes from copper deficient ewes, lambs and 
calves demonstrated unimpaired phagocytic activity of 
Candida albicans in vitro. On the other hand, the killing 
capacity of the leukocytes from copper deficient ruminants
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was significantly reduced when compared to those from 
control animals. Copper repletion of calves restored 
candidacidal activity.
The SOD activities in erythrocytes and leukocytes from 
copper deficient ewes were significantly less than those 
from control animals. The decrease in SOD activity in 
erthrocytes was much greater than the decrease in leukocyte 
SOD activity. In addition, leukocytes from copper deficient 
ewes tended to produce more superoxide anion after 
stimulation, but the results were variable. The authors 
suggested that during copper deficiency, the decrease in 
leukocyte SOD and increase in extracellular O2 - enhanced 
oxidative damage, and thus, impaired cell function and 
candidacidal activity.
The involvement of copper in cellular SOD anti-oxidant 
systems prompted an investigation of infection and 
neutrophil candidacidal activities during copper deficiency 
(Arthur, et a l ., 1981; Boyne and Arthur, 1981; Arthur and 
Boyne, 1985). Neutrophils of copper deficient cattle were 
able to ingest C . albicans. but killing of the yeast cells 
was impaired. Unlike other studies, the activity of SOD in 
neutrophils of the copper deficient cattle was found to be 
similar to that in neutrophils from animals receiving a 
copper-supplemented diet. Moreover, the concentration of 0 2 " 
generated in stimulated neutrophils from copper deficient 
cattle was normal.
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Therefore, the copper deficiency did not appear to 
cause the decreased killing activity by means of superoxide 
damage to the neutrophils. Bovine neutrophil SOD activity 
was not sensitive to changes in copper status of the animal. 
It was suggested that instead, the mechanisms of superoxide 
production were inhibited in copper deficient animals to 
affect candidacidal activity.
Later, Boyne and Arthur (1986) induced copper 
deficiences in cattle with elevated concentrations of 
molybdenum or iron in the diet, and investigated neutrophil 
function. Phagocytosis of C. albicans was impaired in 
neutrophils from cattle made copper deficient by 
supplemental molybdenum or iron. Candidacidal activity also 
was decreased. The results from this study might have been 
due to a more severe copper deficiency than in previous 
studies, or due to effects of the molybdenum or iron.
Summary
In conclusion, deficiencies of magnesium or copper have 
been found to alter immune function including the cellular 
and humoral systems. Magnesium deficiencies appear to alter 
the immune system through the mineral's involvement in 
protein and DNA synthesis. Antibody titers are low and 
lymphocyte proliferation is decreased. The effects observed 
during copper deficiency may be caused by changes in the 
activities of cuproenzymes. In particular, the decrease 
observed in phagocytic killing of microorganisms is thought
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to be influenced by altered enzyme mechanisms during 
microbicidal activities.
Most of the studies, however, involved severe dietary 
deficiencies of magnesium or copper. Magnesium deficiencies 
in the rat and in mice have been induced with diets 
containing 10 to 60 ug magnesium/gm, or 2.5 to 15 percent of 
the NRC requirement. In one study, the magnesium content was 
increased from 10 ug/gm to 142 ug/gm, or 35 percent of the 
requirement to improve the physical condition of the rats 
for sampling.
Many of the in vitro studies used leukocytes from 
normal subjects, and changed the Mg2♦ ion concentration of 
the incubation media. Few have used leukocytes from 
magnesium deficient animals.
Copper deficient diets have contained less than 0.6 ug 
copper/gm or 12 percent of the NRC requirement for the rat. 
One study included a marginal level of 2 ug/gm (40 percent 
of the requirement). The deficient diets for mice also 
contained less than 0 . 6  ug copper/gm, which also is 1 2  
percent of the NRC recommended level for the laboratory 
mouse.
A few studies considered the experimental animals to be 
marginally copper deficient even after consuming a copper 
depleted diet. This was based on the fact that there was an 
absence of clinical symptoms and only a mild depression of 
plasma copper, Cp, and hemoglobin.
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For the most part, studies have not included the more 
clinically prevalent marginal dietary deficiencies. 
Therefore, this reseach project was designed to examine two 
levels of marginal dietary magnesium and copper 
deficiencies, in addition to severe deficiencies, on immune 
function. Furthermore, the interaction of magnesium and 
copper on immunocompetence is unknown. The present research 
attempts to describe those effects.
In the next chapter, the procedures and analytic 
methods followed for each experiment in this research will 
be explained.
Chapter 3 
METHODOLOGY
In order to determine the effects of dietary magnesium 
deficiency, dietary copper deficiency, and a combined 
magnesium and copper deficiency on immune function, this 
study was divided into three experiments. First, the general 
protocol and analytic methods followed for all experiments 
will be discussed. Then, the procedures unique to each 
experiment will be detailed.
General Animal Management Procedures 
Male Sprague Dawley rats with an initial weight of 
approximately 100 gm were used for each experiment. The rats 
were individually housed in stainless-steel, wire-bottom 
cages. A 12/12 hour light/dark cycle was maintained 
throughout the experiments. The rats received a commercial 
diet for one week after shipping to adjust to the new 
environment. Rats then were randomly assigned to treatment 
diets as described for each experiment.
Purified diets were prepared to be adequate in all 
nutrients, except for magnesium and copper, based on 
recommendations of the American Institute of Nutrition 
(1977). Composition of the basal diet is shown in Table 1. 
Appropriate amounts of magnesium and copper were added for 
each experiment based on requirements set by the National
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Table 1. Basal diet formulation based on the AIN-76a diet 
recommendations.
Composition percent
Casein, purified high nitrogen 2 0 . 0
DL-Methionine 0.3
Corn starch 32.5
Sucrose 32.5
Non-nutritive fiber 5.0
Corn oil 5.0
AIN custom mineral mixb 3.5
AIN 76A vitamin mixc 1 . 0
Choline bitartrate 0 . 2
BHT (0.015% of oil)
aAmerican Institute of Nutrition (1977)
bcomposition: calcium phosphate (500.00 gm/kg of mixture), 
sodium chloride (74.00 gm/kg), potassium citrate (220.00 
gm/kg), potassium sulfate (52.00 gm/kg), magnesium oxide 
(24.00 gm/kg for adequate diets), manganous carbonate (3.50 
gm/kg), ferric citrate (6 . 0 0  gm/kg), zinc carbonate (1.60 
gm/kg), cupric carbonate (0.30 gm/kg for adequate diets), 
potassium iodate (0 . 0 1  gm/kg), sodium selenite (0 . 0 1  
gm/kg), chromium potassium sulfate (0.55 gm/kg), sucrose 
(118.00 gm/kg).
ccomposition: thiamine HC1 (600.0 mg/kg mixture), riboflavin 
(600.0 mg/kg), pyridoxine HC1 (700.0 mg/kg), nicotinic acid 
(3.0 gm/kg), D-calcium pantothenate (1.6 gm/kg), folic acid 
(200.0 mg/kg), D-biotin (20.0 mg/kg), cyanocobalamin (1.0 
mg/kg), retinyl palmitate, 250,000 IU/gm (1.6 gm/kg), 
DL-alpha-tocopheryl acetate, 250 IU/gm (20.0 gm/kg), 
cholecalciferol, 400,000 IU/gm (2.5 mg/kg), menaquinone 
(500 ug/kg), sucrose (972.9 gm/kg).
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Research Council (1978). The diets were prepared in 5 kg 
batches at the start of each experiment and stored in 
sealed, black plastic bags.
The powdered diets were placed in special feeders to 
minimize spillage during consumption. The feeders consisted 
of small glass jars secured to saucers to prevent tipping 
and to catch spilled feed. Openings in the jar lids were cut 
so that the rats could reach into the jar to eat, but not be 
able to scoop out the feed.
The feed and deionized water were provided ad libitum 
except to rats in the pair-fed groups. The rats were fed 
every other day and the amount fed was recorded. After two 
days, the remaining feed was weighed and the amount of food 
consumed was calculated. Rats in the pair-fed groups were 
fed daily, and consumption was recorded daily.
On the first day of each experiment, two rats per 
treatment group were weighed, a blood sample was obtained, 
and the rats were placed on the test diet. On each of the 
following three or four days, two rats per treatment were 
started on the experiment. All succeeding sampling was 
maintained on the same daily schedule. This schedule was 
maintained because a maximum of six samples per day could be 
evaluated with the cellular immunology and phagocytic 
function assays. Experimental error due to sampling days was 
then considered in the statistical analysis.
At two-week intervals, the rats were weighed and blood 
samples were obtained to monitor the nutritional status. The
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rats were anesthetized with an intramuscular injection of a 
1:10 dilution of Innovar-VetR (Pitman-Moore, Inc.,
Washington Crossing, NJ), at a dosage of 0.1 ml/100 gm body 
weight. Blood samples were obtained by cardiac puncture, and 
were collected in syringes with preservative-free sodium 
heparin, 10 U/ml blood (Sigma Chemical Co., St. Louis, MO).
At the midpoint of each experiment, half of the rats in 
each treatment group were euthanized, while the remaining 
rats were euthanized at eight weeks. Blood samples were 
obtained at the time of euthanasia for nutritional and 
immunological analyses. The spleen and thymus from all rats 
were removed and weighed.
The nutritional status of the rats was monitored by 
weight gain and feed efficiency, hematocrit and hemoglobin 
concentration, plasma magnesium or copper concentration, and 
bone magnesium or liver copper concentration.
The immune profile included cellular, humoral, and 
phagocytic analyses. Cellular immunity was assessed by total 
and differential counts of white blood cells, T- and B-cell 
quantitation, and lymphocyte stimulation tests. Humoral 
immunity was assessed by antibody response to heterologous 
red blood cells, IgM and IgG quantitation, and serum 
electrophoresis. Bacterial phagocytosis and killing by 
neutrophils also were included in the immunological 
analyses.
In addition to determination of the nutritional status 
and immune function, blood samples from rats consuming the
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copper deficient or combined magnesium and copper deficient 
test diets were analyzed for the enzymes ceruloplasmin, 
erythrocyte catalase, superoxide dismutase, and 
myeloperoxidase.
General Analytical Methods 
Nutritional Assessment 
Whole blood samples collected every two weeks were used 
to determine hematocrit and hemoglobin (Hemoglobinometer, 
Coulter Electronics, Inc., Hialeah, F L). The samples then 
were centrifuged to collect the plasma which was frozen at 
0°C until mineral analyses were conducted. Plasma magnesium 
and copper determinations were made by atomic absorption 
spectroscopy with an air-acetylene flame (Perkin-Elmer, 
Norwalk, C N ).
Plasma was diluted 1:40 with distilled water for 
magnesium determinations. Standard magnesium solutions were 
prepared in distilled water to contain 1, 2 and 3 ug 
magnesium/ml, then were diluted 1:40 to obtain a standard 
curve. Standards and samples were aspirated and read in 
triplicate at a wavelength of 285.2 nm.
Plasma for the copper determinations was diluted 1:1 
with distilled water. Standard copper solutions were 
prepared in distilled water to contain 0.5, 1.0 and 2.0 ug 
copper/ml, then were diluted 1 : 1  with 1 0 % glycerol to match 
the viscosity of the plasma. Due to the small amount of 
plasma available for copper analysis, a Teflon sampling cup
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was used for aspirating 1 0 0  ul of the standards and samples 
(Manning, 1975). Readings were made in triplicate at a 
wavelength of 324.8 nm.
Immunological Assessments 
Tests for immune function were conducted on samples 
collected at the midpoint and the final weeks of each 
experiment. The rats were anesthetized with Innovar-Vet*, 
and 5 to 7 ml blood was collected by cardiac puncture in 
preservative-free heparinized syringes. The rats then were 
euthanized with pentobarbitol. The spleen and thymus were 
removed and weighed.
For each rat, the blood sample was divided as follows: 
two 2 ml samples were placed into sterile capped polystyrene 
tubes for immunological assays, and 1 to 2 ml samples were 
used for nutritional analyses as previously described. Total 
white blood cell counts were obtained with a semi-automated 
cell counter (Coulter Counter, Coulter Electronics, Inc., 
Hialeah, FL). Blood smears for the differential counts were 
prepared using a modification of the Wright’s stain 
technique (LeukoStat, Fisher Diagnostics, Orangeburg, NY).
Cell Separation Technique
The immunologic samples were certrifuged at 680 x g for 
1 0 minutes, and the plasma was removed and refrigerated for 
use in the humoral assays. The cells were resuspended with 
0.9% saline to 20 ml volumes, layered on 3 ml ficoll, sodium
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diatrizoate, 1.077 gm/ml (Ficoll HistopaqueR-1077, Sigma 
Chemical Co., St. Louis, MO) in conical polystyrene tubes, 
and centrifuged at 410 x g for 30 minutes at room 
temperature. The saline-ficoll interface layer containing 
the lymphocytes was collected for the cellular assays.
The red blood cell pellet, containing the neutrophils, 
was resuspended with 8 ml 0.9% saline and layered on 4 ml 
colloidal PVP coated silica, 1.087 gm/ml (PercollR , Sigma 
Chemical Co., St. Louis, MO) in polystyrene tubes. After 
centrifugation at 410 x g for 15 minutes at room 
temperature, the neutrophils were withdrawn at the saline- 
Percoll interface for the phagocytic assay.
Cellular Assays
The methods for assessing cellular immunity were 
conducted at the midpoint and final weeks of each 
experiment. Total and differential white blood cell counts 
also were determined from samples collected at the 
initiation of the experiment to provide baseline data. The 
lymphocytes collected after Ficoll gradient separation (See: 
Cell Separation Technique) were used for T- and B- cell 
quantitation and mitogen stimulation.
T- and B-cell Quantitation
Surface marker assays were used to quantitate T- and B- 
cells (Lo and McClure, 1984). T cells were identified by 
Arachis hypogaea peanut agglutinin (PNA) conjugated to
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fluorescein (FITC), which bound to D-galactose on the cell 
surfaces. B cells were identified by an anti-rat Ig-FITC 
conjugate.
The isolated lymphocytes (See: Cell Separation 
Technique) were washed in 20 ml calcium and magnesium free 
(CMF) Hanks balanced salt solution, pH 7.4, (GIBCO 
Laboratories, Grand Island, NY), and centrifuged at 280 x g 
for 10 minutes. This procedure was repeated three times. The 
supernatant was removed, and 1.5 ml of RPMI-1640 medium 
(GIBCO Laboratories, Grand Island, NY) and 0.5 ml fetal calf 
serum (FCS) were added to the cell pellet. To label 
phagocytic cells, 1 0 0  ul of a 1% suspension of latex beads 
(75 um in diameter) was added and thoroughly mixed. The 
cell-latex suspension then was incubated in a 37°C water 
bath for 30 minutes, and mixed at 10 minute intervals.
After incubation, the cell-latex suspension was layered 
over 1 ml FCS, centrifuged at 210 x g for five minutes, and 
the supernatant was removed. The cell pellet was resuspended 
in 2 ml phosphate buffered saline (PBS), pH 7.4, with 
5% FCS, layered over 1 ml FCS, and centrifuged at 210 x g 
for five minutes. The supernatant was removed, 1 ml RPMI was 
added to the cell pellet, and the cells were counted and 
adjusted to a concentration of 1 x 107 cells/ml with RPMI.
An aliquot of cells was stained with PNA-FITC (EY 
Laboratories, San Mateo, CA), while a separate aliquot of 
cells was stained with goat anti-rat IgG-FITC 
(CopperBiomedical, Inc., West Chester, PA).
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A 1:2 dilution of the PNA-FITC conjugate was prepared 
with PBS containing 0.02% sodium azide, and 0.1 ml was added 
to 0.3 ml of the cell suspension (3 x 106 cells). The 
mixture was incubated at 4°C for 30 minutes. One ml PBS 
solution containing 0.02% sodium azide and 5% FCS was added, 
mixed, and then centrifuged at 500 x g for five minutes. The 
supernatant was removed, and the previous wash was repeated.
Next, the cell pellet was resuspended in 100 ul of the 
PBS, 0.02% sodium azide, 5% FCS solution, and was kept at 
4° C in the dark until viewed and counted under a fluorescent 
microscope. A total of 200 latex-negative mononuclear cells 
were counted. Each field was examined using alternating 
bright-field and fluorescent microscopy with a Leitz Dialux 
phase contrast and epiiluminescence microscope, H 2 filter 
package (Dolen, Scientific, Houston, TX). The fluorescent- 
positive cells were considered T cells, and were expressed 
as percent of total cells counted.
To the other 0.3 ml aliquot of cells (3 x 10® cells), 
0.1 ml goat anti-rat IgG-F(ab’ )2 FITC conjugate was added. 
The conjugate was diluted 1:8 with PBS containing .0.02% 
sodium azide. The dilution was determined previously, and 
was two dilutions below that at which the number of 
fluorescent cells began to decrease. The cell mixture was 
incubated, washed, and counted as described above for the 
PNA procedure. Latex-negative, fluorescent-positive cells 
were considered B cells.
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Lymphocyte Stimulation
Lymphocyte proliferation was analyzed using mitogen 
stimulation, and was quantitated by measuring thymidine 
incorporation into DNA (Barta, et a l ., 1984a). Peripheral 
blood lymphocytes were treated with the following mitogens: 
phytohemagglutinin (PHA), an effector T cell mitogen; 
Concanavalin A (Con A), a suppressor T cell mitogen; and 
pokeweed mitogen (PWM), a general T- and B cell mitogen.
The isolated lymphocytes (See: Cell Separation 
Technique) were washed in 20 ml calcium and magnesium free 
(CMF) Hanks balanced salt solution, pH 7.4, (GIBCO 
Laboratories, Grand Island, NY), and centrifuged at 280 x g 
for 10 minutes. This procedure was repeated three times. The 
supernatant was removed, 1 ml RPMI-1640 medium (GIBCO 
Laboratorie, Grand Island, NY) was added to the cell pellet, 
and the cells were counted and adjusted to a concentration 
of 1 x 107 cells/ml with RPMI.
Lymphocyte cultures were prepared in sterile multi-well 
flat-bottom microtiter plates. Each well received 100 ul of 
20% fetal calf serum in RPMI medium, and 100 ul of the 
lymphocyte suspension. Three ug of PHA, Con A, or PWM were 
added to selected wells, while control cultures received no 
mitogen. Cultures were prepared in triplicate. The plates 
were covered and incubated for 72 hours at 37°C in a 
humidified atmosphere containing 5% CO2 .
One uCi [3 H]thymidine (6.7 mCi/mmole) in RPMI was added 
to each well for the last 16 hours of the 72-hour incubation
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period. The samples were harvested onto glass filters using 
a multisample harvester. The filters were dried, then placed 
into scintillation vials. Two ml of scintillation cocktail 
were added to each vial. The samples were counted in a beta- 
scintillation counter <Tricarb 4640, Packard Instrument Co., 
Downers Grove, IL). The results were reported as counts per 
minute (CPM) and as a stimulation index (SI). The SI was 
calculated as the CPM of cultures with mitogen/CPM of 
cultures without mitogen.
Humoral Assays
Plasma samples obtained before the rats were placed on 
the test diets were used to assess humoral immunity. Then, 
the same procedures were used on the plasma samples from the 
rats euthanized at either the midpoint or at the end of the 
experiment. All plasma samples were refrigerated until 
assayed. Initial samples provided a baseline measure of 
immunoglobulin status before antigen challenge. The rats 
were immunized with a photometrically standardized 0.5% 
suspension of washed sheep red blood cells (sRBC) six days 
prior to euthanasia (Garvey, et a l ., 1977). A single 
intraperitoneal injection was given at 0.1 ml/25 gm body 
weight.
Antibody Response
Antibody response was measured by a hemagglutination 
technique (Garvey, et a l ., 1977), using a 1% suspension of
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sRBC. All plasma samples were heated for 30 minutes in a 
56°C water bath to inactivate complement. To each well in a 
multi-well round-bottom plate, 50 ul phosphate diluent,
0.11 M NafoPO4 -NagHPO* with 0.2% w/v gelatin, pH 7.4, was 
added.
Next, to the first well, 50 ul of either undiluted 
plasma of prechallenge samples or 1:5 diluted plasma of 
postchallenge samples was added. The samples were serially- 
diluted 2-fold to a 1:256 dilution for prechallenge samples 
and 1:640 for postchallenge samples. Fifty ul phosphate 
diluent plus 25 ul sRBC suspension were added to each well. 
The plates were sealed and then incubated at 37°C overnight.
The samples were observed for agglutination, and titers 
were recorded. Titer was determined as the reciprocal of the 
greatest dilution of plasma where agglutination was 
observed. When the titers of postchallenge samples were less 
than 1 0 , the assay was repeated using undiluted samples.
IgG and IgM Quantitation
IgG and IgM were quantitated by rocket 
immunoelectrophoresis (Barta, et a l ., 1984), a technique 
based on antigen-antibody precipitation. During 
electrophoresis, the rat immunoglobulins migrated through a 
gel containing goat anti-rat IgG or IgM antisera. 
Precipitation occurred at the point of optimal antigen- 
antibody proportions. The area of the rocket-shaped
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precipitate was quantitated by comparison with standard 
solutions of rat immunoglobulin.
A 1% agarose gel was prepared by dissolving 1 gm 
agarose, Type 1 low EEO, (Sigma Chemical Co., St. Louis, MO) 
in 100 ml 0.015 M barbital buffer, pH 8 .6 , conductivity 
0.86 m S , and was refrigerated until needed. GelBond™ film 
(FMC BioProducts, Rockland, ME) was cut into a plate size of 
8 x 20.5 cm and placed elevated on a leveling table.
Volumes of agarose gel, 1.3 ml/cm width for IgG assays 
and 1 .8 ml/cm width for IgM, were warmed as needed in a 56°C 
water bath. Undiluted antiserum, 160 ul goat anti-rat IgG or 
360 ul goat anti-rat IgM (Cappel Laboratories, 
CopperBiomedical, Inc., Malverin, PA), was gently mixed into 
the gel and carefully poured on the GelBond™ film. The film 
was allowed to set 40 minutes, and was kept in a humid 
chamber until used.
Wells were punched into the gel film allowing for an 
8 mm distance between the centers. Well sizes used were 2 mm 
for IgG determination and 3 mm for IgM. The BioRad (model 
1400) gel electrophoresis horizontal buffer chambers were 
filled with 0.025 M barbital buffer, pH 8 .6 , conductivity 
1.32 m S , and the cooling system was set to maintain 17°C.
The gel plate was placed on the cooling plate with the wells 
nearer the cathode. Four layers of #2 Whatman filter paper 
were placed on each side of the gel film and into the 
buffer.
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Rat IgG standards (Pel-Freez Biologicals, Rogers, AR) 
or IgM standards (Calbiochem Biochemicals, San Diego, CA) 
and the samples were added to the wells. The voltage was 
applied and maintained at 7 volts per centimeter (28 volts 
total) for three hours. After electrophoresis, the film was 
removed, covered with filter papers, and pressed overnight.
The film then was washed in 0.3 M NaCl for 30 minutes, 
followed by 0.15 M NaCl for 30 minutes. The film was pressed 
under filter papers for 15 minutes, then rinsed with 
distilled water, and allowed to dry in a 60° C oven. The 
precipitated proteins were fixed for 1 0 minutes in a freshly 
prepared destain solution consisting of 90 ml methanol,
90 ml distilled water, and 20 ml acetic acid. The proteins 
then were stained using Coomassie blue (Sigma Chemical Co., 
St. Louis, MO) for 20 minutes, followed by successive 
destaining until the film background was clear.
The stained "rockets" were enlarged on a projection 
screen and traced onto paper. The areas were measured using 
a planimeter, and the concentrations of immunoglobulin in 
the samples were determined from the standard curve obtained 
from the known concentrations of IgG or IgM.
Electrophoresis
Plasma alpha, beta, and gamma globulins were 
quantitated by cellulose acetate electrophoresis (Barta and 
Pourciau, 1984). A Tris-barbital, sodium barbital buffer 
(ElectraR HR buffer, Helena Laboratories, Beaumont, T X ),
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pH 8 .8 , ionic strength 0.05, was prepared. Cellulose acetate 
plates were soaked in buffer for 20 minutes. The 
electrophoresis chamber was prepared by pouring 50 ml buffer 
into each outer compartment. Paper wicks were wetted in the' 
buffer, then draped over the support bridges.
Sample well plates were filled with 6 ul of sample, and 
then covered with a glass slide. A saturated cellulose 
acetate plate was removed from the buffer, blotted, and 
placed on an aligning base. The samples were applied to the 
cellulose acetate plate using a sample applicator. The plate 
then was placed on the wicks in the chamber, and 
electrophoresed at 180 volts for 15 minutes.
The cellulose acetate strips were stained in 
0.5% Ponceau-S (Helena Laboratories, Beaumont, TX) in 
7.5% trichloroacetic acid for six minutes and destained 
three times in 5% acetic acid washes. The strips were 
blotted and dehydrated in methanol for 1 0  minutes.
Next, the strips were soaked for five minutes in a 
freshly prepared clearing solution consisting of 15 ml 
glacial acetic acid, 35 ml anhydrous methanol, and 2 ml 
polyethylene glycol. The strips were dried in a 60°C oven 
until clear. The strips were scanned in a densitometer 
(Quick Scan, Helena Laboratories, Beaumont, TX) at 525 nm to 
determine the percentage of individual proteins. The 
concentrations of the plasma proteins were calculated from 
total protein determined by the Lowry procedure (Lowry, et 
al., 1951).
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Phagocytic Assay
Bacterial phagocytosis and killing were evaluated on 
neutrophils with a method that utilized an acridine orange 
(AO) stain (Smith and Rommel, 1977; Enright and Jeffers, 
1984). The technique allowed phagocytic and bactericidal 
activity to occur in a suspension of neutrophils and 
bacteria. After staining with AO, the neutrophils were 
observed under a fluorescent microscope. AO would combine 
with DNA and fluorese green, and with RNA or denatured DNA 
and fluorese red. Thus, viable phagocytized bacteria emitted 
green, while killed bacteria appeared red.
The neutrophils collected after PercollR separation 
(See: Cell Separation Technique) were washed twice with 
0.9% saline in polypropylene conical tubes, and then 
resuspended in 1 ml Dulbeccos phosphate buffered saline 
(DPBS), pH 7.4 (GIBCO Laboratories, Grand Island, NY). 
Neutrophils were counted in a hemocytometer and adjusted to 
a concentration of 1 x 10® cells/ml with DPBS. Cell 
viability was checked using trypan blue exclusion, and 
usually was greater than 95%.
Fresh E. coli cultures incubated at 37°C overnight on 
nutrient agar plates were harvested with DPBS, and washed 
two times. The cells were resuspended in DPBS to a 
concentration of 1 x 1 0 s cells/ml, determined 
spectrophotometrically at 650 nm with an absorbance of 
0.250, then were diluted for a final concentration of 
1 x 1 0 7 cells/ml.
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Equal volumes (0.5 ml) of the neutrophil and bacteria 
suspensions were combined in polypropylene test tubes, and 
incubated in a 37°C shaker water bath for 90 minutes. After 
incubation, 400 ul of cool 0.014% acridine orange was added 
to each sample, gently mixed, and allowed to stand at room 
temperature for one minute. The samples were centrifuged at 
200 x g for five minutes. The supernatant was discarded, and 
the pellets were resuspended in 100 ul DPBS.
Phagocytosis and killing were examined on a Zeiss epi- 
fluorescent, darkfield microscope, 100-watt Halogen 
illumination, FITC filter package (#48 77 09). A total of 
200 neutrophils were counted, and were classified as:
1) without ingested E. coli; 2) phagocytized E. coli, but 
did not kill; or 3) phagocytized and killed E. coli. Results 
were expressed as percentages for each classification.
Procedures Unique to Each Experiment 
Experiment 1: Magnesium Deficiencies
Forty male Sprague Dawley rats, 145 gm initial weight, 
were used in the experiment designed to determine the 
effects of dietary magnesium deficiency on immune function. 
Four levels of magnesium were used to achieve: 1) an 
adequate level of 400 ug/gm of the diet; 2) a mild 
deficiency of 280 ug/gm; 3) a moderate deficiency of 
160 ug/gm; and 4) a severe deficiency of 50 ug/gm. Magnesium 
oxide was added to the mineral mixture, as listed in Table 2 
to achieve these levels. Actual magnesium concentrations
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Table 2. Magnesium concentration of each diet treatment in 
Experiment 1.
Target diet 
(ug Mg/gm)
MgO added3 
(mg/kg of total feed)
Actual diet 
(ug Mg/gm)
400 618.4 392.7
280 419.2 249.8
160 220.0 140.8
50 37.4 58.9
aThe basal diet without magnesium in the mineral mixture 
contained 27.5 ug magnesium/gm diet. MgO was added to the 
mineral mixture, which then was mixed with the other feed 
ingredients.
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of the total feed mixtures were determined by atomic 
absorption spectroscopy following nitric acid digestion.
Eight rats were randomly assigned to each treatment 
group. A fifth treatment group consisted of eight rats that 
consumed the 400 ug magnesium/gm diet, but were pair fed to 
the rats consuming the 50 ug magnesium/gm diet. The amount 
of feed consumed by each rat on the 50 ug magnesium/gm diet 
was recorded on a daily basis and that amount was fed the 
following day to its paired mate in the 400 ug magnesium/gm 
pair-fed treatment group.
All rats were weighed, and blood samples were obtained 
before being placed on the treatments, and at week two. Four 
rats from each treatment were euthanized at week three. The 
remaining rats were weighed and bled at week four and week 
six, and then were euthanized at week eight. At the time of 
euthanasia, samples were obtained from all rats as described 
in the General Animal Management Procedures section. 
Moreover, the femur was removed and frozen until analyzed 
for bone magnesium content. Nutritional and immunological 
assessments were conducted, as described in the General 
Analytical Methods section.
Bone Magnesium Assay
Bone magnesium in femur diaphyseal sections was 
analyzed as described by Hunt (1969). The bones were cleaned 
of all adhering tissue and split longitudinally. The bone 
marrow was removed, and each fragment was cleaned with
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0.9% saline. The bone fragments were immersed in ether for 
1 0 minutes, then allowed to stand at room temperature for 1 0  
minutes. The wet weight of the bone was recorded. The bone 
fragments were dried at 90°C to a constant weight. After 
cooling in a dessicator, the dry weight was recorded.
The bones were ashed in a muffle furnace for 16 hours 
at 600°C. After removal from the furnace, 2 ml 5 N HC1 were 
added to each sample and heated until the bone dissolved. 
Bone samples were diluted 1:2500 with 0.5% lanthanum 
chloride in distilled water. Magnesium concentrations were 
determined by atomic absorption spectroscopy.
Experiment 2: Copper Deficiencies 
Fifty male Sprague Dawley rats, 100 gm initial weight, 
were used in the experiment designed to determine the 
effects of dietary copper deficiency on immune function.
Four levels of copper were used to achieve: 1) an adequate 
level of 5.0 ug/gm of the diet; 2) a mild deficiency of 
3.5 ug/gm; 3) a moderate deficiency of 2.0 ug/gm; 4) and a 
severe deficiency of 0.5 ug/gm.
Mineral mixtures were prepared (ICN Nutritional 
Biochemicals, Cleveland, OH) to contain copper at the 
following levels: 126 ug/gm, 83 ug/gm, 40 ug/gm, and 
0 ug/gm; and were added to the feed mixtures, as listed in 
Table 3. Actual copper levels of the feed mixtures were 
determined by atomic absorption spectroscopy following 
nitric acid digestion.
65
Table 3. Copper concentration of each diet treatment in 
Experiment 2.
Target diet 
(ug Cu/gm)
Cupric carbonate® 
(mg/gm of mineral mix)
Actual diet 
(ug Cu/gm)
5.0 126 5.20
3.5 83 3.72
2 . 0 40 2 . 1 0
0.5 0 0.59
“The basal diet without copper in the mineral mixture 
contained 0.5 ug copper/gm diet. The custom mineral 
mixtures were 3.5% of the diet.
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Ten rats were randomly assigned to each treatment 
group. A fifth treatment group consisted of 10 rats that 
consumed the 5.0 ug copper/gm diet, but were pair fed to the 
rats consuming the 0.5 ug copper/gm diet. The amount of feed 
consumed by each rat on the 0.5 ug copper/gm diet was 
recorded on a daily basis and that amount was fed the 
following day to its paired mate in the 5.0 ug copper/gm 
pair-fed treatment group.
Several rats in the treatment group with 0.5 ug 
copper/gm died during the experiment, so their paired mates 
in the 5.0 ug copper/gm treatment group were then fed the 
average amount of feed consumed by the remaining rats in the 
0.5 ug copper/gm treatment group.
All rats were weighed and blood samples were obtained 
before being placed on the diets and at week two. Five rats 
from each treatment were weighed and euthanized at week 
four. The remaining rats were weighed and bled at week four, 
and at week six. Rats on the 0.5 ug copper/gm diet were not 
bled at this time because unexpected deaths occurred at week 
four from the cardiac puncture.
The rats were euthanized at week eight. At the time of 
euthanasia, samples were obtained from all rats, as 
described in the General Animal Management Procedures 
section. Moreover, the liver was removed, weighed, and 
frozen until analyzed for copper content. Nutritional and 
immunological assessments were conducted, as described in 
the General Analytical Methods section.
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Ceruloplasmin (Cp) was assessed as an additional 
parameter of copper status for all rats. The effect of Cp's 
ferroxidase activity on iron status then was monitored by 
erythrocyte catalase activity at four and eight weeks. 
Lastly, the effect of copper status on neutrophil superoxide 
dismutase (SOD) and myeloperoxidase (MPO) were studied.
These two enzymes are involved in the bactericidal activity 
of neutrophils. Measurements were performed on the enzymes 
from neutrophils separated during the phagocytic assay.
Liver Copper Assay
A wet nitric acid technique was used to digest liver 
samples (Carthew and Dey, 1985). Approximately 1 gm liver 
samples were weighed and placed into Teflon digestion vials 
with 3 ml of 8 M nitric acid. The capped vials were 
incubated in a 90°C water bath for 45 minutes, cooled, and 
transferred to test tubes. Loss of volume due to evaporation 
was negligible. After cooling, fat particles that rose to 
the top were removed by pipet. The clear solution then was 
diluted 1 : 2  with distilled water for a final dilution of 
1 :6 , and copper concentrations were determined by atomic 
absorption spectroscopy.
Ceruloplasmin
Ceruloplasmin (Cp) activity was determined 
spectrophotometrically, as described by Lehman et a l .
(1974), using o-dianisidine as the substrate. Plasma samples
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were frozen at 0°C until assayed. Two test tubes per sample, 
containing 0.7 ml of 0.1 M acetate buffer, pH 5.0, and 
0.05 ml of plasma, were incubated in a shaking water bath at 
30°C. To each tube, 0.2 ml o-dianisidine reagent
(250 mg/100 ml) was added.
For one set of samples, the reaction was stopped after
five minutes by the addition of 2 ml of 9 M sulfuric acid,
while the reaction in the second set of samples was stopped 
after 15 minutes. The absorbances were measured at 540 nm 
and enzyme activity was calculated from the formula:
(Ais - A s ) x 6.25 x 102 mU/ml, 
where Ai 5 is the absorbance after 15 minutes and As is the 
absorbance after five minutes.
Erythrocyte Catalase
Whole blood samples obtained from the rats euthanized 
at the midpoint and at the end of the experiment were 
measured for catalase activity. The blood samples were 
refrigerated at 4°C until assayed within seven days of 
collection. The procedure (Aebi, 1984; Aebi and Suter, 1969) 
followed the decomposition of hydrogen peroxide by catalase 
spectrophotometrically in the ultraviolet range.
Two ml whole blood samples were centrifuged, then the 
plasma and white cell layer were removed. The red cells were 
washed twice in 0.9% saline, then a stock hemolysate of each 
sample was prepared using 0.5 ml packed cells and 1 ml 
distilled water. The hemoglobin content of the stock
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hemolysate was determined in duplicate (Total Hemoglobin 
Procedure No. 525, Sigma Diagnostics, St. Louis, MO) based 
on the method by Drabkin and Austin (1935).
Immediately before the catalase assay was performed on 
each sample, a 1 : 1 0 0 0  dilution was made of the stock 
hemolysate with 50 mM phosphate buffer, pH 7.0. The sample 
cuvette containing 1 ml of diluted hemolysate, and 1 ml 
phosphate buffer was read at a wavelength of 240 nm against 
a control cuvette containing 1 ml of diluted hemolysate,
1 ml phosphate buffer and 1 ml distilled water. The reaction 
was started in the sample cuvette with the addition of 1 ml 
30 mM hydrogen peroxide. The decrease in absorbance from an 
approximate initial absorbance of 0.500 was recorded for a 
15-second time interval.
The rate constant (k) related to the hemoglobin (Hb) 
content served as the measurement of erythrocyte catalase 
activity. Therefore, the activity was calculated with the 
formula:
k/gm Hb = (2.3/15 sec)(a/b)(log Ai/ ) ,  
where a is the dilution factor, b is the Hb content of the 
hemolysate in gm/1, Ai is the absorbance at time = 0, and Aa 
is the absorbance at time = 15 seconds.
Superoxide Dismutase
For the SOD assay, isolated neutrophils (See: Cell 
Separation Technique, General Analytical Methods section) 
were suspended in DPBS at a concentration of 1 x 106
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cells/ml, were frozen and thawed three times, then were 
sonicated 10 seconds in an ice bath to disrupt the cell 
membranes. The samples were centrifuged at 13,000 x g in a 
microcentrifuge for 15 minutes. The supernatant was assayed 
which contained the cuprozinc SOD from the cytosol fraction 
(Salin and McCord, 1974).
The ferricytochrome c reduction assay developed by 
McCord and Fridovich (1969) was used in which a xanthine- 
xanthine oxidase system was utilized as a source for the 
free radical O2 • - . The reduction rate of cytochrome c was 
spectrophotometrically monitored as SOD competed for the 
superoxide radicals.
The procedure (Flohe and Otting, 1984) with 
modifications to increase sensitivity (Salin and McCord,
1974) defined one unit of SOD as that amount of enzyme 
required to inhibit the rate of cytochrome c reduction by 50 
percent. A standard calibration curve was obtained using 
purified bovine superoxide dismutase (Sigma Chemical Co.,
St. Louis, MO) with SOD standard concentrations plotted 
against the reciprocal absorbance change per minute of 
cytochrome c reduction.
Two solutions were prepared for the assay as follows: 
Solution A was made by mixing 0.76 mg of 5 uM xanthine and 
6.2 mg of 0.5 uM cytochrome c into 10 ml of 0.001 N NaOH, 
which then was added to 100 ml 20 mM sodium carbonate, 
pH 10.0, containing 0.1 mM EDTA. Solution B was a freshly 
prepared solution of xanthine oxidase in 0.1 mM EDTA, with
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approximately 0.2 U/ml. The SOD standard or sample 
supernatant (100 u l ) was added to 2.8 ml Solution A. The 
addition of 100 ul Solution B started the reaction and the 
change in absorbance per minute was recorded at 418 nm.
To obtain a measurement of the cuprozinc SOD in the 
samples, which also contained some mangano-SOD, 1 mM sodium 
cyanide (10 u l ) was added to the reaction mixture (Beauchamp 
and Fridovich, 1973). The cuprozinc enzyme was inhibited by 
the cyanide. Therefore, the cuprozinc SOD was calculated 
from the total SOD measured without cyanide minus the 
manganoenzyme measured with cyanide.
Myeloperoxidase
Myeloperoxidase (MPO) also was measured in the 
neutrophils collected from the rats euthanized at the 
midpoint and at the end of the experiment. The isolated 
cells were suspended at a concentration of 1 x 106 cells/ml 
in a solution containing 0.5% hexadecyltrimethylammonium 
bromide (HTAB) in 50 mM potassium phosphate buffer, pH 6.0. 
The cells were sonicated for 10 seconds in an ice bath, 
freeze-thawed three times, then sonicated again. The samples 
were centrifuged at 13,000 x g in a microcentrifuge for 15 
minutes, and the supernatant was used for the assay.
MPO activity was determined spectrophotometrically 
using o-dianisidine as the substrate (Bradley, et a l .,
1982a; 1982b). The assay solution consisted of 50 mM
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phosphate buffer, pH 6.0, containing 0.167 mg/ml o- 
dianisidine dihydrochloride and 0.0005% hydrogen peroxide.
The supernatant from each sample (0.1 ml) was added to 
2.9 ml assay solution, mixed, and the change in absorbance 
at 460 nm was measured for one minute. The amount which 
degraded one micromole peroxide per minute was defined as 
one unit MPO activity. Therefore, the activity was 
calculated as follows:
MPO x 10-7 U/neutrophil = A/3.76 x 10, 
where A is the change in absorbance per minute.
Experiment 3: Magnesium and Copper Deficiencies 
Sixty male Sprague Dawley rats, 100 gm initial weight, 
were used in the experiment designed to determine the 
effects of a combined dietary magnesium and copper 
deficiency on immune function. One treatment consisted of 
severely deficient levels of magnesium (50 ug/gm) and copper 
(0.5 ug/gm). The two marginal levels of magnesium, 160 ug/gm 
and 280 ug/gm, and the two marginal levels of copper,
2.0 ug/gm and 3.5 ug/gm, were combined in a 2 x 2 factorial 
arrangement. The control treatment consisted of adequate 
magnesium (400 ug/gm) and copper (5.0 ug/gm). Ten rats were 
randomly assigned to each treatment group.
Mineral mixtures without magnesium were prepared to 
contain copper at four levels: 126 ug/gm, 83 ug/gm,
40 ug/gm, and 0 ug/gm (ICN Nutritional Biochemicals, 
Cleveland, OH). Magnesium oxide was added to the mineral
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mixtures in the appropriate amounts. The mineral mixtures 
then were added to the feed mixtures, as listed in Table 4. 
Actual magnesium and copper levels of the total feed 
mixtures, determined by atomic absorption spectroscopy 
following nitric acid digestion also are listed in Table 4.
All rats were weighed and blood samples were obtained 
before being placed on the diets and at. week two. Five rats 
from each treatment were euthanized at week four. The 
remaining rats were weighed at weeks four and six, but due 
to unexpected mortality in the previous experiment with 
copper deficiencies, blood samples were not obtained. The 
rats were euthanized at week eight.
At the time of euthanasia, samples were obtained from 
all rats, as described in the General Animal Management 
Procedures section. Moreover, the femur and liver were 
collected and analyzed, as indicated in Experiments 1 and 2, 
respectively. Nutritional and immunological assessments were 
conducted (See: General Analytical Methods section). 
Catalase, Cp, SOD and MPO also were assessed which were 
outlined in the section for Experiment 2.
Statistical Analyses 
The nutritional data were analyzed as a split plot 
design. Dietary treatments were considered the whole plots 
while sampling time-periods were considered the subplots 
(Steel and Torrie, 1980). The whole plot error term was the 
variance among the rats within diets.
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Table 4. Magnesium and copper concentration of each diet 
treatment in Experiment 3.
Target diet 
(ug/gm)
Mineral added3 Actual diet 
(ug/gm)
Mg Cu Mgb Cuc Mg Cu
400 5.0 618.4 126 401.0 6.21
280 3.5 419.2 83 300.8 3.26
160 3.5 220.0 83 168.1 3.25
280 2.0 419.2 40 311.4 1.98
160 2.0 220.0 40 175.5 1.90
50 0.5 37.4 0 68.5 0. 33
a The basal diet without magnesium and copper in the mineral 
mixture contained 27.5 ug magnesium/gm diet and 0.5 ug 
copper/gm diet.
bMgO (mg/kg of total feed). MgO was added to the mineral 
mixture, which then was mixed with the other feed 
ingredients.
e CuCOa (mg/gm of mineral mix). The custom mineral mixtures 
were 3.5% of the diet.
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Data obtained at the midpoint and at the end of each 
experiment were analyzed as a completely randomized design 
with a factorial arrangement of treatments (diets x sampling 
time-periods). A randomized complete block design with a 
factorial arrangement of treatments was used for cellular 
immunologic and neutrophil function data. The blocks 
consisted of sampling days when data were collected from one 
rat per treatment per day. The pre-test data from the 
humoral assessments were included as covariates.
Additionally, mitogen stimulation responses and 
antibody responses were analyzed with regression analysis. 
Plasma mineral levels were the independent variable and 
immune responses were the dependent variable (Steel and 
Torrie, 1980).
The null hypotheses, that treatment means were equal, 
were tested at the 0.95 level of significance. When the null 
hypotheses were rejected, least square mean paired t-tests 
were used to test differences between the treatment means 
and the interaction means. When the null hypotheses were not 
rejected based on the F-tests, no further mean comparisons 
were made.
The analyses were conducted on the data using the 
general linear model procedure of the statistical analysis 
system (SAS, 1985).
In the next chapter the results of the three 
experiments will be presented, followed by Chapter 5 with a 
summary, discussion and conclusions based on the findings.
Chapter 4 
RESULTS
The rats in each experiment showed the characteristic 
clinical signs associated with copper and/or magnesium 
deficiencies. Immunological responses were varied, but some 
trends emerged according to nutritional status as affected 
by dietary copper or magnesium level. The results, based on 
least square means, will be reported for each experiment. 
Statistical significance was based on the analysis of 
variance computations, and the minimum significance was set 
at the 0.05 level.
The tables in this chapter show only the significant 
mean comparisons between the treatments and the controls. 
When the diet*week interactions in the analysis of variance 
were not significant, statistical differences were reported 
only for the main effect means. Information on mean 
comparisons among all treatments are located in the 
Appendix, with the summaries of the statistical models.
Experiment 1: Magnesium Deficiencies 
The rats were similar before the dietary treatments in 
weight (158.9 + 2.2 gm) , hemoglobin (13.5 + 0.2 gm/100 ml), 
hematocrit (37.8+0.4 percent), and plasma magnesium 
(2.19+0.04 mg/100 ml). Significant differences among the
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dietary treatments and the sampling time-periods then 
existed after the initiation of the treatments.
Clinical signs of magnesium deficiency began to appear 
in the rats consuming the low magnesium (50 ug/gm) diet two 
weeks into the study and remained. These included ulcerative 
lesions about the head and neck, a coarse hair coat, and 
skin necrosis. One rat in the 160 ug magnesium/gm treatment 
group died after heart puncture at week two of the 
experiment.
Nutritional Status 
During the eight-week time period of the experiment, 
plasma magnesium levels reflected the dietary levels of 
magnesium (P<0.001). Table 5 shows that rats on the 50 ug 
magnesium/gm diet had the lowest mean plasma magnesium, 
followed by rats on the 160 ug magnesium/gm diet, the 280 ug 
magnesium/gm diet, and the 400 ug magnesium/gm ad lib diet. 
Rats in the pair-fed treatment group had mean plasma 
magnesium levels similar to the control rats.
Plasma magnesium levels fell at two weeks for all rats, 
with the greatest decrease in the 50 ug magnesium/gm diet 
group. Plasma magnesium remained low throughout the study in 
that group of rats. Although the plasma magnesium 
concentrations for the rats in the 280 ug magnesium/gm diet 
group were lower than the controls, they were not 
significantly different. By eight weeks, the plasma 
magnesium concentration for the rats in the diet with
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Table 5. Least square mean plasma magnesium concentrations
(mg/100 ml) for each magnesium dietary treatment at each
sampling period (n=8).
Mg Diet 
ug/gm Initial 2
Sampling Week 
3 4 6 8
Mean
SE
50 2.12 0.57<= 0.57c 0.53c 0. 70c 0.65c
o 
o
O 
CO
 
n
160 2.12 1.51c 1.440 1 . 370 1.350 1.89 1 .63c 
0.09
280 2.17 1.84 1.72 1.98 1.69 2.25 1.94 
0.07
400, 
ad lib, 
control
2.26 2.02 2.05 2.03 1.97 2.11 2.07
0.07
400,
pair fed
2.30 1.92 1.93 1.80 2.04 2.17 2.03
0.07
Mean 2.19 1.57 1. 54 1.54 1.55 1.81
SE 0.04 0.04 0.06 0.06 0.06 0.06
a, different from control within each week (P<0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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160 ug magnesium/gm diet group also was not significantly 
different from that of the control animals.
The rats on the 50 ug magnesium/gm diet had a 
significantly lower mean hemoglobin concentration than the 
other treatment groups (Table 6). Hemoglobin values 
increased by the end of the eight-week time period for all 
rats, except those on the severely deficient diet. Similar 
results were found for the hematocrit, but the rats on the 
160 ug magnesium/gm diet were similar to the severely 
deficient rats (Table 7).
Growth of the rats differed according to the diets. As 
expected, the rats receiving the adequate level of magnesium 
ad lib had the highest mean weight (281.3^5.7 gm), followed 
by the rats on the marginal levels (273.0+.5.7 gm and 
272.0+6.7 gm), with the severely deficient rats having the 
smallest mean weight (244.0+J3.7 gm). The mean weight of the 
pair-fed rats (247.1±5.7 gm) matched that of their mates, 
illustrating the effect of restricted calories. The 
difference in weights occurred after the initiation of the 
treatments, and were statistically significant (P<0.001).
The trend in growth also was apparent when total weight 
gain was considered (Table 8). Rats consuming the adequate 
diet ad lib had the highest mean weight gain, followed by 
those on the 280 ug magnesium/gm diet and the 160 ug 
magnesium/gm diet, respectively. The smallest mean weight 
gain was for those on the 50 ug magnesium/gm diet. Pair-fed 
rats had a mean weight gain similar to their matched mates.
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Table 6. Least square mean hemoglobin (gm/100 ml) for each
magnesium dietary treatment at each sampling period (n=8).
Mg Diet 
ug/gm Initial 2
Sampling
3
; Week 
4 6 8
Mean
SE
50 13.1 14.7 15.6 13.3«> 16.4c 13. lc 14. 4C 
0.2
160 13.5 15.6 15.7 15.7 17.3c 14.6 15.4
0.3
280 13.6 15.7 14.9 16.6 17. 8*> 15.2 15.6
0.2
400, 
ad lib, 
control
13.5 15.3 14.3 15.5 20.3 15.9 15.8
0.2
400,
pair fed
13.6 16.1 14.6 15.7 18.3b 15.4 15.6
0.2
Mean 13.5 15.5 15.0 15.3 18.0 14.8
SE 0.2 0.2 0.3 0.3 0.3 0.3
a, different from control within each week (P<0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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Table 7. Least square mean hematocrit (%) for each magnesium
dietary treatment at each sampling period (n=8).
Mg Diet 
ug/gm Initial 2
Sampling Week 
3 4 6 8
Mean
SE
50 36.9 41.4 43.1 38.4 43.1° 38. 4b 40.2c
0.5
160 37.6 43.3 44.9 a 40.6 35. 9C 40.9 40.5»>
0.6
280 37.9 42.9 42.8 46.0a 45.3c 43.8 43.1 
0.5
400, 
ad lib, 
control
38.4 42.3 40.4 42. 1 51.3 43.8 43.0
0.5
400,
pair fed
38.0 43.5 40.8 43.5 47 .0* 43.3 42.7
0.5
Mean 37.8 42.7 42.4 42.1 44.5 42.0
SE 0.4 0.4 0.6 0.7 0.7 0.7
a, different from control within each week (PC0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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Table 8. Least square mean weight gain (gm), and feed
efficiency (gm weight gain/gm feed intake) for each
magnesium treatment at each sampling period (n=4).
3
Sampling Week
8
Mean
SE
Mg Diet 
ug/gm
weight
gain
feed 
eff.
weight
gain
feed
eff.
weight
gain
feed 
ef f .
50 82.0 0.21 153.8 0.16 117.9c 
• 8.7
0.18» 
0.01
160 90.8 0.20 201.3 0.20 146.0
9.4
0.20a
0.01
280 106.8 0.23 200.0 0.18 153.4
8.7
0.21
0.01
400, 
ad lib, 
control
129. 3 0.30 205. 3 0. 19 167.3
8.7
0.24
0.01
400,
pair fed
98.0 0.25 152.5 0.17 125.3» 
8.7
0.21
0.01
Mean 101.4 0.24 182.6 0.18
SE 5.5 0.01 5.7 0.01
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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When total feed intake was compared to total weight 
gain, differences among the treatment groups were found, as 
also shown in Table 8. Rats on the 50 ug magnesium/gm diet 
consumed the least amount of food and had low feed 
efficiency. Their pair-fed mates ate similar amounts of 
food, but their feed efficiency was higher. This indicated 
that the magnesium deficiency reduced weight gain not only 
by a decreased caloric intake, but also by a less efficient 
utilization of the feed.
The rats in the other groups consumed similar amounts 
of feed, with the rats in the adequate group having the 
highest feed efficiency. For all rats, feed efficiency was 
higher at three weeks than at eight weeks.
Bone magnesium was significantly altered by dietary 
magnesium as shown in Table 9. The amount of magnesium in 
the bone also highly correlated with plasma magnesium at 
three weeks (r=0.95, PC0.001), and at eight weeks (r=0.84, 
P<0.001). The severely deficient diet depleted bone 
magnesium stores to 58 percent of the adequate levels at 
three weeks, and to 40 percent at eight weeks (P<0.001).
The marginal diets slightly reduced bone magnesium. The 
levels at three weeks were similar for the 160 ug 
magnesium/gm diet and the 280 ug magnesium/gm diet. At eight 
weeks, the 160 ug magnesium/gm diet resulted in lower bone 
magnesium than the control diet. Both diets with adequate 
magnesium maintained bone magnesium stores throughout the 
study.
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Table 9. Least square mean bone magnesium (mg/gm bone, dry
weight) for each magnesium dietary treatment at each
sampling period (n=4).
Sampling Week
Mg Diet 
ug/gm 3 8
Mean
SE
50 2.79^ 1 .93c 2.36c
0.08
160 4.33 3.94c 4.13c 
0.08
280 4.47 4.59 4.53
0.08
400, 
ad lib, 
control
4.82 4.78 4.80
0.08
400,
pair fed
4.73 4.64 4.69
0.08
Mean 4.23 3.98
SE 0.05 0.05
a, different from control within each week (P<0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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Lymphoid Organs 
For comparative purposes, the spleen and thymus weights 
were expressed as a percent of total body weight (Table 10). 
Spleen weight negatively correlated with plasma magnesium at 
three weeks (r = -0.61, P<0.01) and at eight weeks (r = - 0 .78, 
P<0.001). The severely magnesium deficient rats had 
significantly enlarged spleens (P<0.001). Spleens were 
0.30+0.01 percent of the total body weight compared to 
controls at 0.21+_0.01 percent. Rats in all other treatment 
groups had spleens that were 0.20 + 0.01 percent of the total 
body weight. That percentage was higher at three weeks 
(0.24+0.01 percent), indicating a greater change in body 
weight than in spleen weight during the eight-week period.
Thymus weight was not significantly altered by dietary 
magnesium. Again, as total body weight increased, the 
percentage decreased from 0.23+0.01 percent at three weeks 
to 0.16+0.01 percent at eight weeks.
Cellular Immunity 
Total white blood cell (WBC) counts were negatively 
correlated with plasma magnesium at three weeks (r=-0.69, 
P<0.001). The differences among the treatment groups 
remained, but because plasma magnesium levels at eight weeks 
were similar among the marginal and adequate treatment 
groups, the correlation was not as strong (r=-0.30, P<0.22).
Table 11 shows that overall, rats consuming the 50 ug 
magnesium/gm diet had the highest total WBC count, followed
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Table 10. Least square mean spleen and thymus weights (gm)
as percent of total body weight (gm) for each magnesium
dietary treatment at each sampling period (n=4).
Sampling Week
3 8
Mean
SE
Mg Diet 
ug/gm spleen thymus spleen thymus spleen thymus
50 0.30 0.23 0.30 0.15 0.30° 
0.01
0.19
0.01
160 0.22 0.21 0.19 0.18 0.20
0.01
0.20
0.01
280 0.23 0.25 0.18 0.16 0.20
0.01
0.20
0.01
400, 
ad lib, 
control
0.22 0.23 0.20 0.15 0.21
0.01
0.19
0.01
400,
pair fed
0.23 0.21 0.18 0.15 0.20
0.01
0.18
0.01
Mean 0.24 0.23 0.21 0.16
SE 0.01 0.01 0.01 0.01
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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Table 11. Least square mean total white blood cell counts
(x 103/ul) and differentials for each magnesium dietary
treatment for both sampling periods (n=8).
Mg Diet Total Percent Percent Percent Percent Percent
ug/gm WBC Baso Eos Neut Lymph Mono
50 12.5a 0.2 5. 7b 17.8 73.0® 2.5
SE 1.4 0.1 0.6 2.7 3.0 0.5
160 7.7 0.0 4.3 15.6 77.6 1.8
SE 1.6 0.2 0.7 2.9 3.3 0.5
280 10.4 0.3 2.4 19.9 73.6a 2.6
SE 1.4 0.1 0.6 2.7 3.0 0.5
400,
ad lib, 7.2 0.1 2.6 11.2 82.5 2.0
control
SE 1.4 0.1 0.6 2.7 2.9 0.5
400,
pair fed 6.5 0.0 2.4 10.4 84.7 1.5
SE 1.5 0.1 0.6 2.8 3.2 0.5
a, different from control (P<0. 05)
b, different from control (P<0. 01)
c, different from control (P<0. 001)
differentials (x 103/ul) based on percent of total WBC:
Mg Diet
ug/gm Baso Eos Neut Lymph Mono
50
oo
0.7 2.2 9.1 0.3
160 0.0 0.3 1.2 6.0 0.1
280 0.0 0.2 2.1 7.7 0.3
400 , 
ad lib, 
control
0.0 0.2 0.8 5.9 0.1
400
pair fed 0.0 0.2 0.7 5.5 0.1
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by those in the 280 ug magnesium/gm treatment group. The 
rats in the 160 ug magnesium/gm treatment group had total 
WBC counts similar to those in the adequate ad lib and pair- 
fed groups. The differences could be attributed to an 
increase in the number of neutrophils and a significant 
increase of eosinophils.
Dietary treatment had no effect on the percentage of 
T cells and B cells. Of the total lymphocytes, 63 to 67±3 
percent were T cells, while 31 to 37+3 percent were B cells.
Lymphocyte stimulation was not affected by changes in 
dietary magnesium at three and eight weeks. As shown in 
Table 12, large variation within each dietary treatment 
group existed. When regression analyses were conducted using 
plasma magnesium as the independent variable and lymphocyte 
stimulation response as the dependent variable, no linear or 
quadratic relationships existed.
Humoral Immunity 
Dietary magnesium deficiencies affected total plasma 
protein, with changes in the albumin and globulin, 
concentrations (Table 13). Significant decreases in plasma 
proteins was observed with the severely deficient, 50 ug 
magnesium/gm diet, but not with the marginally deficient 
diets. At the same time, the restricted caloric intake in 
the pair-fed treatment did not affect plasma protein. Plasma 
protein levels increased for all rats during the eight-week
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Table 12. Least square mean lymphocyte stimulation responses
for each magnesium dietary treatment for both sampling
periods (n=8).
PHA Con A PWM
Mg Diet 
ug/gm CPM* SI** CPM* SI* * CPM* SI**
50 7,356 12.2 47,797 90. 3 13,492 21.5
SE 2,927 6.2 17,006 31.0 4,372 7.7
160 5,064 12.6 45,510 121.0 12,495 36.2
SE 3, 186 6.9 18,514 33. 7 4,760 8.4
280 6,644 12.4 39,972 94.4 6,286 14.4
SE 2,927 6.2 17,006 31.0 4, 372 7.7
400,
ad lib, 
control
4,630 15.5 38,964 96.9 11,179 21.6
SE 2, 927 6.2 17,006 31.0 4,372 7.7
400,
pair fed 8,201 8.6 29,964 31.9 10,800 14.8
SE 2,927 6.2 17,006 31.0 4,372 7.7
*, Counts per minute 
**, Stimulation index
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Table 13. Least square mean total plasma protein, albumin
and globulins (gm/100 ml) for each magnesium dietary
treatment for both sampling periods (n=8).
Mg Diet 
ug/gm
Total
Protein Albumin A1
Globulins 
A2 Beta Gamma
A/G
Ratio
50 7.55a 3.50® 1. 15»> 0.69 2.05 0.2 la 0.84
SE 0. 37 0.21 0.11 0.06 0.12 0.03 0.06
160 9.61 4.62 1.82 0.65 2.31 0.28 1.01
SE 0.40 0.23 0.11 0.07 0.16 0.03 0.07
280 8.36 4.25 1.39 0.54 1.89 0.32 1.00
SE 0. 37 0.20 0.10 0.06 0.13 0.03 0.06
400,
ad lib, 
control
8.75 4.21 1 .65 0.63 2.01 0.29 0.86
SE 0. 37 0.21 0.11 0.06 0.14 0.03 0.06
400,
pair fed 8.64 4.41 1.32 0.55 1.90 0.34 1.14»>
SE 0. 37 0. 20 0.13 0.06 0.12 0.03 0.06
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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time period with a consistent overall increase in albumin 
and the globulins.
The lower plasma protein content for the animals 
receiving the 50 ug magnesium/gm diet could be attributed to 
lower amounts of albumin, and the alpha 1 and gamma 
globulins. However, when expressed as a percentage of total 
protein, the percent albumin, alpha 1 and gamma globulins 
were not statistically different from the ad lib controls. 
Instead, the percent of alpha 2 and beta globulins were 
higher than the control group.
The severely deficient rats also had significantly 
lower levels of IgM and IgG as indicated in Table 14. Rats 
consuming marginal levels of magnesium, and those consuming 
adequate levels but with restricted intakes, were not 
statistically different from control animals. Yet, IgM 
levels in all animals correlated with their plasma magnesium 
concentrations at three weeks (r=0.63, P<0.01) and at eight 
weeks (r=0.57, P<0.01). The rats consuming diets severely 
deficient in magnesium had mean IgM levels 60 to 70 percent 
lower than the other animals. No significant changes 
occurred between the three- and eight-week sampling periods.
Similarly, the severely deficient animals had IgG 
levels that were approximately half that of the ad lib and 
pair-fed control animals. In addition, rats consuming 160 ug 
magnesium/gm had IgG levels that were 62 percent lower than 
the control group, while those on the 280 ug magnesium/gm 
diet were similar to the controls. An overall 78 percent
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Table 14. Least square mean IgM and IgG (mg/ml) for each
magnesium dietary treatment at each sampling period (n=4).
Sampling
3
Week
8
Mean
SE
Mg Diet 
ug/gm IgM IgG IgM IgG IgM IgG
50 0.96 6.62 0.78 5.72 0.87b 
0.13
6. 17b 
1. 36
160 1.30 9.40 1.30 5.60 1.30
0.14
7.50^
1.43
280 1.28 10.86 1 .66 11.60 1.47 
0.14
11.23
1.33
400, 
ad lib, 
control
1.25 12.88 1.46 11.30 1. 35 
0.12
12 .09 
1.33
400,
pair fed
1.30 16.56 1.48 9.83 1.39
0.12
13.19 
1. 33
Mean 1.22 11.26 1.34 8.81
SE 0.08 0.84 0.08 0.87
a, different from control (P<0.05)
b, different from control (PC0.01)
c, different from control (P<0.001)
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decrease in IgG was observed between the three- and eight- 
week sampling periods for all rats. IgG levels correlated 
with plasma magnesium at three weeks (r=0.58, P<0.01), but 
not at eight weeks (r=0.04, P<0.87).
When mean comparisons were conducted on the specific 
antibody response data, large variation contributed to no 
statistical differences among the diets, although some 
general trends appeared (Table 15). Mean specific antibody 
titer for the 50 ug magnesium/gm diet was consistently lower
than that of the control, ad lib group.
Analyses also were conducted when antibody was 
expressed as the log of the reciprocal titer. Severely
deficient rats had a mean log antibody response half that of
ad lib controls. Mean log titers at three and eight weeks 
were similar for the ad lib control animals, but were higher 
at eight weeks for all other dietary groups.
Antibody titer did not exhibit a linear or quadratic 
relationship with plasma magnesium. At the same time, titers 
correlated with IgM levels at three weeks (r=0.49, PC0.05) 
and at eight weeks (r=0.45, P<0.05).
Neutrophil Function 
Neutrophil phagocytosis of E. coli and intracellular 
killing was similar for all rats, regardless of diet, as 
shown on Table 16. More than 30 percent of the neutrophils 
from rats in each dietary treatment group ingested E. coli.
Of those, approximately 90 percent killed the bacteria.
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Table 15. Least square mean specific antibody titer and log
titer for each magnesium dietary treatment at each sampling
period (n=4).
Mg Diet 
ug/gm
Sampling Week 
3 8
Log
Titer Titer
Log
Titer Titer
Mean
SE
Log
Titer Titer
50
160
280
21
53
70
12
16
13 10
154 20
193 20
17
44
104
49
131
44
8
3
16
4
18
3
400, 
ad lib, 
control
130 16 93 17 112
46
17
3
400,
pair fed
18 11 80 17 49
44
14
3
Mean
SE
58
28
13
2
107
28
17
2
95
Table 16. Least square mean neutrophil phagocytosis and
killing (%) for each magnesium dietary treatment for both
sampling periods (n=8).
____________ %_neutrophils____________________
Mg Diet without with bacteria, with bacteria,
ug/gm bacteria not killed killed
50 64 . 3 2.6 33.1
SE 3.1 0.5 3.0
160 66. 1 2.9 30.9
SE 3.3 0.6 3.3
280 69.0 2.0 29.0
SE 3.1 0.5 3.0
400,
ad lib, 
control
69.3 2.9 27.8
SE 3.1 0.5 3.0
400,
pair fed 63.6 2.5 33.9
SE 3.1 0.5 3.0
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The incubation medium had 1.48 mg magnesium/100 ml, 
analyzed by atomic absorption spectroscopy, which could have 
been sufficient to allow for normal activity for the 
deficient neutrophils. To match the plasma magnesium 
concentration of deficient rats, DPBS medium with 0.72 mg 
magnesium/100 ml was used in duplicate assays for 
neutrophils from the rats consuming the 50 ug magnesium/gm 
diet. Comparisons using the deficient medium also were made 
for neutrophils from the control rats. No differences 
existed for neutrophils from deficient and control animals 
incubated in deficient medium compared to medium containing 
magnesium.
Experiment 2: Copper Deficiencies
The rats were similar before the dietary treatments in 
weight (116.0+.1.8 gm) , hemoglobin (13.0 + 0.2 gm/100 ml), 
hematocrit (36.7^0.4 percent), plasma copper 
(0.93+0.03 ug/ral), and ceruloplasmin (27.1+1.4 mU/ml). 
Significant differences then existed after the initiation of 
the treatments.
Three rats in the severely deficient, 0.5 ug copper/gm 
diet treatment group died after blood sampling, one at two 
weeks and the other two at four weeks. A rat on the 2.0 ug 
copper/gm diet died after the week six sampling period, and 
another severely deficient rat died before the end of the 
experiment. All deaths with the exception of the last, were 
attributed to internal bleeding after heart puncture.
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Statistical analyses for missing observations and unbalanced 
data were used.
Nutritional Status 
Plasma copper levels reflected the dietary levels of 
copper during the eight-week experiment (P<0.001). The 
lowest mean plasma copper concentration was for the rats on
the 0.5 ug copper/gm diet as presented in Table 17. This was
followed by mean plasma copper for rats on the 2.0 ug 
copper/gm diet and the 3.5 ug copper/gm diet. Highest mean 
levels were found in rats consuming the adequate 5.0 ug 
copper/gm diets, ad lib and with restricted intakes.
Table 17 also shows that with all three deficiencies, 
plasma copper decreased two weeks into the experiment.
Later, mean plasma copper levels further dropped for the
severely deficient rats, but slightly increased for rats on
the marginally deficient diets.
By week eight, mean plasma copper was statistically 
similar for rats in the 3.5 ug copper/gm diet group and the 
two 5.0 ug copper/gm diet groups. Mean plasma copper 
remained significantly lower for rats on the 2.0 ug 
copper/gm diet and the 0.5 ug copper/gm diet.
Ceruloplasmin (Cp) activity was highly correlated with 
plasma copper at two weeks (r=0.83, P<0.001), at four weeks 
(r=0.71, PC0.001), and at eight weeks (r=0.64, P<0.01). 
Significant differences in Cp activity existed among the
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Table 17. Least square mean plasma copper concentrations
(ug/ml) for each copper dietary treatment at each sampling
period (n=10).
Cu Diet 
ug/gm Initial
Sampling
2
Week
4 8
Mean
SE
0.5 0.97 0. 10C 0.05c 0.06c 0.29c
0.08
2.0 1.03 0. 38c 0.44c 0.58c 0.61c
0.06
3.5 0.94 0.69a 0.84® 1.11 0.89
0.06
5.0, 
ad lib, 
control
0.87 0.88 1.09 1. 36 1.05
0.06
5.0,
pair fed
0.86 0.89 1.03 1.17 0.99
0.06
Mean 0.93 0. 59 0.69 0.86
SE 0.03 0.03 0.03 0.06
a, different from control within each week (P<0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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diets, as presented in Table 18, and trends similar to those 
in plasma copper were seen throughout the experiment. The 
ferroxidase activity of Cp had no effect on catalase 
activity among the treatment groups.
The rats on the 0.5 ug copper/gm diet had significantly 
lower hemoglobin concentrations than the other treatment 
groups during the eight weeks of the experiment (Table 19). 
For the other dietary treatment groups, the hemoglobin 
increased throughout the study.
A more graded response was seen with the hematocrit 
measurements, with differences existing between the severely 
deficient, marginally deficient and copper-adequate animals 
(Table 20). Hematocrit increased more during the eight weeks 
for rats consuming the adequate copper diets, than for rats 
on the other diets.
Dietary copper significantly altered the growth of the 
rats. Those consuming the severely deficient, 0.5 ug 
copper/gm diet had the smallest overall mean weight 
(250.8+_4.8 gm), which was matched by the pair-fed group 
(245.8^3.8 gm). Interestingly, rats on the 2.0 ug copper/gm 
diet had a mean weight equal to the control rats consuming
5.0 ug copper/gm ad lib (276.5+3.9 gm) , while those on the
3.5 ug copper/gm diet had the highest mean weight 
(287.1^3.8 gm). The difference in the rats on the 3.5 ug 
copper/gm diet occurred after the fourth week of the 
experiment.
100
Table 18. Least square mean plasma ceruloplasmin activity
(mU/ml) for each copper dietary treatment at each sampling
period (n=10).
Cu Diet 
ug/gm Initial
Sampling Week 
2 4 8
Mean
SE
0.5 28.88 2.57c 1.66c 5. 57*» 9.67c
2.76
2.0 22.19 7.32c 1 0 .8 2 c 8.74c 12.26c 
2.14
3.5 30.69 20.25 15. 72*> 34.28 25.24b
2.01
5.0, 
ad lib, 
control
27.63 30.88 34.00 36.76 32.32
2.01
5.0,
pair fed
26.06 36.69 25.38 44.25 33.10 
2.01
Mean 27.09 19.54 17.52 25.92
SE 1.38 1 .38 2.25 2.60
a, different from control within each week (PC0.05)
b, different from control within each week (PC0.01)
c, different from control within each week (P<0.001)
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Table 19. Least square mean hemoglobin (gm/100 ml) for each
copper dietary treatment at each sampling period (n=10).
Cu Diet 
ug/gm Initial
Sampling
2
Week
4 8
Mean
SE
0.5 12.6 11.7= 11.5= 13. 5b 12.3=
0.3
2.0 12.8 13.3 15.2 16.1 14.3
0.3
3.5 13.2 13.5 15.6 15.3a 14.4
0.2
5.0, 
ad lib, 
control
13.0 13.7 16.0 16.9 14.9
0.2
5.0,
pair fed
13.4 15. lb 16.1 17.5 15.5
0.2
Mean 13.0 13.5 14.9 15.9
SE 0.2 0.2 0.2 0.3
a, different from control within each week (P<0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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Table 20. Least square mean hematocrit (%) for each copper
dietary treatment at each sampling period (n=10).
Cu Diet 
ug/gm Initial
Sampling
2
Week
4 8
Mean
SE
0.5 36.8 33.3' 32.6' 37 . 9b 35.2'
0.7
2.0 35.4 38.0 39. 3' 40.7b 38.3'
0.6
3.5 36.6 39 .0 43.0 42. 0* 40.2
0.6
5.0, 
ad lib, 
control
37.0 38.4 43.5 45.8 41.2
0.6
5.0,
pair fed
37.8 41 . 3a 44.2 46.1 42.4
0.6
Mean 36 . 7 38.0 40.5 42.5
SE 0.4 0.4 0.4 0.7
a, different from control within each week (PC0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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Total weight gains did not significantly differ among 
treatment groups until after week four (Table 21). Then, the 
severely deficient rats and their pair-fed mates had similar 
total weight gains. These were significantly lower than 
weight gains for rats in the other treatment groups. Rats on 
the 3.5 ug copper/gm diet gained the most weight.
Feed efficiency, also shown in Table 21, differed among 
the treatment groups, reflecting the trends observed in 
weight gained. At four weeks, feed efficiencies were similar 
for all treatment groups, as were weight gains.
After eight weeks, rats on the 0.5 ug copper/gm diet 
had a low mean feed efficiency. Their pair-fed mates on the
5.0 ug copper/gm diet had a slightly higher mean feed 
efficiency. The other rats on the marginal diets with 2.0 ug 
copper and 3.5 ug copper/gm were similar to those on the 
control, ad lib 5.0 ug copper/gm diet. Only those on the 
severely deficient diet were statistically different from 
the controls. For all rats, feed efficiency was higher at 
three weeks than at eight weeks.
Actual mean liver weights were not different among rats 
in the treatment groups. Yet, when expressed as a percent of 
total body weight as in Table 22, livers from the severely 
deficient rats were significantly larger than those from 
animals in the other groups, including the pair-fed rats. 
Liver weight as a percent of body weight was negatively 
correlated with plasma copper at four weeks (r=-0.43,
P<0.05) and at eight weeks (r=-0.74, P<0.001).
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Table 21. Least square mean weight gain (gm), and feed
efficiency (gm weight gain/gm feed intake) for each copper
treatment at each sampling period (n=5).
4
Sampling Week
8
Mean
SE
Cu Diet 
ug/gm
weight
gain
feed 
e ff.
weight
gain
f eed 
e ff.
weight
gain
feed
eff.
0.5 161.9 0.30 202.7C 0.21 182.3c 
9. 1
0.25a
0.01
2.0 180.0 0.32 265.6 0.21 222.8
8.0
0.27
0.01
3.5 187.8 0.32 301 .5 0.25 244.7
7.5
0.28
0.01
5.0, 
ad lib, 
control
184.3 0.32 276.4 0.23 230.4
7.5
0.27
0.01
5.0,
pair fed
162.7 0.31 208. lc 0.21 185.4c
7.5
0.26
0.01
Mean 175.4 0.31 250.9 0.22
SE 4.9 0.00 5.2 0.00
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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Table 22. Least square mean liver weights (gm) as percent of 
total body weight (gm) and liver copper concentration (ug/gm 
liver, wet weight) for each copper dietary treatment at each 
sampling period (n=5).
4
Sampling Week
8
Mean
SE
Cu Diet 
ug/gm weight Cu weight Cu weight Cu
0.5 5 .40 0.45 5.45 0.42 5.43a
0.23
0.43c
0.20
2.0 4.96 2.07 4.67 2. 32 4.82
0.20
2.20c 
0. 18
3.5 4.84 3.12 4.23 3.19 4.54
0.19
3.16
0.17
5.0,
ad lib, 
control
4.84 3.14 4.23 3. 58 4.53 
0.19
3.36
0.17
5.0,
pair fed
4.84 2.85 4.25 2.93 4.54 
0. 19
2.89
0.17
Mean 4.98 2. 32 4.57 2.49
SE 0. 12 0.11 0.13 0.11
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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Table 22 also shows that liver copper was significantly 
altered by dietary copper. Plasma copper highly correlated 
with liver copper stores at four weeks (r=0.76, P<0.001) and 
at eight weeks (r=0.87, P<0.001). Similarly, Cp highly 
correlated with liver copper at four weeks (r=0.66, P<0.001) 
and at eight weeks (r=0.62, P<0.01).
The severely deficient diet depleted four and eight 
week liver copper concentrations to 13 percent of the 
control value. The 2.0 ug copper/gm diet also significantly 
reduced liver copper to 65 percent of the control. The other 
marginal diet of 3.5 ug copper/gm was similar to the 
control. Restriction of feed intake also affected liver 
copper which was 86 percent of the ad lib control.
Lymphoid Organs
The spleen and thymus weights, like liver weights, were 
expressed as a percent of total body weight for comparisons 
(Table 23). At four weeks, the mean weight of spleens from 
all rats was 0.23+0.01 percent of total body weight, and at 
eight weeks it was 0.21+0.01 percent of total body weight. 
Dietary treatment had no effect. On the other hand, the 
thymuses were affected by dietary copper. The severely 
deficient rats had thymuses that were a smaller percentage 
of total body weight compared to controls, while others were 
similar to the controls. The percentage for all rats at four 
weeks, 0.20+0.01 percent, dropped to 0.15+0.01 percent,
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Table 23. Least square mean spleen and thymus weights (g m )
as percent of total body weight (gm) for each copper dietary
treatment at each sampling period (n=5).
4
Sampling Week
8
Mean
SE
Cu Diet 
ug/gm spleen thymus spleen thymus spleen thymus
0.5 0.21 0.16 0.23 0.10 0.22
0.01
0.13b 
0.02
2.0 0.25 0.22 0.22 0.17 0.23
0.01
0.19 
0.01
3.5 0.23 0. 24 0.19 0. 18 0.21
0.01
0.21
0.01
5.0, 
ad lib, 
control
0.23 0.22 0.20 0.16 0.21
0.01
0.19
0.01
5.0,
pair fed
0.24 0.19 0.21 0.16 0.22
0.01
0.17
0.01
Mean 0.23 0.20 0.21 0.15
SE 0.01 0.01 0.01 0.01
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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indicating a greater change in body weight than in thymus 
weight during the eight-week time period.
Cellular Immunity
Total and differential white blood cell counts were not 
altered by dietary copper as shown in Table 24. Some 
statistically significant changes in the differential 
percentages occurred over time. Mean lymphocyte counts 
decreased from 6.5 x 103/ul at four weeks to 5.8 x 103/ul at 
eight weeks with concomitant increases in all other 
leukocytes.
The percentages of T- and B-cells also were not changed 
by copper deficiency. Of the total lymphocytes, 68 to 77+_3 
percent were T cells, while 23 to 27+2 percent were B cells.
When mean comparisons were conducted on the lymphocyte 
stimulation data, large variation contributed to no 
differences according to diet, although some general trends 
appeared. As indicated in Table 25, all mean lymphocyte 
stimulation indexes for rats on the 0.5 ug copper/gm diet 
were lower than those of control animals. The PHA SI was 
13.6 percent of the control, Con A SI was 37.6 percent of 
the control, and PWM SI was 45.6 percent of the control.
The PHA SI and PWM SI for rats on the 2.0 ug copper/gm 
diet also were lower than the control, while the Con A SI 
was higher than the control. Rats on the 3.5 ug copper/gm 
diet had a Con A SI that was similar to those on the 2.0 ug 
copper/gm diet.
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Table 24. Least square mean total white blood cell counts
(x 103/ul) and differentials for each copper dietary
treatment for both sampling periods (n=10).
Cu Diet 
ug/gm
Total
WBC
Percent
Baso
Percent
Eos
Percent
Neut
Percent
Lymph
Percent
Mono
0.5 6.1 0.0 0.9 11.4 84.8 2.7
SE 1.2 0.2 0.5 2.5 2.7 0.7
2.0 7.1 0.0 1.0 9.5 86.8 2.4
SE 0.8 0.1 0.4 1.9 2.1 0.5
3.5 6.6 0.1 1.1 7.7 88.6 2.5
SE 0.7 0.1 0.4 1.8 2.0 0.5
5.0,
ad lib, 
control
7.2 0.1 1.2 8.6 87 .6 2.4
SE 0.7 0.1 0.4 1.8 2.0 0.5
5.0,
pair fed 7.1 0.5 1.1 6.8 88.9 2.6
SE 0.7 0.1 0.4 1.8 1.9 0.5
differentials (x 103/ul) based on percent of total WBC:
Cu Diet 
ug/gm Baso Eos Neut Lymph Mono
0.5 0.0 0.1 0.7 5.2 0.2
o
•
<M 0.0 0.1 0.7 6.2 0.2
3.5 0.0 0.1 0.5 5.9 0.2
5.0, 
ad lib, 
control
0.0 0.1 0.6 6.3 0.2
5.0,
pair fed 0.0 0.1 0.5 6.3 0.2
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Table 25. Least square mean lymphocyte stimulation responses
for each copper dietary treatment for both sampling periods
(n=10).
PHA Con A PWM
Cu Diet 
ug/gm CPM* SI** CPM* SI** CPM* SI**
0.5 232 1.5 2,549 15.7 811 5.7
SE 1,176 4.1 5,153 26.7 920 3.1
2.0 873 5.2 13,594 72.8 2,311 9.7
SE 885 3.1 3,880 20.1 693 2.4
3.5 896 3.1 16,782 72.2 2,939 10.9
SE 828 2.9 3,629 18.8 648 2.2
5.0,
ad lib, 
control
3,398 11.0 11,716 41.7 3,581 12.5
SE 828 2.9 3,629 18.8 648 2.2
5.0,
pair fed 1,411 7.3 11,214 62.9 2,599 12.7
SE 828 2.9 3,629 18.8 648 2.2
*, Counts per minute 
**, Stimulation index
I l l
Regression analysis provided greater insight as to how 
dietary copper affected lymphocyte proliferation. At four 
weeks, PHA CPM fit a linear and quadratic curve with plasma 
copper concentrations as the independent variable (P<0.05). 
The PHA SI regressions also were significant (P<0.05).
Humoral Immunity
Dietary copper deficiencies did not significantly 
affect total plasma protein, nor did they change albumin and 
globulin distributions (Table 26). There were small, but 
statistically significant, increases in the beta-and gamma 
globulin concentrations between four and eight weeks. These 
had no overall effects on the albumin/globulin ratio.
For all rats, IgM and IgG levels increased between the 
four- and eight-week sampling periods. Table 27 shows that 
the severely deficient rats had a mean IgM concentration 
which was 38 percent that of all other treatment groups.
Rats on the 2.0 ug copper/gm diet had a higher IgG 
concentration than all others. No differences existed among 
the other diets.
Specific antibody response to heterologous RBCs was 
variable among the dietary treatments (Table 28). Regression 
analysis was used to test whether copper status had an 
effect on antibody response. Plasma copper was the 
independent variable and specific antibody titer the 
dependent variable. At four weeks, no linear or quadratic 
relationship existed. At eight weeks, a quadratic
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Table 26. Least square mean total plasma protein, albumin
and globulins (gm/100 ml) for each copper dietary treatment
for both sampling periods (n=10).
Globulins
Cu Diet 
ug/gm
Total
Protein Albumin A1 A2 Beta Gamma
A/G
Rati
0.5 11.18 5.53 1. 18 0.98 2.71 0.33 1.08
SE 1 .11 0.66 0. 18 0.11 0.27 0.05 0.06
2.0 10.52 5.25 1. 58 0.95 2.46 0.30 1.01
SE 0.80 0.48 0.14 0.08 0.21 0.04 0.05
3.5 9. 33 4.87 1. 32 0.79 2.06 0.25 1.01
SE 0.75 0.46 0.14 0.08 0.20 0.04 0.05
5.0,
ad lib, 
control
9.62 4.92 1.47 0.85 2.13 0.29 1.06
SE 0.75 0.45 0.13 0.08 0.20 0.04 0.05
5.0,
pair fed 9.61 4.92 1.51 0.79 2. 16 0.28 1.03
SE 0.76 0.45 0.13 0.08 0.20 0.04 0.05
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Table 27. Least square mean IgM and IgG (mg/ml) for each
copper dietary treatment at each sampling period (n=5).
Sampling
4
Week
8
Mean
SE
Cu Diet 
ug/gm IgM IgG IgM IgG IgM IgG
0.5 0.46 9.48 0.74 12.78 0.60c
0.20
11.13 
1.93
2.0 1.17 11.59 1.72 18.84 1.45 
0.16
15 . 21a 
1.52
3.5 1.42 6.82 1.55 11.76 1.49 
0.15
9.29
1.41
5.0, 
ad lib, 
control
1.48 10.20 1.66 10.53 1.57 
0.16
10.36 
1.43
5.0,
pair fed
1.42 10.68 2.16 13.68 1.79
0.15
12.18
1.41
Mean 1.19 9.75 1.57 13.52
SE 0.10 0.91 0.11 1.04
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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Table 28. Least square mean specific antibody titer and log
titer for each copper dietary treatment at each sampling
period (n = 5 ) .
Cu Diet 
ug/gm
Sampling
4
Week
8
Mean
SE
Titer
Log
Titer Titer
Log
Titer
Log
Titer Titer
0.5 22 6 33 13 27 9
7 2
2.0 23 9 7 3 15 6
6 2
3.5 16 7 18 8 17 8
5 1
5.0,
ad lib, 10 5 6 3 8 4
control 5 1
5.0,
pair fed 15 4 18 6 16 5
6 2
Mean 17 6 16 7
SE 3 1 4 1
/
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relationship was significant (P<0.01). Similar results were 
observed when specific antibody was expressed as the log of 
the reciprocal titer (P>0.01 at eight weeks).
Plasma copper concentrations varied within the 
marginal, 2.0 ug copper/gm diet treatment (0.25 to 
0.98 ug/ml), and within the 3.5 ug copper/gm treatment (0.65 
to 1.66 ug/ml). In general, it appeared that specific 
antibody response was less at marginal plasma copper 
concentrations compared to higher and very low plasma copper 
concentrations.
Neutrophil Function 
Table 29 shows that neutrophil phagocytosis of E. coli 
and intracellular killing was statistically similar for all 
rats, regardless of diet. Yet, more than half of the 
neutrophils from the severely deficient rats (0.5 ug 
copper/gm diet) ingested E . coli. while less than half of 
the neutrophils from rats in the other treatments ingested 
the bacteria. At week four, 50 to 60 percent of the 
neutrophils that ingested E . coli. also showed bactericidal 
activity. Then at eight weeks, killing was observed in more 
than 90 percent of neutrophils with ingested E. coli.
The neutrophil cupro-enzyme, SOD, was not altered by 
the treatments (Table 30), nor by changes in plasma_copper 
or Cp. The ferroxidase activity of Cp also appeared not to 
affect neutrophil MPO activity. Neutrophil phagocytosis and 
killing did not correlate with SOD activity at week four. On
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Table 29. Least square mean neutrophil phagocytosis and
killing (%) for each copper dietary treatment for both
sampling periods (n=10).
 % neutrophils____________________
Cu Diet without with bacteria, with bacteria,
ug/gm bacteria not killed killed
0.5 44.7 10.5 44.8
SE 6.3 2.8 6.2
2.0 56.4 9.6 34.0
SE 4.7 2.1 4.7
3.5 62.9 11.8 25.0
SE 4.4 2.0 4.4
5.0,
ad lib, 
control
57.5 12.6 29.9
SE 4.4 2.0 4.4
5.0,
pair fed 63.2 8.4 28.4
SE 4.4 2.0 4.4
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Table 30. Least square mean neutrophil myeloperoxidase (MPO)
and superoxide dismutase (SOD) in U x 10"7/neutrophi1 for
each copper dietary treatment at each sampling period (n=5).
Sampling Week Mean
_______4_______   8_______  SE
Cu Diet
ug/gm MPO SOD MPO SOD MPO SOD
0.5 0.32 114.1 1.70 149.7 1.01 131.9
0.29 29.1
2.0 0.74 129.8 1.08 117.6 0.91 123.7
0.23 22.5
3.5 0.57 102.7 1.85 139.7 1.21 121.2
0.22 21.3
5.0,
ad lib, 0.78 131.2 1.60 119.8 1.19 125.5
control 0.22 21.3
5.0, 0.52 205.3 1.15 152.6 0.84 179.0
pair fed 0.22 21.3
Mean 0.59 136.6 1.48 135.9
SE 0.14 13.8 0.16 15.6
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the other hand, at week four, MPO activity and neutrophil 
ingestion and killing were significantly correlated (r=0.52, 
P<0.01). At week eight, the correlation was not as strong 
(r=0.40, P<0.07). SOD activity correlated with neutrophil 
ingestion and killing at week eight (r=0.44, P<0.05).
Experiment 3: Magnesium and Copper Deficiencies 
The rats were similar before the dietary treatments in 
weight (116.9+2.0 gm), hemoglobin (12.5+0.2 gm/100 ml), 
hematocrit (35.9+0.5 percent), plasma magnesium 
(1.80+0.02 mg/100 ml), and plasma copper (1.15j+0.03 ug/ml). 
Significant differences in all nutritional parameters then 
existed after the initiation of the treatments.
There were four deaths caused by internal bleeding 
after heart puncture during the experiment. Two rats on the 
severely deficient diet, one rat on the 280 ug magnesium and
2.0 ug copper/gm diet, and one on the 160 ug magnesium and
3.5 ug copper/gm diet, died after the week two sampling 
period. Statistical analyses for missing observations and 
unbalanced data were used.
Clinical signs of magnesium deficiency were apparent in 
rats receiving the 50 ug magnesium and 0.5 ug copper/gm 
dietary treatment. These included ulcerative lesions about 
the head and neck, a coarse hair coat, and skin necrosis. 
Hyperirritability also was noticeable, and seizure activity 
was observed in one rat during the fifth week of the 
experiment.
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Nutritional Status 
Severe and moderately deficient levels of dietary 
magnesium affected plasma magnesium during the eight-week 
experiment as shown in Table 31. Rats receiving 50 ug 
magnesium/gm diet had significantly lower plasma magnesium 
concentrations after initiation of the treatments than all 
other treatment groups (P<0.001). Rats receiving moderately 
deficient levels of magnesium (160 ug/gm) had low mean 
plasma magnesium regardless of dietary copper concentration. 
Mean plasma magnesium for both groups were significantly 
lower than controls.
Throughout the experiment, the rats consuming less 
copper had slightly lower plasma magnesium concentrations 
than rats consuming more copper. Rats consuming the diets 
with 280 ug magnesium/gm had plasma magnesium levels similar 
to control rats consuming 400 ug magnesium/gm.
Bone magnesium also was significantly affected by 
severe (50 ug/gm) and moderate (160 ug/gm) dietary magnesium 
deficiencies, regardless of dietary copper levels 
(Table 32). The lowest mean bone magnesium concentration was 
found in the 50 ug magnesium and 0.5 ug copper/gm diet 
group, followed by the 160 ug magnesium/gm diets with 2.0 ug 
copper/gm and 3.5 ug copper/gm. Rats consuming 280 ug 
magnesium/gm had bone magnesium concentrations similar to 
the control animals. The controls consumed 400 ug 
magnesium/gm, and had a mean bone magnesium concentration of 
4.50 mg/gm bone. The amount of magnesium in the bone also
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Table 31. Least square mean plasma magnesium (mg/100 ml) for
each combined magnesium and copper dietary treatment at each
sampling period (n=10).
Diet
ug/gm Initial
Sampling
2
Week
4 8
Mean
SE
50 Mg 
0.5 Cu
1.87 0.44c 0.34c 0.44c 0.77c
0.04
160 Mg 
2.0 Cu
2.03 1 . 15c 1.17» 1.24c 1 .40c 
0.03
280 Mg 
2.0 Cu
1 . 74 1.51 1.61 1.60 1.61
0.03
160 Mg 
3.5 Cu
1. 70 1. 33«> 1.57 1 .29» 1.47c
0.03
280 Mg 
3.5 Cu
1 .72 1.54 1. 79 1.67 1.68 
0.03
400 Mg 
5.0 Cu
1. 75 1. 56 1.56 1.65 1.63
0.03
Mean 1.80 1.25 1.34 1.31
SE 0.02 0.02 0.04 0.04
a, different from control within each week (P<0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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Table 32. Least square mean bone magnesium (mg/gm bone, dry
weight) for each combined magnesium and copper dietary
treatment at each sampling period (n=5).
Diet
ug/gm
Sampling
4
Week
8
Mean
SE
50 Mg 2 .00 1.39 1.69c
0.5 Cu 0.16
160 Mg 3.40 3.97 3.69c
2.0 Cu 0.15
280 Mg 4.35 4.78 4.57
2.0 Cu 0.15
160 Mg 3.78 3.79 3. 78b
3.5 Cu 0.15
280 Mg 4.14 4.41 4.28
3.5 Cu 0.15
400 Mg 4.56 4.44 4.50
5.0 Cu 0.15
Mean 3.71 3.80
SE 0.09 0.09
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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highly correlated with plasma magnesium at four weeks 
(r=0.74, PC0.001) and at eight weeks (r=0.92f P<0.001).
All levels of dietary copper affected plasma copper 
concentrations throughout the experiment (PC0.001). Dietary 
magnesium appeared to have no influence on the plasma copper 
concentration. Plasma copper concentrations reflected 
dietary copper levels as shown in Table 33. Differences were 
observed at week two and remained throughout the eight 
weeks.
Cp followed a similar trend, as presented in Table 34, 
and highly correlated with plasma copper at week two 
(r=0.92, P<0.001), at week four (r=0.86, P<0.001), and at 
week eight (r=0.94, P<0.001). The mean Cp during the whole 
experiment was similar for the diets with 0.5 ug copper/gm 
and 2.0 ug copper/gm. However, Cp activity initially was 
higher, then dramatically decreased at week two in the 
severely deficient rats and remained extremely low by the 
eight-week sampling period. On the other hand, Cp activity 
for the rats consuming 2.0 ug copper/gm began to recover 
after the initial drop at week two.
The ferroxidase activity of Cp did not appear to 
immediately affect catalase. By eight weeks, however, Cp 
activity and catalase activity were significantly correlated 
(r=0.53, P<0.01). Rats on the severely deficient diet had 
the lowest mean catalase activity. Those consuming the 
280 ug magnesium and 3.5 ug copper/gm diet were similar to 
the control rats, with the highest catalase activity.
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Table 33. Least square mean plasma copper concentrations
(ug/ml) for each combined magnesium and copper dietary
treatment at each sampling period (n=10).
Diet
ug/gm Initial
Sampling
2
Week
4 8
Mean
SE
50 Mg 
0.5 Cu
1.15 0 . 25c 0.25c 0 . 19c 0.46c
0.05
160 Mg 
2.0 Cu
1.15 0. 42° 0 . 52c 0. 79c 0.72c
0.05
280 Mg 
2.0 Cu
1 . 14 0 . 35c 0.57c 0 .66c 0 .68c
0.05
160 Mg 
3. 5 Cu
1.12 0. 84b 1 .10a 1.41 1.12b 
0.05
280 Mg 
3.5 Cu
1 . 16 0.81b 1.07b 1.28* 1 .08c 
0.05
400 Mg 
5.0 Cu
1 . 19 1.07 1.44 1.59 1.32 
0.05
Mean 1.15 0.62 0.83 0.99
SE 0.03 0.03 0.04 0.04
a, different from control within each week (P<0.05)
b, different from control within each week (PC0.01)
c, different from control within each week (PCO.OOl)
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Table 34. Least square mean plasma ceruloplasmin activity
(mll/ml) for each combined magnesium and copper dietary
treatment at each sampling period (n=10).
Diet
ug/gm Initial
Sampling
2
Week
4 8
Mean
SE
5 0  Mg 
5 . 0  Cu
3 2 . 7 5 2 . 6 9 c 5 . 2 2 c 0 . 4 6 c 1 0 . 2 8 c
2 . 6 2
1 6 0  Mg 
2 . 0  Cu
1 6 . 0 0 c 4 .  3 8 c 8 . 3 2 c 18 . 81c 1 1 . 8 8 c  
2 . 3 4
2 8 0  Mg 
2 . 0  Cu
1 5 . 0 0 c 3 . 8 2 c 9 . 7 9 c 1 3 . 8 6 c 1 0 . 6 2 c
2 . 4 8
1 6 0  Mg 
3 . 5  Cu
2 0 . 6 3 c 2 9 . 2 5 2 3 . 9 4 * 5 0 . 8 0 3 1 . 16c  
2 . 4 8
2 8 0  Mg 
3 . 5  Cu
3 4 . 2 5 2 5 . 2 5 a 3 8 .  25 4 7 . 8 8 36. 41«>
2 . 3 4
4 0 0  Mg 
5 . 0  Cu
3 6 . 6 3 3 4 . 5 7 4 2 . 1 0 5 6 . 0 3 4 2 . 3 3
2 . 3 4
Mean 2 5 . 8 8 1 6 . 6 6 2 1 . 2 7 3 1 . 3 1
SE 1 .  26 1 . 2 6 2 . 0 5 2 . 1 4
a, different from control within each week (P<0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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Liver copper content also reflected dietary copper 
levels. For each level of dietary copper, liver copper 
content was significantly different from all others.
Table 35 shows that all dietary treatments were 
significantly different from the control. Dietary magnesium 
did not appear to influence liver copper.
Rats consuming 0.5 ug copper/gm had liver stores 
depleted to 13 percent of the control values. The diets with
2.0 ug copper/gm reduced liver copper to approximately 55 
percent of the control. Those with 3.5 ug copper/gm lowered 
liver copper to an average of 83 percent of the control. The 
amount of copper in the liver also was highly correlated at 
four weeks with plasma copper concentration (r=0.93,
P<0.001) and Cp (r=0.80, P<0.001). High correlations also 
were found at eight weeks between liver copper and plasma 
copper (r=0.90, P<0.001) and Cp (r=0.82, P<0.001).
In contrast to the changes observed in liver copper 
with various dietary copper levels, only the diet with 
0.5 ug copper/gm altered liver weight when expressed as a 
percent of total body weight (Table 35). Livers were 
significantly enlarged by the severely deficient dietary 
treatment, and were bleached in color.
By the end of the experiment hemoglobin and hematocrit 
were significantly lower in the severely deficient rats 
consuming the 50 ug magnesium and 0.5 ug copper/gm diet than 
for all other rats (Tables 36 and 37). There were no 
differences between the marginal dietary deficiencies and
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Table 35. Least square mean liver weights (gm) as percent of 
total body weight (gm), and liver copper concentration 
(ug/gm liver, wet weight) for each combined magnesium and 
copper dietary treatment at each sampling period (n=5).
4
Sampling Week
8
Mean
SE
Diet
ug/gm weight Cu weight Cu weight Cu
50 Mg 
0.5 Cu
5.52 0.71 6 . 59 0.25 6.05c 
0.16
0.48c
0.20
160 Mg 
2.0 Cu
5.12 1.97 4.49 2.20 4.80
0.15
2.08c 
0 . 18
280 Mg 
2.0 Cu
5.07 2.16 4.40 1.89 4.73 
0 . 16
2 .02c
0.19
160 Mg 
3.5 Cu
5.05 3.03 4.01 2.91 4 . 53 
0.16
2.97«>
0.19
280 Mg 
3.5 Cu
4.74 3.27 4.41 3.14 4 .57 
0.15
3.20a
0.18
400 Mg 
5.0 Mg
4.65 4.02 4.35 3.46 4.50
0.15
3. 74 
0.18
Mean 5.02 2.53 4.71 2.31
SE 0.09 0.11 0.09 0.11
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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Table 36. Least square mean hemoglobin (gm/100 ml) for each
combined magnesium and copper dietary treatment at each
sampling period (n=10).
Diet
ug/gm Initial
Sampling
2
Week
4 8
Mean
SE
50 Mg 
0.5 Cu
11.5 13 . 0a 11.7 8 . 5C 11.2«= 
0.4
160 Mg 
2.0 Cu
12.2 13.9 14.4 15.0 13.8
0.3
280 Mg 
2.0 Cu
12.9 14.2 13.9 14.7 13.9
0.4
160 Mg 
3.5 Cu
12 . 5 14 .0 13.4 15.1 13.7
0.4
280 Mg 
3.5 Cu
12.9 14.5 14.2 15.5 14.3
0.3
400 Mg 
5.0 Cu
12.8 14.5 13.9 15.7 14.2
0.3
Mean 12.5 14 .0 13.6 14.1
SE 0.2 0.2 0.3 0.3
a, different from control within each week (P<0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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Table 37. Least square mean hematocrit (%) for each combined
magnesium and copper dietary treatment at each sampling
period (n=10).
Diet
ug/gm Initial
Sampling
2
Week
4 8
Mean
SE
50 Mg 
0.5 Cu
36 .0 37.0 34.5» 28.9c 34. lc 
0.8
160 Mg 
2.0 Cu
36.4 40.2 42.4 45.0 40.0
0.8
280 Mg 
2.0 Cu
36 .9 40.3 41.1 44.0 40.6
0.8
160 Mg 
3.5 Cu
36.0 40.4 38.6 45.3 40. 1 
0.8
280 Mg 
3.5 Cu
33. 3 40.4 40.8 47.3 40.4
0.8
400 Mg 
5.0 Cu
36.7 39.5 42. 7 45.1 41.0
0.8
Mean 35.9 39.6 40.0 52.6
SE 0.5 0.5 0.7 0.8
a, different from control within each week (P<0.05)
b, different from control within each week (P<0.01)
c, different from control within each week (P<0.001)
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the control diet throughout the experiment. For those rats, 
hematocrit increased with time, as did hemoglobin to a 
lesser extent, while decreases were observed in the 50 ug 
magnesium and 0.5 ug copper/gm diet group.
The combined magnesium and copper marginal deficiencies 
did not significantly affect growth. Weight gain was similar 
among all groups except for those on the severely deficient 
50 ug magnesium and 0.5 ug copper/gm diet (Table 38). The 
difference in weight occurred early in the experiment and 
continued to the end. The mean weight gains at four and 
eight weeks for the severely deficient rats were 
approximately 60 percent that for control animals.
With the exception of the severely deficient rats, feed 
efficiency was similar for all dietary treatments, also 
shown in Table 38. Mean feed efficiency during the eight- 
week experiment was significantly lower for the rats 
consuming the 50 ug magnesium and 0.5 ug copper/gm diet, 
than for rats consuming marginal or adequate levels of both 
nutrients.
Lymphoid Organs 
Both the spleen and thymus were affected by a severe 
combined dietary deficiency of magnesium and copper. When 
organ weight was expressed as a percent of total body 
weight, spleens were significantly enlarged by the 50 ug 
magnesium and 0.5 ug copper/gm diet, and thymuses were much 
smaller than those from animals on the other dietary
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Table 38. Least square mean weight gain (gm), and feed 
efficiency (gm weight gain/gm feed intake) for each combined 
magnesium and copper dietary treatment at each sampling 
period (n =5).
4
Sampling Week
8
Mean
SE
Diet
ug/gm
weight
gain
feed 
ef f .
weight
gain
feed 
ef f .
weight
gain
feed 
eff.
5 0  Mg 
0 . 5  Cu
1 1 8 .  1 0 . 2 4 1 7 1 . 7 0 . 1 7 1 4 4 . 9 c
1 0 . 8
0 . 2 0 c
0 . 0 1
1 6 0  Mg 
2 . 0  Cu
1 8 0 . 4 0 . 3 1 2 6 6 . 9 0 . 2 3 2 2 3 . 7
9 . 7
0 . 2 7
0 . 0 1
2 8 0  Mg 
2 . 0  Cu
1 7 3 . 2 0 . 3 1 2 6 4 . 2 0 . 2 3 2 1 8 . 7
1 0 . 3
0 . 2 7
0 . 0 1
1 6 0  Mg 
3 . 5  Cu
1 6 2 . 4 0 . 3 0 2 7 2 . 2 0 . 2 3 2 1 7 . 3
1 0 . 3
0 . 2 7
0 . 0 1
2 8 0  Mg 
3 . 5  Cu
1 7 8 . 7 0 .  32 2 7 1 . 8 0 . 2 3 2 2 5 . 3
9 . 7
0 . 2 8
0 . 0 1
4 0 0  Mg 
5 . 0  Cu
1 9 1 .  7 0 . 3 4 2 8 1  . 2 0 . 2 3 2 3 6 . 5
9 . 7
0 . 2 9
0 . 0 1
Mean 1 6 7 . 4 0 . 3 1 2 5 4 . 7 0 . 2 2
SE 5 . 7 0 . 0 1 5 . 9 0 . 0 1
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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treatments (Table 39). As total body weight increased from 
week four to eight, the percentage decreased for both spleen 
and thymus weight.
Cellular Immunity
Total white blood cell counts were altered by the 
severely deficient, 50 ug magnesium and 0.5 ug copper/gm 
diet as shown in Table 40. The mean total WBC count at week 
four for rats on that diet was twice the amount for rats on 
the control diet (14.0 x 103/ul and 7.0 x 103/ul, 
respectively). There was a significant increase of 
neutrophils. By week eight, however, the neutrophil count 
decreased, and the total WBC count for the severely 
deficient rats dropped to a level that was not significantly 
different from the controls (7.3 x 103/ul and 8.6 x 103/ul, 
respectively).
At four weeks total WBC count was negatively correlated 
with plasma magnesium (r=-0.66, P<0.001), and also to plasma 
copper (r=-0.57, P<0.001). Then, at eight weeks, mean total 
WBC counts, as well as the differentials, were similar for 
all dietary treatments.
The percentage of B cells was not significantly changed 
by combined dietary magnesium and copper deficiencies, as 
shown in Table 41. The mean percentage dropped from 26+2 
percent at four weeks to 20+2 percent at eight weeks.
A similar decrease over time was observed with the 
percentage of T cells (74+2 percent at four weeks to
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Table 39. Least square mean spleen and thymus weights (gm) 
as percent of total body weight (gm) for each combined 
magnesium and copper dietary treatment at each sampling 
period (n=5).
Sampling Week
4 8
Mean
SE
Diet
ug/gm spleen thymus spleen thymus spleen thymus
5 0  Mg 
0 .  5 Cu
0 . 4 3 c 0.20 0 . 31c 0.10 0 . 3 7 c
0.01
0 . 15b 
0.01
1 6 0  Mg 
2 . 0  Cu
0 . 2 6 0 . 2 5 0.21 0 . 1 7 0 . 2 4
0.01
0.21
0.01
2 8 0  Mg 
2 .0 Cu
0.22 0 . 2 3 0.21 0 . 1 4 0.21
0.01
0 . 1 8  
0.01
1 6 0  Mg 
3 .  5 Cu
0 . 2 3 0 . 2 4 0.20 0 . 1 5 0.22
0.01
0.20
0.01
2 8 0  Mg 
3 .  5 Cu
0 . 2 6 0 . 2 3 0.21 0 . 1 6 0 . 2 4
0.01
0 .  19  
0.01
4 0 0  Mg 
5 .0 Cu
0 . 2 4 0 . 2 4 0.21 0 . 1 6 0.22
0.01
0.20
0.01
Mean 0 . 2 7 0 . 2 3 0.22 0 . 1 5
SE 0.01 0.01 0.01 0.01
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (PC0.001)
133
Table 40. Least square mean total white blood cell counts
(x 103/ul) and differentials for each combined magnesium and
copper dietary treatment for both sampling periods (n=10).
Diet
ug/gm
Total
WBC
Percent
Baso
Percent
Eos
Percent
Neut
Percent
Lymph
Percent
Mono
50 Mg 
0.5 Cu 
SE
10. 7b 
0.7
0. 3a 
0.3
2.8
0.5
22.8c
2.2
71.3c
2.7
3.5
0.6
160 Mg 
2.0 Cu 
SE
8.8
0.7
0. 3a 
0.3
1.6
0.4
8.3
2.0
87.6
2.5
1.4* 
0.5
280 Mg 
2.0 Cu 
SE
7.2
0.7
0 . lb 
0.3
1.1 
0.5
9.4
2.1
87. 1 
2.5
2.3
0.5
160 Mg 
3. 5 Cu 
SE
6.5
0.7
0.9
0.3
0.8
0.5
11.0
2.1
85.4
2.5
2.0
0.5
280 Mg 
3.5 Cu 
SE
7.3
0.7
0. 4a 
0.3
1.3
0.4
11.6
1.9
83.2
2.4
3.2
0.5
400 Mg 
5.0 Cu 
SE
7.8
0.7
1.1
0.3
1.9
0.4
9.7
1.9
84.2
2.4
3.0
0.5
a, (P<0.05); b, (P<0. 01); c, (P<0.001)
differentials (x 103/ul) based on percent of total WBC:
Diet ug/gm Baso Eos Neut Lymph Mono
50 Mg 0 . 5 Cu 0.0 0.3 2.4 7.6 0.4
160 Mg 2.0 Cu 0.0 0.1 0.7 7.7 0.1
280 Mg 2.0 Cu 0.0 0.1 0.7 6.3 0.2
160 Mg 3.5 Cu 0.1 0.1 0.7 5.6 0.1
280 Mg 3.5 Cu 0.0 0.1 0.8 6.1 0.2
400 Mg 5.0 Cu 0.1 0.1 0.8 6.6 0.2
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Table 41. Least square mean B cells (%) and T cells (%) for
each combined magnesium and copper dietary treatment at each
sampling period (n=5).
Diet
ug/gm
Sampling Week
4 8
Mean
SE
B cell T cell B cell T cell B cell T cell
50 Mg 26 87 18 68 22 78b
0.5 Cu 3 4
160 Mg 20 83 16 61 18 72^
2.0 Cu 3 3
280 Mg 23 70 19 60 21 65
2.0 Cu 3 3
160 Mg 32 73 14 62 23 67
3.5 Cu 3 3
280 Mg 25 69 25 61 25 65
3.5 Cu 3 3
400 Mg 31 64 25 59 28 62
5.0 Cu 3 3
Mean 26 74 20 62
SE 2 2 2 2
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (PCO.OOl)
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62+2 percent at eight weeks). Table 41 also shows that diet 
had an influence on mean T cell percentages. Rats on the 
50 ug magnesium and 0.5 ug copper/gm diet and the 160 ug 
magnesium and 2.0 ug copper/gm diet had an elevated T cell 
percentage when compared to rats on the other dietary 
treatments. Furthermore, T cell percentage was increased by 
low dietary magnesium (160 ug/gm), especially when combined 
with low dietary copper (2.0 ug/gm).
Data for lymphocyte stimulation was available only on 
the eight-week samples. The four-week samples could not be 
used due to contamination. Lymphocyte proliferation was not 
statistically different among dietary treatments with PHA 
and Con A stimulation (Table 42).
Although large variation existed in the data, mean PHA 
CPM for lymphocytes from the rats consuming the severely 
deficient, 50 ug magnesium and 0.5 ug copper/gm diet were 
10 percent of the control, and the mean SI was 44 percent of 
the control. In addition, the mean CPM for lymphocytes from 
rats on the marginally deficient, 160 ug magnesium and
2.0 ug copper/gm diet were 68 percent of the control, and 
the mean SI was 87 percent of the control.
Significant differences among dietary treatments 
existed when PWM was used to stimulate lymphocyte 
proliferation. The mean CPM was lowered by the severely 
deficient levels of magnesium (50 ug/gm) and copper 
(0.5 ug/gm), the moderately deficient level of copper 
(2.0 ug/gm), and the mildly deficient level of magnesium
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Table 42. Least square mean lymphocyte stimulation responses
for each combined magnesium and copper dietary treatment for
the week eight sampling period (n=5).
PHA Con A PWM
Diet
ug/gm CPM* SI** CPM* SI** CPM* SI**
50 Mg 
0.5 Cu 
SE
343
1,469
3.2
3.3
21,061 
7,378
105.9
34.4
6,418b
3,496
38.6
12.1
160 Mg 
2.0 Cu 
SE
2,230 
1,287
6.2
2.9
22,748
6,467
73.0
30.2
8 ,221b
3,065
22.5
10.6
280 Mg 
2.0 Cu 
SE
3,189 
1,469
8.9
3.3
20,675
7,378
101.7
34.4
8,374b
3,496
38.2
12.1
160 Mg 
3.5 Cu 
SE
3,265
1,469
6.8
3.3
29,676 
7, 378
89.2
34.4
19,766
3,496
49.4
12.1
280 Mg 
3.5 Cu 
SE
3,495
1,287
7.9
2.9
30,420
6,467
75.3
30.2
9,612a
3,065
26.5
10.6
400 Mg 
5.0 Cu 
SE
3,306
1,287
7.1
2.9
34,824
6,467
72.4
30.2
21,263 
3,065
43.1 
10.6
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
*, Counts per minute 
**, Stimulation index
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(280 ug/gm). Therefore, lymphocytes from rats receiving 
those dietary treatments showed less proliferation than 
those from the other diets. At the same time, there were no 
statistical differences in the mean stimulation indexes 
among the dietary treatments.
Regression analyses were conducted using plasma 
magnesium or copper as the independent variable and 
lymphocyte stimulation response as the dependent variable.
No linear or quadratic relationships existed for any of the 
mitogens.
Humoral Immunity 
Mean plasma protein concentrations for all rats 
increased during the eight-week experiment. Rats consuming 
diets with 50 ug magnesium and 0.5 ug copper/gm or 160 ug 
magnesium and 2.0 ug copper/gm had significantly lower 
plasma protein concentrations than animals on the other 
dietary treatments (Table 43). Plasma protein depression 
caused by the 2.0 ug copper/gm diet occurred only when the 
diet contained 160 ug magnesium/gm.
The lower plasma protein content could be attributed to 
lower mean amounts of albumin, and the alpha 1 and gamma 
globulins. A large decrease in the gamma globulins from the 
severely deficient rats was observed at the eight-week 
sample (0.02+0.03 gm/100 ml) when compared to the result of 
the four-week sample (0.104^0.02 gm/100 ml).
138
Table 43. Least square mean total plasma protein, albumin
and globulins (gm/100 ml) for each combined magnesium and
copper dietary treatment for both sampling periods (n=10).
Globulins
Diet
ug/gm
Total
Protein Albumin A1 A2 Beta Gamma
A/G
Ratio
50 Mg 
0.5 Cu 
SE
6 .01c
0.35
3.22c
0.22
0.48c
0.07
0.52
0.05
1.73
0.10
0.06a
0.02
1.15 
0.07
160 Mg 
2.0 Cu 
SE
6.64a 
0. 35
3.76
0.24
0.85a
0.06
0. 39 
0.04
1.59
Q . 09
0.12
0.02
1.26
0.06
280 Mg 
2.0 Cu 
SE
7.63
0.33
3.97
0.24
0.91
0.07
0.56
0.05
1 .96a 
0.10
0.14
0.02
1.18 
0.07
160 Mg 
3.5 Cu 
SE
7. 19 
0.33
4.15
0.22
1.08 
0.06
0.46
0.05
1.40 
0.10
0 . 10 
0.02
1. 37 
0.06
280 Mg 
3.5 Cu 
SE
6.96
0.31
3.93
0.20
0.98
0.06
0.45
0.04
1.47
0.10
0.11
0.02
1.31
0.06
400 Mg 
5.0 Cu 
SE
7 .67 
0. 30
4.35 
0 . 20
1.06 
0.06
0. 53 
0.04
1.66 
0.09
0.10
0.02
1.30 
0.06
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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When expressed as a percent of total protein, the 
albumin and gamma globulin levels were similar among all 
dietary treatments. The percent of alpha 1 was significantly 
lower for the severely deficient rats with higher 
percentages for the alpha 2 and beta globulins. The rats 
consuming the 160 ug magnesium and 2.0 ug copper/gm diet had
lower percentages of the alpha 2 globulins, and a slightly
higher percentage of the gamma globulins, although these
differences were not significant.
The severely deficient rats also had significantly 
lower levels of IgM and IgG as shown in Table 44. IgM was 59 
percent of the control concentration and IgG was 53 percent 
of the control. In contrast, rats consuming moderately 
deficient levels of copper (2.0 ug/gm), regardless of 
magnesium content, had higher levels of IgM and IgG compared 
to the control animals. No significant changes occurred 
between the four- and eight-week sampling periods.
When mean comparisons were conducted on the specific 
antibody response data, large variation contributed to no 
statistical differences among the diets, although some 
general trends appeared. Table 45 shows that mean specific 
antibody titer and log titer for the 50 ug magnesium and 
0.5 ug copper/gm diet were much less than that of the 
control. In addition, the other diet treatments generally 
had titers less than the control diet.
Regression analysis was used to find whether magnesium 
or copper status had an effect on specific antibody
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Table 44. Least square mean IgM and IgG (mg/ml) for each
combined magnesium and copper dietary treatment at each
sampling period (n=5).
Sampling
4
Week
8
Mean
SE
Diet
ug/gm IgM IgG IgM IgG IgM IgG
50 Mg 
0.5 Cu
1.75 6.43 1 .32 3.91 1.53a
0.38
5.17a 
1.44
160 Mg 
2.0 Cu
3.13 10.78 3.84 13.37 3.48
0.35
12.07
1.35
280 Mg 
2.0 Cu
3.85 10.36 3.93 9.96 3.89a
0.39
10.16 
1. 30
160 Mg 
3.5 Cu
2.02 7.26 2.37 11.68 2.20
0.36
9.47 
1.43
280 Mg 
3.5 Cu
2.36 9.35 2.61 12.06 2.49
0.35
10. 71 
1.29
400 Mg 
5.0 Cu
2.42 7.53 2.81 12.06 2.61
0.34
9.79 
1.30
Mean 2.59 8.62 2.81 10. 51
SE 0.20 0.76 0.21 0.80
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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Table 45. Least square mean specific antibody titer and log
titer for each combined magnesium and copper dietary
treatment at each sampling period (n=5).
Sampling Week Mean
8   SE
Diet Log Log Log
ug/gm Titer Titer Titer Titer Titer Titer
50 Mg 24 8 16 5 20 6
0.5 Cu 67 3
160 Mg 73 15 110 19 92 17
2.0 Cu 60 3
280 Mg 67 13 70 14 69 13
2.0 Cu 64 3
160 Mg 297 18 14 13 156 16
3.5 Cu 64 3
280 Mg 93 20 53 12 73 16
3.5 Cu 60 3
400 Mg 113 19 143 17 128 18
5.0 Cu 60 3
Mean 111 16 68 13
SE 35 2 36 2
)
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response, using plasma magnesium or copper as the 
independent variable and antibody titer as the dependent 
variable. At four weeks, no linear or quadratic 
relationships existed. At eight weeks, plasma magnesium and 
the log titer had a significant linear relationship 
(P<0.01), as well as a quadratic relationship (P<0.05).
Neutrophil Function
Neutrophil phagocytosis of E. coli and intracellular 
killing was similar for all rats, except for those consuming 
the 50 ug magnesium and 0.5 ug copper/gm diet. For them, 
significantly more neutrophils phagocytized E. coli, as 
presented in Table 46. Once the bacteria were ingested, 
killing was statistically similar, greater than 80 percent, 
among all dietary treatments. When a magnesium deficient 
medium was used, similar results were found.
Neutrophil MPO activity was significantly higher in the 
50 ug magnesium and 0.5 ug copper/gm dietary treatment 
(Table 47). Furthermore, MPO activity highly correlated with 
neutrophil phagocytosis at four weeks (r=0.64, P<0.001) and 
at eight weeks (r=0.62, P<0.001). Neutrophil SOD was not 
significantly altered by the dietary treatments, as also 
shown in Table 47.
Summary
In general, these experiments indicated that severe 
single nutrient deficiencies affected immunocompetence in
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Table 46. Least square mean neutrophil phagocytosis and
killing (%) for each combined magnesium and copper dietary
treatment for both sampling periods (n=10).
% neutrophils
Diet
ug/gm
without
bacteria
with bacteria, 
not killed
with bacteria, 
killed
50 Mg
0. 5 Cu 20.4c 1.5 78. lc
SE 7.7 0.7 7.9
160 Mg
2.0 Cu 52.0 3.6 44.4
SE 6.8 0.6 7.0
280 Mg
2 .0 Cu 59.0 3.4 37.6
SE 7.3 0.6 7.5
160 Mg
3.5 Cu 62. 7 2.2 35.1
SE 7.3 0.6 7.5
280 Mg
3.5 Cu 60.9 2.3 36.7
SE 6.8 0.6 7.0
400 Mg
5.0 Cu 68.4 2.3 30.4
SE 6.8 0.6 7.0
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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Table 47. Least square mean neutrophil myeloperoxidase (MPO) 
and superoxide dismutase (SOD) in U x 10"7/neutrophil for 
each combined magnesium and copper dietary treatment at each 
sampling period (n=5).
Sampling
4
Week
8
Mean
SE
Diet
ug/gm MPO SOD MPO SOD MPO SOD
50 Mg 
0.5 Cu
1.46 222.8 2. 19 206 .8 1.83' 
0.23
214.8
38.5
160 Mg 
2.0 Cu
0.65 176.8 0.43 142.6 0. 54 
0.20
159.7
31.9
280 Mg 
2.0 Cu
0. 72 205. 3 0.34 121.2 0. 53 
0.22
163. 3 
33.8
160 Mg 
3.5 Cu
0.42 235 . 3 0.42 69.5 0.42 
0 . 22
152.4
33.8
280 Mg 
3.5 Cu
0. 72 108.4 0.80 119.8 0. 76 
0 . 20
114.1
31.9
400 Mg 
5.0 Cu
0.58 216.8 0.32 168.3 0.45
0.20
192.5
31.9
Mean 0. 76 194.2 0. 75 138.0
SE 0 .12 18.8 0.13 20.1
a, different from control (P<0.05)
b, different from control (P<0.01)
c, different from control (P<0.001)
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some way. In addition, marginal single nutrient deficiencies 
depressed some immunological functions, but not to the 
extent as severe deficiencies. The depression of .immunity 
appeared to correlate with the degree of the nutritional 
deficiency, in spite of large variation that existed among 
the animals in each dietary treatment.
In the next chapter a summary of this research project 
and a discussion of each experiment will be presented.
Chapter 5 
SUMMARY AND DISCUSSION
For many years it has been recognized that malnourished 
individuals and animals are more susceptible to disease. 
Dietary deficiencies generally have a negative affect on 
immunocompetence. Both cell-mediated and humoral immunity 
are depressed when the immunological mechanisms are altered, 
but the influence of specific nutrients remains unclear.
When multiple nutrient deficiencies are present in 
malnutrition, it becomes difficult to define the causal 
relationships.
Recently, studies concerning single nutrient 
deficiencies were conducted to gain a clearer understanding 
about the involvement of nutrients in immunity. Most of 
these have used severely deficient animals. But few studies 
to date have investigated marginally deficient animals. 
Therefore, the objectives of this research project were to 
determine: 1) the effects of dietary magnesium or copper 
deficiencies on immune function; and 2) the effects of a 
combined dietary magnesium and copper deficiency on 
immunity. Furthermore, marginal deficiencies were examined 
as well as severe deficiencies.
Previous experiments with magnesium deficient animals 
found leukocytosis with neutrophilia and eosinophilia. In 
severely deficient rats thymic hyperplasia and splenomegaly
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were observed, and immunoglobulin levels and antibody titers 
were depressed.
Other studies involving magnesium deficiencies found a 
depression of lymphocyte proliferation when cells were 
stimulated by various mitogens. DNA and protein synthesis 
were inhibited by magnesium deficiencies, which indicated a 
requirement for the nutrient for lymphocyte proliferation. 
Magnesium also appeared to be required for neutrophil 
phagocytosis. As was pointed out in the review of 
literature, the effect of magnesium on immunocompetence 
appeared to primarily be through its role in protein and DNA 
synthes is.
Other research reviewed suggested that the involvement 
of copper in the immune system may be related to its 
activity in metalloenzymes. Copper deficient animals had 
lower resistance to bacterial infections. Thymus glands were 
small, while spleens were enlarged in laboratory animals. 
Moreover, there was a reduction in antibody-producing cells, 
and lower responsiveness of lymphocytes to mitogen 
stimulation. Finally, neutrophils from copper deficient 
ruminants have shown impaired microbicidal activities, 
possibly caused by changes in SOD activity.
The studies, summarized in the review of literature, 
used diets depleted in magnesium or copper, to produce 
severe deficiencies. Marginal deficiencies, however, are 
becoming more clinically recognized, and the effects of 
these types of deficiencies on immunocompetence are unknown.
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The diets in this research were designed to induce various 
levels of magnesium or copper deficiencies in rats, 
including severe, moderate and mild deficiencies. The 
interactions of the two marginal magnesium and copper 
deficiencies also were included.
Three experiments were conducted to study magnesium 
deficiencies, copper deficiencies, and a combined magnesium 
and copper deficiency. Male rats were placed on a diet with 
severe, moderately marginal, mildly marginal, or adequate 
levels of the appropriate mineral. Their nutritional status 
was monitored every two weeks. Plasma mineral levels, 
hemoglobin, hematocrit and weight gain were assessed.
After three or four weeks, half of the rats in each 
dietary treatment group were euthanized, while the remaining 
rats were euthanized at eight weeks. Immunological analyses 
were conducted, including T- and B-cell quantitation, 
lymphocyte proliferation, specific antibody response, IgG 
and IgM quantitation, and neutrophil phagocytosis and 
killing.
Statistical analyses of the nutritional data .for the 
eight-week time period were conducted with a completely 
randomized split-plot design with repeated measures. 
Immunological data were analyzed using a factorial 
arrangement of diets and sampling-time periods. Pre-test 
data were included as covariates. In addition, regression 
analyses were applied to lymphocyte proliferation and 
antibody responses with nutritional parameters.
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The remainder of this chapter will discuss the major 
findings of each experiment, will present the conclusions, 
and will offer some recommendations for future research.
Discussion 
Experiment 1: Magnesium Deficiencies 
The first outward indication of magnesium deficiency 
appeared within the first two weeks of the experiment. The 
characteristic clinical signs were similar to those reported 
by Aikawa (1981) . The extensive hemorrhagic and necrotic 
skin lesions observed in the rats on the 50 ug magnesium/gm 
diet, were similar to those described by Hunt (1971) in 
young and mature rats after 12 days on a 66 ug magnesium/gm 
diet.
Nutritional Status
Early in the experiment, plasma magnesium reflected the 
amount of magnesium in the diet. Similar findings were 
reported by Hunt (1971). Later, rats consuming the marginal 
levels of dietary magnesium had plasma magnesium levels 
similar to controls.
The young growing animals had a high demand for 
magnesium that was utilized during protein synthesis, bone 
maturation, and for other physiological functions. By eight 
weeks, the rats had reached puberty, growth rate decreased, 
and the high demands for magnesium had diminished. It was
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believed that for this reason, the plasma magnesium pool 
increased.
Although pair-fed rats consumed less food than the ad 
lib control rats, the level of magnesium in their diet,
400 ug/gm, was enough to support adequate magnesium status. 
When the total dietary magnesium intake was calculated as 
mg magnesium consumed/100 gm body weight, the pair-fed rats 
consumed levels of magnesium similar to the ad lib controls. 
On the other hand, the rats on the 50 ug magnesium/gm diet 
had consumed magnesium levels, per 100 gm body weight, that 
were 14 percent of the levels consumed by rats on the 400 ug 
magnesium/gm diets.
The severely deficient (50 ug/gm) and moderately 
deficient (160 ug/gm) diets also caused a decrease in bone 
magnesium concentrations. Hunt (1971) reported a similar 
effect in young rats, and found that changes in dietary 
magnesium in growing animals closely corresponded to changes 
in the concentration of bone magnesium. In this experiment, 
the mild deficiency (280 ug/gm) did not affect bone 
magnesium concentration.
The feed efficiencies explain the differences observed 
in weight gained among the rats receiving the dietary 
treatments. At four weeks, the rats.receiving adequate 
levels of magnesium had the highest feed efficiencies, 
indicating that the feed was effectively utilized for 
growth. The feed efficiencies decreased as dietary magnesium 
levels decreased, thus, total growth had been lowered. At
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eight weeks, the feed efficiencies for the rats on the 
marginal levels of magnesium improved, and total weight 
gains were similar to those of the ad lib control animals.
The rats on the pair-fed treatment had weight gains 
similar to the severely deficient rats throughout the 
experiment due to the caloric restriction, but their feed 
efficiencies were near those of the control animals. The 
severely deficient magnesium diet significantly affected 
feed efficiency and weight gain throughout the experiment. 
Therefore, the magnesium deficiency contributed to a less 
efficient utilization of the feed for growth.
The severely deficient rats had lower hemoglobin 
concentration and hematocrit than the rats on the other 
dietary treatments. It was reported that magnesium 
deficiency produces a hemolytic anemia, perhaps due to a 
loss of membrane integrity and a shortened survival time of 
the erythrocyte (Elin, 1980). This also might explain the 
lower mean hematocrit and hemoglobin concentrations found 
with the rats on the moderately deficient, 160 ug 
magnesium/gm diet.
Lymphoid Organs
Only the severely deficient, 50 ug magnesium/gm diet 
affected spleen weight. The significantly enlarged spleens 
were similar to those reported by others (Alcock, et a l ., 
1973; Elin, 1975; McCoy and Kenney, 1975; Zieve, et al.,
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1977). Thymuses were not altered, unlike those in the 
experiment by Alcock, et al. (1973).
Cellular Immunity 
Leukocytic Effects
The typical leukocytosis, eosinophilia, and 
neutrophilia described in rats consuming diets with 30 to 
60 ug magnesium/gm (Battifora, et a l ., 1968; Hass, et a l ., 
1980) was seen in the severely deficient (50 ug/gm) rats in 
this experiment. The mean total WBC count for the rats on 
the 280 ug magnesium/gm diet also was significantly higher 
than those on the 160 ug magnesium/gm and 400 ug 
magnesium/gm diets. One rat on the 280 ug magnesium/gm diet 
had a high total WBC count (29.9 x 103/ul), which skewed the 
mean total WBC count. Excluding that rat, the mean total WBC 
count for the 280 ug magnesium/gm treatment group was 7.6 x 
103/ul, which was similar to the control rats and those rats 
in the other marginally deficient group.
Lymphocyte Proliferation
Dietary magnesium deficiencies did not alter in vitro 
lymphocyte proliferation when peripheral blood mononuclear 
cells were stimulated by the mitogens, PHA, Con A and PWM. 
The incubation medium, RPMI, contained magnesium ions, which 
might have allowed for the normal regulation of electrolyte 
concentrations and normal cell proliferation. Recently, it 
was shown that iri vitro alterations in extracellular Mg2 +
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content affected cell membrane permeability and the Ca2+ 
pump, and thus affected DNA synthesis and cell proliferation 
(Sanui and Rubin, 1982; Abboud, et a l ., 1985; Okazaki, et 
al., 1987).
The results of this experiment support the suggested 
effects of extracellular magnesium on lymphocyte 
proliferation. The peripheral lymphocytes from the deficient 
rats in this experiment had response rates similar to 
controls. It appeared that perhaps alterations did not occur 
in the cell itself during magnesium deficiency. Instead, the 
availability of extracellular magnesium must be adequate for 
normal proliferation.
Gunther and Averdunk (1979) observed lower 
proliferation rates of magnesium deficient rat spleen and 
thymus cells incubated in normal RPMI. The stimulation rates 
in the control cells also were relatively low when compared 
to peripheral lymphocytes. The two authors suggested that 
the lower rates were due to fewer mitotically active cells 
present in the thymus in contrast to the peripheral 
lymphocytes.
Humoral Immunity
Plasma Proteins and Immunoglobulins
Total plasma protein, albumin and globulin 
concentrations for all rats, except the severely deficient 
rats, were within the normal range as reported by Mitruka 
and Rawnsley (1977). Rats consuming 50 ug magnesium/gm had
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significantly reduced plasma proteins. This result was not 
surprising due to the role of magnesium in protein synthesis 
(Aikawa, 1981). The marginal deficiencies provided adequate 
amounts of magnesium for the synthesis of albumin and the 
globulins.
Part of the reduction in total plasma protein in the 
severely deficient rats was a result of a decrease in gamma 
globulins. IgM and IgG, which comprise most of the gamma 
globulins, also were decreased. Similar changes were found 
by other investigators (Alcock and Shils, 1974; Elin, 1975; 
McCoy and Kenney, 1975). In this experiment, the moderately 
deficient rats (160 ug/gm) also had lower IgG levels than 
control rats. Overall, plasma magnesium concentrations 
appeared to influence immunoglobulin levels, based on the 
correlation between the two, especially early in the 
experiment.
The pair-fed rats had plasma protein and immunoglobulin 
levels similar to the ad lib control rats. The restriction 
of total calories did not appear to depress protein 
synthesis. Therefore, the reduction in protein synthesis 
seen in the rats consuming 50 ug magnesium/gm was associated 
with the magnesium deficiency and not with a more 
generalized malnutrition.
Antibody Response
The rats were immunized once with a sheep red blood 
cell suspension, initiating a primary immune response. The
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specific antibody titers appeared to correspond with IgM 
levels both at three weeks and at eight weeks. IgM 
concentrations and mean titers were lower for the severely 
deficient rats, but the difference in specific antibody 
response was not statistically significant. The tendency for 
the severely deficient rats to have lower titers paralleled 
the reduction in plasma protein synthesis.
Antibody formation is dependent on antigen presentation 
by the macrophage to T cells, and with the production of 
interleukins, stimulate B cells, which undergo 
transformation to blast cells (Golub, 1981). In this 
experiment, the percentages of peripheral T- and B-cells did 
not differ among the dietary treatments, nor did the 
proliferation rates of the peripheral blood mononuclear 
cells. Lower mean specific antibody titers in the severely 
deficient rats probably were not the result of changes in 
the T cell/B cell interactions, but rather were due to a 
failure to synthesize interleukins or the antibody protein.
Neutrophil Function
In vitro neutrophil phagocytosis of E. coli and 
intracellular killing was not affected by magnesium 
deficient diets. This was true when Mg2* was adequate or 
deficient in the incubation medium. Extracellular magnesium 
has been shown to enhance neutrophil ingestion (Stossel,
1973) and NADPH oxidase activity (Johnston, et a l ., 1985).
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The magnesium concentration in the deficient medium might 
have been sufficient for optimum phagocytosis.
Experiment 2: Copper Deficiencies 
Three unexpected deaths occurred in the severely 
deficient, 0.5 ug copper/gm dietary treatment group within 
the first half of the experiment after obtaining blood 
samples. Excessive hemorrhages were found in the 
pericardium.
Changes in the morphology of the heart have been 
observed in copper deficient animals, and in rats, the heart 
becomes pale and friable (Fell, 1987). Studies have shown a 
reduction in lysyl oxidase activity, and thus, a failure of 
elastin and collagen biosynthesis. The strength of the 
cardiac tissues was reduced. Additionally, a high proportion 
of copper deficient rats died from rupture of the myocardium 
(Davis and Mertz, 1987). It was believed that for this 
reason, the hearts of the copper deficient rats in this 
experiment could not properly heal after the cardiac 
puncture.
Nutritional Status
Plasma copper concentrations rapidly reflected the 
dietary levels of copper throughout the experiment. Rats 
consuming 0.5 ug copper/gm were severely deficient in plasma 
copper throughout the eight weeks, and those consuming
2.0 ug copper/gm were moderately deficient throughout the
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eight-week time period. Rats on the 3.5 ug copper/gm diet 
were mildly deficient in plasma copper during the first half 
of the experiment. Later, their plasma copper concentrations 
remained lower than the controls, but they were not 
significantly different.
Although pair-fed rats consumed less food than the ad 
lib control rats, the level of copper in their diet,
5.0 ug/gm, was enough to support adequate copper status.
When the total dietary copper intake was calculated as mg 
copper consumed/100 gm body weight, the pair-fed rats 
consumed levels of copper similar to the ad lib controls. On 
the other hand, the rats on the 0.5 ug copper/gm diet had 
consumed copper levels, per 100 gm body weight, that were 
less than 10 percent of the levels consumed by rats on the
5.0 ug copper/gm diets.
A decline in Cp activity was observed, and was highly 
correlated with plasma copper. All levels of dietary copper, 
including the marginal levels, were reflected in the Cp 
activities. This was reported in other experiments involving 
copper deficient rats (Davis and Mertz, 1987; Frieden and 
Hsieh, 1976; Prohaska, et a l ., 1983).
The characteristic microcytic and hypochromic anemia 
due to a severe copper deficiency was present in the rats of 
this experiment consuming 0.5 ug copper/gm diet. Three 
factors known to contribute to the anemia are: 1) defects in 
heme synthesis caused by reduced Cp activity; 2) a delay in
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the maturation of red blood cells; and 3) a shortened 
survival time of circulating red blood cells (Fell, 1987).
These factors may occur only in severe or prolonged 
copper deficiency. This may explain why the severely 
deficient rats on the 0.5 ug copper/gm diet were anemic 
throughout the experiment, while those rats on the 2.0 ug 
copper/gm diet only began to develop anemia after the fourth 
week of the experiment.
Liver copper concentration also was affected by the 
copper content of the diet, and was related to plasma copper 
and Cp activity. Others have found similar results in rats 
(Davis and Mertz, 1987) and in mice (Prohaska, et a l .,
1983) .
The livers from the severely deficient rats were 
significantly enlarged relative to total body size. In 
addition, rats on the 2.0 ug copper/gm diet also tended to 
have larger livers in proportion to body size. Severe and 
prolonged marginal deficiencies in rats were shown to be 
accompanied by enlargement of hepatocyte mitochrondria 
(Fell, 1987).
The feed efficiencies may explain the differences 
observed in weight gain. The rats consuming marginal and 
adequate levels of copper had similar feed efficiencies, and 
total weight gains were statistically similar. The severely 
deficient level of copper significantly decreased feed 
efficiency and growth. Pair-fed rats were similar in weight
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to their mates as a result of a restriction in calories, but 
feed utilization was better.
Lymphoid Organs
Thymus glands from the severely copper deficient rats 
(0.5 ug/gm), when expressed as a percent of total body 
weight, were significantly smaller than those from all other 
rats. This also was observed in mice (Prohaska, et a l ., 
1983). In this experiment, spleen size and weight were not 
affected by dietary copper deficiencies.
Cellular Immunity 
Leukocytic Effects
Dietary copper deficiencies did not alter total white 
blood cell counts, nor did they largely change the 
differential counts. Furthermore, T and B cell percentages 
were similar among all dietary treatment groups. All values 
were within the normal ranges for laboratory rats (Baker, et 
a l ., 1980; Carter and Bazin, 1980).
Lymphocyte Proliferation
All lymphocyte stimulation indexes (SI) for PHA, Con A, 
and PWM were approximately 50 percent lower for the 0.5 ug 
copper/gm group than for all other treatment groups, even 
though the differences were not statistically significant. 
These results were similar to those reported by Lukasewycz 
and Prohaska (1983) for copper deficient mice splenocytes.
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The SI for PHA and PWM were lowered by the marginal 
deficiencies to some extent. The significant regression 
analysis for the PHA CPM and SI data indicated that cell 
proliferation, when stimulated by PHA, was dependent on the 
copper status of the animal, as determined by plasma copper 
concentrations. Lukasewycz, et a l . (1987) recently suggested
that the reduction of cellular proliferation appeared to be 
proportional to the degree of copper deficiency. This seemed 
to be true in regards to PHA in this experiment.
On the other hand, the mean SI for Con A in the 
marginally deficient diet treatments were higher than that 
for the control group. These differences occurred at eight 
weeks, when the SI for both treatments were more than twice 
that for the control. The differences were not statistically 
significant, but suggested that there might be more 
suppressor T cell activity in the marginally deficient 
copper rats.
Davis, et a l . (1987) recently found that the rate of
lymphoid cell proliferation after Con A stimulation was 
according to tissue source. Cervical lymph node cells from 
copper deficient rats consuming 0.6 ug copper/gm diets had 
higher proliferation rates, while spleen cells had lower 
rates of proliferation. In this experiment the peripheral 
lymphocytes from rats consuming 0.5 ug copper/gm diets had 
lower proliferation rates than those from control rats.
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Humoral Immunity
Plasma Proteins and Immunoglobulins
Total plasma protein, albumin and globulin 
concentrations were not altered by dietary copper 
deficiencies. All groups were within the normal range 
(Mitruka and Rawnsley, 1977). Although the gamma globulin 
concentration for the severely deficient rats was similar to 
the other rats, the concentration of IgM was significantly 
lower in this group.
Antibody Response
Humoral-mediated immunity was found to be impaired in 
copper deficient mice (Prohaska and Lukasewycs, 1981; 
Lukasewycz and Prohaska, 1981) and rats (Roller, et a l ., 
1987). In this study, the impairment of the primary response 
to heterologous RBCs was found in the marginally deficient 
rats after eight weeks. Regression analysis suggested that 
specific antibody response was dependent on the plasma 
copper status of the animal. Rats with low plasma copper had 
titers similar to rats with high plasma copper, while those 
with marginal levels of plasma copper had lower titers.
The difference in specific antibody response may be 
explained by the difference found in the marginally 
deficient copper diet treatments in Con A stimulation of the 
lymphocytes. The results indicated higher proliferation 
rates by Con A, suggesting greater suppressor T cell
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proliferation. And, suppressor T cells act to depress 
antibody responses (Golub, 1981).
On the other hand, rats with low plasma copper tended 
to have high specific antibody titers. Rats on the severely 
deficient diet had a Con A SI that was approximately one- 
third of the control values. The reduction in suppressor 
T cell proliferation might be one factor which would allow 
for antibody responses to continue with less regulation.
Neutrophil Function
Investigations of ruminant neutrophil function have 
shown a depression of candidacidal activity with copper 
deficiencies (Jones and Suttle, 1981; Arthur, et a l ., 1981; 
Boyne and Arthur, 1981; Arthur and Boyne, 1985). In 
contrast, the phagocytosis and bactericidal activity of 
neutrophils from copper deficient rats in this experiment 
were not affected. Ingestion of E. coli by the neutrophils 
from the severely deficient rats on the 0.5 ug copper/gm 
diet tended to be higher, but the killing capacity was not 
different than that for neutrophils from the other animals.
During phagocytosis, O 2 - is produced and is involved in 
bacterial killing (Babior, et a l . , 1973). The cuproenzyme, 
SOD, in neutrophils scavenges the ions to protect the cell 
from oxidative damage. It had been proposed that impaired 
microbicidal activity of neutrophils from copper deficient 
animals was associated with a lack of SOD (Jones and Suttle, 
1981). But, neutrophils from copper deficient cattle did not
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have reduced SOD activity (Boyne and Arthur, 1981). In this 
experiment, rat neutrophil SOD activity was not altered by 
changes in plasma copper or Cp.
Neutrophil SOD also is required for the dismutation of 
02“ to H 2 O 2 . MPO reacts with H 2 O2 to form hydroxyl radicals 
which are potent cytotoxic agents against microorganisms 
(Klebanoff, et a l ., 1984). It was postulated that perhaps a 
defect in MPO, a heme enzyme, may result from decreased Cp 
ferroxidase activity from copper deficiency. It was observed 
that MPO activity significantly correlated with neutrophil 
microbicidal activity. But, a reduction of Cp activity in 
the copper deficient rats did not affect neutrophil MPO 
activity.
Experiment 3: Magnesium and Copper Deficiencies 
Rats on the severely deficient diet with 50 ug 
magnesium and 0.5 ug copper/gm began to show clinical signs 
of the magnesium deficiency within the first two weeks.
These were similar to those described in Experiment 1.
During the fifth week of the experiment, seizure 
activity was observed in one of the severely deficient rats. 
A study of seizure susceptibility with magnesium deficiency 
found that rats fed diets with 60 ug magnesium/gm and 
adequate levels of calcium and phosphorus were highly prone 
to seizures (Chaistitwanich, el a l ., 1987). The authors 
found that all rats consuming the diet had low serum 
magnesium and elevated levels of serum potassium. This
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condition favored seizures which were observed in all rats 
in the treatment group.
Nutritional Status
Both plasma magnesium and copper concentrations 
reflected the amount of mineral in the diet. The differences 
were apparent at two weeks, and continued throughout the 
eight-week time period. Cp activity followed plasma copper 
concentrations. Additionally, bone magnesium and liver 
copper content were indicative of dietary magnesium and 
copper content, respectively. These patterns were similar to 
those in the first two experiments.
The combined severe magnesium and copper deficiency 
produced anemia that by eight weeks was more severe than the 
anemia found in rats deficient in only one of the minerals. 
The anemia appeared to be hemolytic, microcytic and 
hypochromic. Reticulocytosis was common. Contributing to the 
severe anemic state was diminished cell membrane integrity 
from the magnesium deficiency (Elin, 1980), and a defect in 
heme synthesis from the copper deficiency (Fell, 1987). Both 
mineral deficiencies delayed maturation and shortened 
survival time of the erythrocyte (Elin, 1980; Fell, 1987). 
Marginal deficiencies did not produce anemia.
The combined magnesium and copper marginal deficiencies 
did not affect growth of the rats. Only those consuming the 
severely deficient diet with 50 ug magnesium and 0.5 ug 
copper/gm gained significantly less weight. The feed
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efficiency for those rats was lower, indicating that 
utilization of the feed was poor.
Lymphoid Organs
In this experiment, both the spleen and thymus of the 
severely deficient rats were affected. Enlarged spleens, 
common in magnesium deficiencies (Alcock, et a l ., 1973;
Elin, 1975; McCoy and Kenney, 1975; Zieve, et a l ., 1977) and 
also reported in copper deficiencies (Prohaska, et a l .,
1983) were found in the rats on the 50 ug magnesium and 
0.5 ug copper/gm diet. Thymus glands were small, as reported 
in copper deficiencies (Prohaska, et a l ., 1983), rather than 
enlarged as reported in magnesium deficiencies (Alcock, et 
a l ., 1973). The other treatments did not affect spleen and 
thymus weights.
Cellular Immunity 
Leukocytic Effects
Leukocytosis and neutrophilia was present in the rats 
on the 50 ug magnesium and 0.5 ug copper/gm diet during the 
first half of the experiment. This corresponded to the 
effects reported with a magnesium deficiency (Battifora, et 
a l . , 1968; Hass et a l ., 1980). Although the nutritional 
status of the rats remained poor at eight weeks, the total 
WBC and neutrophil counts improved to come within the normal 
range. McCreary, et a l ., (1967) found a tendency of elevated
leukocyte counts to diminish after two weeks. They found
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that to sustain leukocytosis in rats, the magnesium content 
of the diet had to be reduced to 30 ug/gm.
A combined severe deficiency of magnesium (50 ug/gm) 
and copper (0.5 ug/gm), and a combined moderate deficiency 
of magnesium (160 ug/gm) and copper (2.0 ug/gm) elevated 
T cell percentages. This did not happen when either mineral 
was deficient in Experiments 1 and 2. The elevated T cell 
percentage has not been reported in the major literature for 
either mineral. All other dietary deficiency treatments were 
similar to the control treatment.
Lymphocyte Proliferation
Proliferation responses of cells stimulated with PHA 
tended to be lower in the 50 ug magnesium and 0.5 ug 
copper/gm diet treatment group. Lower rates have been 
reported by others with splenocytes and thymocytes from 
magnesium deficient rats (Gunther and Averdunk, 1979), and 
splenocytes from copper deficient mice (Lukasewycz and 
Prohaska, 1983).
The stimulation indexes for Con A were higher in the 
50 ug magnesium and 0.5 ug copper/gm treatment and in the 
280 ug magnesium and 2.0 ug copper/gm treatment. In 
Experiment 2, marginal copper deficiencies also increased 
Con A stimulation rates, but the severe copper deficiency 
decreased the SI. The differences, however, were not 
statistically significant.
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Significantly lower proliferation rates were found when 
the lymphocytes from rats consuming diets deficient in 
magnesium (50 ug/gm and 280 ug/gm) and in copper (0.5 ug/gm 
and 2.0 ug/gm) were stimulated with PWM. Splenocytes from 
mice consuming a 0.6 ug copper/gm diet, also had reduced 
proliferation rates when stimulated with PWM (Lukasewycz and 
Prohaska, 1983).
Together, the higher Con A and lower PWM rates would 
suggest that cell-mediated responses may be altered in the 
treatment groups with the severe combined deficiencies and 
the marginal deficiencies with 2.0 ug copper/gm.
Humoral Immunity
Plasma Proteins and Immunoglobulins
Total plasma proteins were reduced by a combined severe 
deficiency of magnesium (50 ug/gm) and copper (0.5 ug/gm), 
and by a combined moderate deficiency of magnesium 
(160 ug/gm) and copper (2.0 ug/gm). The effect of the severe 
deficiency was expected because of the role of magnesium in 
protein synthesis (Aikawa, 1981). In Experiment 1, the 
marginal magnesium deficiencies did not affect total plasma 
proteins. Yet, in combination with the copper deficiency, 
the 160 ug/gm level of magnesium did reduce total plasma 
proteins.
The gamma globulins were dramatically reduced during 
the eight-week experiment in the 50 ug magnesium and 0.5 ug 
copper/gm treatment. This was consistent with the
1 6 8
significantly lower concentrations of IgM and IgG. Similar 
decreases were found in Experiment 1 with the 50 ug 
magnesium/gm treatment, and in Experiment 2 for IgM in the 
0.5 ug copper/gm treatment.
Antibody Response
Mean specific antibody response for the treatments 
appeared to follow the lymphocyte stimulation rates with 
PWM. Those treatments with low transformation in response to 
PWM also tended to have low specific antibody titers. PWM is 
a stimulator of B cells, resulting in B cell proliferation. 
Therefore, reduced B cell proliferation and differentiation 
would decrease antibody production (Golub, 1981).
A primary antibody response was measured, rather than a 
secondary response because the rats were immunized once, six 
days prior to sampling. The decrease in IgM in the 50 ug 
magnesium and 0.5 ug copper/gm treatment corresponded with 
the low specific antibody titer. This was not true, however, 
for the rats on the diets with 2.0 ug copper/gm, that had 
higher IgM levels.
Neutrophil Function
A greater percentage of neutrophils from the severely 
deficient rats consuming the 50 ug magnesium and 0.5 ug 
copper/gm diet ingested E. coli than neutrophils from rats 
in all other treatment groups. But, bactericidal activity 
did not differ among the treatments. When the neutrophils
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were incubated in a magnesium deficient medium, the results 
were the same.
In Experiment 2, slightly more neutrophils from rats 
consuming a diet with 0.5 ug copper/gm ingested the E.coli. 
when compared to neutrophils from the other treatments, but 
the difference was not statistically significant. In this 
experiment, with the additional magnesium deficiency, the 
ingestion by neutrophils was significantly higher.
Neutrophils produce a "respiratory burst" when 
stimulated, altering oxygen metabolism to generate 
microbicidal oxidants. The membrane bound enzyme that 
catalyzes the reduction of oxygen to O 2 ■ is NADPH oxidase 
(Cross, et a l ., 1985; Markert, et a l ., 1985).
Oxidase activity is low in resting cells, and the 
phagocyte must be stimulated to transform the latent 
activity to an expressed activity (Forman and Thomas, 1986). 
The transformation and activation processes must occur for 
greater phagocytic responses. These appear to be receptor- 
mediated processes, and involve depolarization of membrane 
potential. Changes in Ca2 + also appear to occur in the 
stimulation process. The specific factors involved are 
uncertain.
In this experiment, alterations in Mg2+ and Cu2♦, with 
possible changes in Ca2+ or Zn2+ metabolism might have 
affected the oxidase system and phagocytosis.
In this experiment, as in the second experiment, 
neutrophil SOD activity was not altered by copper
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deficiencies. On the other hand, MPO activity was 
significantly higher in the neutrophils from rats on the 
50 ug magnesium and 0.5 ug copper/gm diet. Furthermore, MPO 
activity significantly correlated with neutrophil 
microbicidal activity.
It was thought, however, that in the deficient 
treatment groups, there would have been a reduction of MPO 
activity because of depressed Cp ferroxidase activity from 
the copper deficiency. Cp did not affect another heme 
enzyme, catalase, at four weeks. But later, Cp and catalase 
activity were correlated. Effects from the ferroxidase 
activity of Cp may occur after a prolonged deficiency.
Conclusions
The dietary treatments used in these experiments were 
successful in inducing severe and marginal deficiencies in 
the rats as indicated by the nutritional parameters. 
Differences among all treatments were found midway through 
the experiment. By the end of the experiments, rats 
consuming severely deficient diets (50 ug magnesium/gm or 
0.5 ug copper/gm) remained in a poor nutritional state. Rats 
consuming the marginally deficient diets tended to improve, 
with rats on the mildly deficient diets (280 ug magnesium/gm 
or 3.5 ug copper/gm) becoming similar in nutritional status 
to the control animals.
The severe dietary deficiencies of magnesium and/or 
copper affected immunocompetence of the rats in these
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experiments. In general, lower specific antibody titers and 
depressed lymphocyte proliferation responses were found. 
However, many of the results were not statistically 
significant because of the large variation in the responses. 
A magnesium deficiency appeared to have its effect on 
protein synthesis, while a copper deficiency altered 
cellular proliferation by some unknown mechanism. 
Furthermore, a severe copper deficiency increased neutrophil 
phagocytosis of bacteria, but killing was not changed.
Marginal deficiencies did not always alter immune 
function. One finding, even though not statistically 
significant, was the increased response of the lymphocytes 
to Con A stimulation with a corresponding decrease in 
antibody production. Overall, other cellular and humoral 
immune responses, and neutrophil functions were not affected 
by marginal deficiencies.
In the final analysis, the results suggested that 
within some physiological interval, a marginal deficiency of 
magnesium or copper would not effect immune function. But, 
beyond that interval a deficiency would become critical to 
optimum immunocompetence.
Recommendations for Further Research 
One limitation of the experiments in this research 
project were the number of rats used in each treatment 
group. The large variation in the immunological responses 
contributed to not being able to detect significant
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differences. This can only be overcome by larger sample 
sizes. The resources also must be present, however, to 
handle the larger number of animals and samples.
Unlike previous studies, this project investigated the 
effects of marginal single nutrient deficiencies on immune 
function. More experiments are required to explore these 
effects of not only magnesium and copper, but also other 
essential nutrients. Furthermore, the effects of long-term 
marginal deficiencies is unknown. Other experiments may 
study the deficiencies in older animals and for a time 
period that extends beyond eight weeks.
It appeared that marginal copper deficiencies might 
increase T suppressor cell proliferation and
differentiation. Confirmation of these results is indicated. 
Another study could determine the mechanism that might be 
altered by the change in copper status could be done. 
Furthermore, more information is required about how single 
nutrients are involved in immune mechanisms.
One experiment in this research project investigated a 
combined magnesium and copper deficiency. Ingestion by 
neutrophils from rats deficient in both nutrients was 
greater than those from control animals. The biochemical 
reactions responsible for this change may be observed in 
another study. Other combinations of minerals could be 
explored to provide more information on nutrient 
interactions in the immune system.
BIBLIOGRAPHY
173
174
Abboud, C.N., Scully, S.P., Lichtman, A.H., Brennan, J.K. 
and Segel, G.B. (1985) The requirements for ionized 
calcium and magnesium in lymphocyte proliferation. J. 
Cell. Physiol. 122, 64-72.
Aebi, H. (1984) Catalase in_ vitro. Methods Enzymol. 105, 
121-126.
Aebi, H. and Suter, H. (1969) Catalase. In: Biochemical
Methods in Red Cell Genetics (Yunis, J.J., ed.), pp. 
255-288, Academic Press, New York.
Aikawa, J.K. (1981) Magnesium: Its Biologic Significance,
CRC Press, Inc., Boca Raton, Florida.
Alcock, N.W. and Shils, M.E. (1974) Serum immunoglobulin G 
in the magnesium-depleted rat. Proc. Soc. Exp. Biol. 
Med. 145, 855-858.
Alcock, N.W., Shils, M.E., Lieberman, P.H. and Erlandson, 
R.A. (1973) Thymic changes in the magnesium-depleted 
rat. Cancer Res. 33, 2196-2204.
Alford, R.H. (1970) Metal cation requirements for
phytohemagglutinin-induced transformation of human 
peripheral blood lymphocytes. J. Immunol. 104, 698- 
703.
Allen, T.A. (1986) Specialized nutrition. Proc. Amer.
College Vet. Int. Med. 2, 55-64.
American Institute of Nutrition (1977) Report of the AIN Ad 
Hoc Committe on standards for nutritional studies. J. 
Nutr. 107, 1340-1348.
175
Andrewartha, K.A. and Caple, I.W. (1980) Effects of changes 
in nutritional copper on erythrocyte superoxide 
dismutase activity in sheep. Res. Vet. Sci. 28, 101- 
104.
Arthur, J.R. and Boyne, R. (1985) Superoxide dismutase and 
glutathione peroxidase activities in neutrophils from 
selenium deficient and copper deficient cattle. Life 
Sci. 36, 1569-1575.
Arthur, J.R., Boyne, R., Okolow-Zubkowska, M.J. and Hill, 
H.A.O. (1981) Neutrophils from Se and Cu deficient 
cattle. In: Trace Element Metabolism in Man and Animals 
(Gawthorne, J.M., Howell, J.McC. and White, C.L., eds), 
pp. 368-370, Springer-Verlag, New York.
Babior, B.M., Kipnes, R.S. and Curnutte, J.T. (1973) The 
production by leukocytes of superoxide, a potential 
bactericidal agent. J. Clin. Invest. 52, 741-744.
Baker, H.J., Lindsey, J.R. and Weisbroth, S.H. (1980)
Selected normative data. In: The Laboratory Rat, Vol.
II (Baker, H.J., Lindsey, J.R. and Weisbroth, S.H., 
eds.), pp. 257-258, Academic Press, New York.
Barta, O., Oyekan, P.P. and Shaffer, L.M. (1984a) Lymphocyte 
transformation (activation) test. In: Laboratory 
Techniques of Veterinary Clinical Immunology (Barta,
O . , ed. ), pp. 86-100, Charles C.. Thomas, Springfield, 
Illinois.
Barta, O. and Pourciau, S.S. (1984) Electrophoresis. In:
Laboratory Techniques of Veterinary Clinical Immunology
176
(Barta, 0., ed.)» PP* 116-122, Charles C. Thomas, 
Springfield, Illinois.
Barta, 0., Pourciau, S.S. and Hubbert, N.L. (1986b)
Immunoelectrophoretic techniques. In: Laboratory 
Techniques of Veterinary Clinical Immunology (Barta,
0., ed.), pp. 123-137, Charles C. Thomas, Springfield, 
Illinois.
Battifora, H.A., McCreary, P.A., Hahneman, B.M., Laing, G.H. 
and Hass, G.M. (1968) Chronic magnesium deficiency in 
the rat. Arch. Pathol. 86, 610-620.
Beauchamp, C.O. and Fridovich, I. (1973) Isozymes of
superoxide dismutase from wheat germ. Biochim. Biophys. 
Acta. 317, 50-64.
Beisel, W.R. (1977) Magnitude of the host nutritional
responses to infection. Am. J. Clin. Nutr. 30, 1236- 
1247.
Beisel, W.R. (1980) Effects of infection on nutritional 
status and immunity. Fed. Proc. 39, 3105-3108.
Beisel, W.R. (1982) Single nutrients and immunity. Am. J.
Clin. Nutr. 35 (Suppl. 2), 417-468.
Beisel, W.R., Edelman, R., Nauss, K. and Suskind, R.M.
(1981) Single-nutrient effects on immunologic 
functions. J. Am. Med. Assoc. 245, 53-58.
Bois, P. (1963) Effect of magnesium deficiency on mast cells 
and urinary histamine in rats. B r . J. Exp. Path. 44, 
151-155.
Bowen-Pope, D.F., Vidair, C., Sanui, H. and Rubin, A.H.
(1979) Separate roles for calcium and magnesium in 
their synergistic effect on uridine uptake by cultured 
cells: significance for growth control. Proc. Natl. 
Acad. Sci. USA. 76, 1308-1312.
Boyne, R. and Arthur, J.R. (1981) Effects of selenium and
copper deficiency on neutrophil function in cattle. J. 
Comp. Path. 91, 271-276.
Boyne, R. and Arthur, J.R. (1986) Effects of molybdenum or 
iron induced copper deficiency on the viability and 
function of neutrophils from cattle. Res. Vet. Sci. 41, 
417-419.
Bradley, P.P., Christensen, R.D. and Rothstein, G. (1982a) 
Cellular and extracellular myeloperoxidase in pyogenic 
inflammation. Blood. 60, 618-622.
Bradley, P.P., Priebat, D.A., Christensen, R.D. and 
Rothstein, G. (1982b) Measurement of cutaneous 
inflammation: estimation of neutrophil content with an 
enzyme marker. J. Invest. Dermatol. 78, 206-209.
Brennan, J.K., Seelig, C.B. and Lichtman, M.A. (1980) The 
role of magnesium in neutrophil production and 
function. In: Magnesium in Health and Disease (Cantin, 
M. and Seelig, M.S., eds), pp. 169-183, Spectrum 
Publications, Inc., New York.
Brewer, N.R. (1987) Comparative metabolism of copper. J. Am. 
Vet. Med. Assoc. 190, 654-658.
178
Camakaris, J. (1987) Copper transport absorption and
storage. In: Copper in Animals and Man, Vol. I (Howell, 
J.McC. and Gawthorne, J.M., eds.), pp. 63-77, CRC 
Press, Inc., Boca Raton, Florida.
Carter, P.B. and Bazin, H. (1980) Immunology. In: The
Laboratory Rat, Vol. II (Baker, H.J., Lindsey, J.R. and 
Weisbroth, S.H., eds.), pp, 181-212, Academic Press,
New York.
Carthew, G.W. and Dey, R.L. (1985) A rapid tissue extraction 
method for determining liver copper content by atomic 
absorption spectroscopy. N. Z. Vet. J. 33, 168-170.
Chaistitwanich, R., Mahoney, A.W., Hendricks, D.G. and
Sisson, D.V. (1987) Dietary calcium and phosphorus and 
seizure susceptibility of magnesium deficient rats. 
Pharmacol. Biochem. Behav. 27, 443-449.
Chandler, L.U. (1951) Nutritional aspects of resistance. J. 
Am. Vet. Med. Assoc. 118, 179-183, 256-260.
Chandra, R.K. (1980) Cell-mediated immunity in nutritional 
imbalance. Fed. Proc. 39, 3088-3092.
Chandra, R.K. (1988) Nutrition and Immunology, Alan R. Liss, 
Inc., New York.
Chandra, R.K. and Dayton, D.H. (1982) Trace element
regulation of immunity and infection. Nutr. Res. 2, 
721-733.
Chandra, R.K., Joshi, P., Au, B., Woodford, G. and Chandra, 
S. (1982) Nutrition and immunocompetence of the 
elderly: effect of short-term nutritional
179
supplementation on cell-mediated immunity and 
lymphocyte subsets. Nutr. Res. 2, 223-232.
Chandra, R.K. and Newberne, P.M. (1977) Nutrition, Immunity, 
and Infection, Plenum Press, New York.
Crane, C.S. (1965) Infectious bovine rhinotracheitis 
abortion and its relationship to nutrition in 
California beef cattle. J. Am. Vet. Med. Assoc. 147, 
1308-1309.
Cross, A.R., Parkinson, J.F. and Jones, O.T.G. (1985) 
Mechanism of the superoxide-producing oxidase of 
neutrophils. Biochem. J. 226, 881-884.
Crowe, D.T. (1985) Nutritional support for the seriously ill 
or injured patient: an overview. J. Vet. Emer. Crit. 
Care. 1, 1-7.
Cunningham-Rundles, S. (1982) Effects of nutritional status 
on immunological function. Am. J. Clin. Nutr. 35, 1202- 
1210 .
Davis, G.K. and Mertz, W. (1987) Copper. In: Trace Elements
in Human and Animal Nutrition, Vol. 1 (Mertz, W . , e d.),
pp. 301-364, Academic Press, Inc., San Diego,
California.
Davis, M.A., Johnson, W.T., Briske-Anderson, M. and Kramer, 
T.R. (1987) Lymphoid cell functions during copper
deficiency. Nutr. Res. 7, 211-222.
Dowd, P.S. and Heatley, R.V. (1984) The influence of
undernutrtion on immunity. Clin. Sci. 66, 241-248.
180
Drabkin, D.L. and Austin, J.H. (1935) Spectrophotometric 
studies II. Preparations from washed blood cells; 
nitric oxide hemoglobin and sulfhemoglobin. J. Biol. 
Chem. 112, 51-65.
Effros, R.B. and Walford, R.L. (1987) Infection and immunity 
in relation to aging. In: Aging and the Immune Response 
(Goidl, E.A., ed.), pp. 45-65, Marcel Dekker, Inc., New 
York.
Elin, R.J. (1975) The effect of magnesium deficiency in mice 
on serum immunoglobulin concentrations and antibody 
plaque-forming cells. Proc. Soc. Exp. Biol. Med. 148, 
620-624.
Elin, R.J. (1980) Role of magnesium in membranes:
erythrocyte and platelet function and stability. In: 
Magnesium in Health and Disease (Cantin, M. and Seelig, 
M.S., eds.), pp. 113-124, Spectrum Publications, Inc., 
New York.
Enright, F.M. and Jeffers, G.W. (1984) Function tests for 
mononuclear phagocytes. In: Laboratory Techniques of 
Veterinary Clinical Immunology (Barta, 0., ed.), pp. 
58-64, Charles C. Thomas, Springfield, Illinois.
Fell, B.F. (1987) The pathology of copper deficiency in 
animals. In: Copper in Animals and Man, Vol. II 
(Howell, J.McC. and Gawthorne, J.M., eds.), pp. 1-28, 
CRC Press, Inc., Boca Raton, Florida.
Fletcher, M.P., Gershwin, M.E., Keen, C.L. and Hurley, L. 
(1988) Trace element deficiencies and immune
181
responsiveness in humans and animal models. In: 
Nutrition and Immunology (Chandra, R.K., ed.), pp. 215- 
239, Alan R. Liss, Inc., New York.
Flohe, L. and Otting, F. (1984) Superoxide dismutase assays.
Methods Enzymol. 105, 93-104.
Forman, H.J. and Thomas, M.J. (1986) Oxidant production and 
bactericidal activity of phagocytes. Ann. Rev. Physiol. 
48, 669-680.
Fridovich, I. (1983) Superoxide radical: an endogenous
toxicant. Ann. Rev. Pharmacol. Toxicol. 23, 239-257. 
Frieden, E. and Hsieh, H.S. (1976) Ceruloplasmin: the copper 
transport protein with essential oxidase activity. Adv. 
Enzymol. 44, 187-235.
Garvey, J.S., Cremer, N.E. and Sussdorf, D.H. (1977) Methods 
in Immunology, pp. 140-143, 209-210, W.A. Benjamin, 
Inc., Reading, Massachusetts.
Gershwin, M.E., Beach, R.S. and Hurley, L.S. (1985)
Nutrition and Immunity, Academic Press, Inc., Orlando, 
Florida.
Golub, E.S. (1981) The Cellular Basis of the Immune
Response, Sinauer Associates, Inc., Massachusetts. 
Gross, R.L. and Newberne, P.M. (1980) Role of nutrition in 
immunologic function. Physiol. Rev. 60, 188-302. 
Gunther, T. and Averdunk, R. (1979) Reduced lectin
stimulation of lymphocytes from magnesium-deficient 
rats. J. Clin. Chem. Clin. Biochem. 17, 51-55.
182
Hass, G.M., Laing, G.H., McCreary, P.A. and Galt, R.M.
(1978) Magnesium deprivation in the rat causes loss of 
induced immunity to malignant lymphoma. Clin. Res. 26,
710A.
Hass, G.M., McCreary, P.A., Laing, G.H. and Galt, R.M.
(1980) Lympho-proliferative and immunologic aspects of 
magnesium deficiency. In: Magnesium in Health and 
Disease (Cantin, M. and Seelig, M.S., eds.), pp. 185- 
200, Spectrum Publications, Inc., New York.
Hunt, B.J. (1969) The estimation of magnesium in plasma, 
muscle and bone, by atomic absorption 
spectrophotometry, Clin. Chem. 15, 979-996.
Hunt, B.J. (1971) Age and magnesium deficiency in the rat 
with emphasis on bone and muscle magnesium. Am. J. 
Physiol. 221, 1809-1817.
Johnston, R.B., Suzuki, H . , Guthrie, L.A., McPhail, L.C., 
Pabst, M.J. and Henson, P.M. (1985) The respiratory 
burst enzyme in human neutrophils: priming for enhanced 
activity on exposure of the cells to endotoxin, and 
modulation of catalytic activity by divalent cations.
In: Macrophage Biology (Reichard, S. and Kojima, M . , 
eds.), pp. 535-544, Alan R. Liss, Inc., New York.
Jones, D.G. and Suttle, N.F. (1981) Some effects of copper 
deficiency on leucocyte function in sheep and cattle. 
Res. Vet. Sci. 31, 151-156.
183
Jones, D.G. and Suttle, N.F. (1983) The effect of copper
deficiency on the resistance of mice to infection with 
Pasteurella haemolytica. J. Comp. Path. 93, 143-149.
Kappel, L.C., Morgan, E.B., Kilgore, L., Ingraham, R.H. and 
Babcock, D.K. (1985) Seasonal changes of mineral 
content of southern forages. J. Dairy Sci. 68, 1822- 
1827.
Klebanoff, S.J., Waltersdorph, A.M. and Rosen, H. (1984) 
Antimicrobial activity of myeloperoxidase. Methods 
Enzymol. 105, 399-403.
Roller, L.D., Mulhern, S.A., Frankel, N.C., Steven, M.G. and 
Williams, J.R. (1987) Immune dysfunction in rats fed a 
diet deficient in copper. Am. J. Clin. Nutr. 45, 997- 
1006 .
Kraeuter, S.L. and Schwartz, R. (1980) Blood and mast cell 
histamine levels in magnesium-deficient rats. J. Nutr. 
110, 851-858.
Kroll, M.H. and Elin, R.J. (1985) Relationships between
magnesium and protein concentrations in serum. Clin. 
Chem. 31, 244-246.
Larvor, P. (1980) Magnesium, humoral immunity and allergy. 
In: Magnesium in Health and Disease (Cantin, M. and 
Seelig, M.S., eds.), pp. 201-224, Spectrum 
Publications, Inc., New York.
Lehmann, H.P., Schosinsky, K.H. and Beeler, M.F. (1974)
Standardization of serum ceruloplasmin concentrations 
in international enzyme units with o-dianisidine
184
dihydrochloride as substrate. Clin. Chem. 20, 1564- 
1567 .
Lewis, L.D., Morris, M.L. and Hand, M.S. (1987) Small Animal 
Clinical Nutrition, Mark Morris Associates, Topeka, 
Kansas.
L o , J.W. and McClure, J.J. ( 1984) Surface markers of
lymphocytes. In: Laboratory Techniques of Veterinary 
Clinical Immunology (Barta, 0., ed.), pp. 65-85,
Charles C. Thomas, Springfied, Illinois.
Lowry, O.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J. 
(1951) Protein measurement with the Folin phenol 
reagent. J. Biol. Chem. 193, 265-275.
Lukasewycz, O.A., Kolquist, K.L. and Prohaska, J.R. (1987) 
Splenocytes from copper-deficient mice are low 
responders and weak stimulators in mixed lympohocyte 
reactions. Nutr. Res. 7, 43-52.
Lukasewycz, O.A. and Prohaska, J.R. (1981) Dietary copper
deficiency suppresses the immune response of C58 mice. 
Fed. Proc. 40, 918.
Lukasewycz, O.A. and Prohaska, J.R. (1983) Lymphocytes from 
copper-deficient mice exhibit decreased mitogen 
reactivity. Nutr. Res. 3, 335-341.
McCord, J.M. and Fridovich, I. (1969) Superoxide dismutase. 
An enzymic function for erythrocuprein. J. Biol. Chem. 
244, 6049-6055.
185
McCoy, J.H. and Kenney, M.A. (1975) Depressed immune
response in the magnesium-deficient rat. J. Nutr. 105, 
791-797.
McCreary, P.A., Battifora, H.A., Hahnman, B.M., Laing, G.H. 
and Hass, G.M. (1967) Leukocytosis, bone marrow 
hyperplasia and leukemia in chronic magnesium 
deficiency in the rat. Blood 29, 683-690.
McCreary, P., Laing, G. and Hass, G. (1973) Susceptibility 
of normal and magnesium-deficient rats to weekly 
subtumorigenic doses of live lymphoma cells. Am. J. 
Pathol. 70, 89a-90a.
McMurray, D.N., Loomis, S.A., Casazza, L.J., Bey, H. and 
Miranda, R. (1981) Development of impaired cell- 
mediated immunity in mild and moderate malnutrition.
Am. J. Clin. Nutr. 34, 68-77.
Manning, D.C. (1975) Aspirating small volume samples in
flame atomic absorption spectroscopy. Atomic Absorption 
Newsletter. 14(4), 99-102.
Markert, M . , Gloss, G.A. and Babior, B.M. (1985) Respiratory 
burst oxidase from human neutrophils: purification and 
some properties. Proc. Natl. Acad. Sci. USA. 82, 3144- 
3148.
Miller, R.F. (1975) Impact of nutrition on the immune 
system. Anim. Nutr. Health. 30(1), 4-7.
Mitruka, B.M. and Rawnsley, H.M. (1977) Clinical Biochemical 
and Hematological Reference Values in Normal
186
Experimental Animals, Masson Publishing USA, Inc., New 
York.
Morris, M. and Collins, D.R. (1967) Anorexia in the dog.
Vet. Med./Small Anim. Clin. 62, 753-759.
National Research Council (1978) Nutrient Requirements of
Laboratory Animals, No. 10, pp. 7-37, National Academy 
of Sciences, Washington, D.C.
Nauss, K.M. and Newberne, P.M. (1981) Trace elements and
immunocompetence. In: Trace Element Metabolism in Man 
and Animals (Gawthorne, J.M., Howell, J.McC. and White, 
C.L., eds.), pp. 603-610, Springer-Verlag, New York. 
Neumann, C.G., Lawlor, G.J., Stiehm, E.R., Swendseid, M.E., 
Newton, C., Herbert, J., Ammann, A.J. and Jacob, M. 
(1975) Immunologic responses in malnourished children. 
Am. J. Clin. Nutr. 28, 89-104.
Newberne, P.M. (1977) Interactions of nutrition, infection 
and immune responses in animals. In: Nutrition,
Immunity and Infection (Chandra, R.K. and Newberne, 
P.M., eds.), pp. 127-180, Plenum Press, New York. 
Newberne, P.M., Hunt, C.E. and Young, V.R. (1968) The role 
of diet and the reticuloendothelial system in the 
response of rats to Salmonella typhimurium infection. 
Br. J. Exp. Pathol. 49, 448-457.
Okazaki, T., Mochizuki, T., Tashima, M . , Sawada, H. and
Uchino, H. (1987) Magnesium deprivation inhibits the 
expression of differentiation-related phenotypes in
187
human promyelocytic leukemia HL-60 cells. J. Cell. 
Physiol. 131, 50-57.
Paynter, D.L. and Allen, J.D. (1981) Copper-superoxide
dismutase and copper deficiency in ruminants. In: Trace 
Element Metabolism in Man and Animals (Gawthorne, J.M., 
Howell, J. M cC. and White, C.L., eds.), pp. 374-376, 
Springer-Verlag, New York.
Paynter, D.D., Moir, R.J. and Underwood, E.J. (1979) Changes 
in activity of the Cu-Zn superoxide dismutase enzyme in 
tissues of the rat with changes in dietary copper. J. 
Nutr. 109, 1570-1576.
Prohaska, J.R. (1983) Changes in tissue growth,
concentrations of copper, iron, cytochrome oxidase and 
superoxide dismutase subsequent to dietary or genetic 
copper deficiency in mice. J. Nutr. 113, 2048-2058.
Prohaska, J.R., Downing, S.W. and Lukasewycz, O.A. (1983) 
Chronic dietary copper deficiency alters biochemical 
and morphological properties of mouse lymphoid tissue. 
J. Nutr. 113, 1583-1590.
Prohaska, J.R. and Lukasewycz, O.A. (1981) Copper deficiency 
suppresses the immune response of mice. Science. 213, 
559-561.
Pruzansky, J.J. and Patterson, R. (1988) Evidence for in
vitro regulation of IgE receptors on the human basophil 
membrane by their removal and reexpression: effects of 
Ca2+, Mg2 + , some metabolic inhibitors and fetal calf 
serum. Int. Archs. Allergy Appl. Immun. 85, 368-373.
188
Rubin, H., Vidair, C. and Sanui, H. (1981) Restoration of
normal appearance, growth behavior, and calcium content 
to transformed 3T3 cells by magnesium deprivation.
Proc. Natl. Acad. Sci. USA. 78, 2350-2354.
Salimonu, L.S., Johnson, A.O.K., Williams, A.I.O., Iyabo 
Adeleye, G. and Osunkoya, B.O. (1982) Phagocyte 
function in protein-calorie malnutrition. Nutr. Res. 2, 
445-454.
Sanui, H. and Rubin, H. (1977) Correlated effects of
external magnesium on cation content and DNA synthesis 
in cultured chicken embryo fibroblasts. J. Cell. 
Physiol. 92, 23-32.
Sanui, H. and Rubin, H. (1982) Changes of intracellular and 
externally bound cations accompanying serum stimulation 
of mouse BALB/c 3T3 cells. Exp. Cell. Res. 139, 15-25.
Salin, M.L. and McCord, J.M. (1974) Superoxide dismutases in 
polymorphonuclear leukocytes. J. Clin. Invest. 54, 
1005-1009.
SAS (1985) User’s Guide: Statistics, Version 5 Edition, SAS 
Institute Inc., Cary, NC.
Schlesinger, L. and Stekel, A. (1974) Impaired cellular
immunity in marasmic infants. Am. J. Clin. Nutr. 27, 
615-620.
Scrimshaw, N.S., Taylor, C.E. and Gordon, J.E. (1968)
Interactions of Nutrition and Infection, monograph 57, 
World Health Organization Monograph Series, Geneva.
189
Sell, J. L. and Fontenot, J.P. (1980) Magnesium in Animal
Nutrition, National Feed Ingredients Association, West 
Des Moines, Iowa.
Sheffy, B.E. (1966) Comments on the role of nutrition. J.
Am. Vet. Med. Assoc. 149, 708-710.
Sheffy, B.E. and Williams, A.J. (1982) Nutrition and the 
immune response. J. Am. Vet. Med. Assoc. 180, 1073- 
1076.
Smith, D.L. and Rommel, F. (1977) A rapid micro method for 
the simultaneous determination of phagocytic- 
microbiocidal activity of human peripheral blood 
leukocytes in vitro. J. Immunol. Methods. 17, 241-247.
Steel, R.G.D. and Torrie, J.H. (1980) Principles and
Procedures of Statistics, McGraw-Hill, Inc., New York.
Stiehm, E.R. (1980) Humoral immunity in malnutrition. Fed. 
Proc. 39, 3093-3097.
Stinnett, J.D. (1983) Nutrition and the Immune Response, CRC 
Press, Inc., Boca Raton, Florida.
Stossel, T.F. (1973) Quantitative studies of phagocytosis: 
kinetic effect of cations and heat-labile opsonin. J. 
Cell Biol. 58, 346-356.
Suskind, R., Sirishinha, S., Vithayasai, V., Edelman, R.,
Damrongsak, D., Charupatana, C. and Olson, R.E. (1976) 
Immunoglobulins and antibody response in children with 
protein-calorie malnutrition. Am. J. Clin. Nutr. 29, 
836-841.
190
Suttle, N.F. (1983) Use of erythrocyte copper:zinc
superoxide dismutase activity and hair or fleece copper 
concentrations in the diagnosis of hypocuprosis in 
ruminants. Res. Vet. Sci. 35, 46-52.
Suttle, N.F. (1986) Copper deficiency in ruminants; recent 
developments. Vet. R e c . 119, 519-522.
Suttle, N.F. (1987) The nutritional requirement for copper 
in animals and man. In: Copper in Animals and Man,
Vol. 1 (Howell, J. M c C . and Gawthorne, J.M., eds.), pp. 
21-43, CRC Press, Inc., Boca Raton, Florida.
Suzuki, H . , Pabst, M.J. and Johnston, R.B. (1985)
Enhancement by Ca2+ or Mg2+ of catalytic activity of 
the superoxide-poroducing NADPH oxidase in membrane 
fractions of human neutrophils and monocytes. J. Biol. 
Chem. 260, 3635-3639.
Turnlund, J.R. (1988) Copper nutriture, bioavailability, and 
the influence of dietary factors. J. Am. Diet. Assoc. 
8 8 , 303-308.
Wester, P.O. (1987) Magnesium. Am. J. Clin. Nutr. 45, 1305- 
1312.
Whang, R. (1987) Magnesium deficiency: pathogenesis,
prevalence, and clinical implications. Am. J. Med. 82, 
24-29.
Williams, D.M., Lynch, R.E., Lee, G.R. and Cartwright, G.E. 
(1975) Superoxide dismutase activity in copper- 
deficient swine. Proc. Soc. Exp. Biol. Med. 149, 534- 
536.
191
ieve, F.J., Freude, K.A. and Zieve, L. (1977) Effects of 
magnesium deficiency on protein and nucleic acid 
synthesis in vivo. J. Nutr. 107, 2178-2188.
APPENDIX
192
193
Table 48. Summary of the statistical model for plasma 
magnesium in Experiment 1, and the least square mean 
probabilities for the diet main effect and for the diet*week 
interaction.
Source DF SS PR > F
Diet 4 25.92 0.0001
Rat(Diet) 35 4.33
Week 5 10.82 0.0001
Diet*Week 20 5.69 0.0001
Error 92 5.50
Mg Diet 
(ug/gm)
MAIN EFFECT
50 
PR > T
160 280
400 
ad lib
400 
pair fed
50
160 0.001 -
280 0.001 0.01 -
400, ad lib 0.001 0.001 NS -
400, pair fed 0.001 0.001 NS NS
WEEK Initial PR > T
50 -
160 NS -
280 NS NS -
400, ad lib NS NS NS -
400, pair fed NS NS NS NS —
WEEK 2 PR > T
50 -
160 0.001 -
280 0.001 0.01 -
400, ad lib 0.001 0.001 NS -
400, pair fed 0.001 0.001 NS NS
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Table 48. (continued)
Mg Diet 
(ug/gm)
WEEK 3
50 
PR > T
160 280
400 
ad lib
400 
pair fed
50
160
280
400, ad lib
0.001
0.001
0.001
NS
0.01 NS
400, pair fed 0.001 0.01 NS NS —
WEEK 4 PR > T
50 -
160 0.001 -
280 0.001 0.01 -
400, ad lib 0.001 0.01 NS -
400, pair fed 0.001 0.05 NS NS
WEEK 6 PR > T
50 -
160 0.01 -
280 0.001 NS -
400, ad lib 0.001 0.01 NS -
400, pair fed 0.001 0.001 NS NS
WEEK 8 PR > T
50 -
160 0.001 -
280 0.001 NS -
400, ad lib 0.001 NS NS -
400, pair fed 0.001 NS NS NS
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Table 49. Summary of the statistical model for hemoglobin in
Experiment 1, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 4 30.79 0.0004
R at(Diet) 35 39.64
Week 5 254.82 0.0001
Diet*Week 20 40.55 0.0162
Error 92 94.83
Mg Diet 400 400
(ug/gm)
MAIN EFFECT
50 
PR > T
160 280 ad lib pair fed
50
160 0.01 -
280 0.001 NS -
400, ad lib 0.001 NS NS -
400, pair fed 0.001 NS NS NS —
WEEK Initial PR > T
50 -
160 NS -
280 NS NS -
400, ad lib NS NS NS -
400, pair fed NS NS NS NS —
WEEK 2 PR > T
50 -
160 NS -
280 NS NS -
400, ad lib NS NS NS -
400, pair fed 0.01 NS NS NS
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Table 49. (continued)
Mg Diet 
(ug/gm) 50 160 280
400 
ad lib
400 
pair fed
WEEK 3 PR > T
50 -
160 NS -
280 NS NS -
400, ad lib NS NS NS -
400, pair fed NS NS NS NS —
WEEK 4 PR > T
50 -
160 0.01 -
280 0.001 NS -
400, ad lib 0.01 NS NS -
400, pair fed 0.01 NS NS NS —
WEEK 6 PR > T
50 -
160 NS -
280 NS NS -
400, ad lib 0.001 0.001 0.01 -
400, pair fed 0.05 NS NS 0.01 —
WEEK 8 PR > T
50
160 NS -
280 0.01 NS -
400, ad lib 0.001 NS NS -
400, pair fed 0.01 NS NS NS
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Table 50. Summary of the statistical model for hematocrit in
Experiment 1, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 4 177.60 0.0006
R a t (Diet) 35 246.23
Week 5 782.68 0.0001
Diet*Week 20 431.31 0.0001
Error 92 584.35
Mg Diet 
(ug/gm) 50 160 280
400 
ad lib
400 
pair fed
MAIN EFFECT PR > T
50 -
160 NS -
280 0.001 0.01 -
400, ad lib 0.001 0.01 NS -
400, pair fed 0.01 0.05 NS NS
WEEK Initial PR > T
50 -
160 NS -
280 NS NS -
400, ad lib NS NS NS -
400, pair fed NS NS NS NS —
WEEK 2 PR > T
50
160 NS -
280 NS NS -
400, ad lib NS NS NS -
400, pair fed NS NS NS NS
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Table 50. (continued)
Mg Diet 
(ug/gm) 50 160 280
400 
ad lib
400 
pair fed
WEEK 3 PR > T
50 -
160 NS -
280 NS NS -
400, ad lib NS 0.05 NS -
400, pair fed NS 0.05 NS NS —
WEEK 4 PR > T
50 -
160 NS -
280 0.001 0.05 -
400, ad lib NS NS 0.05 -
400, pair fed 0.01 NS NS NS —
WEEK 6 PR > T
50 -
160 0.001 -
280 NS 0.001 -
400, ad lib 0.001 0.001 0.01 -
400, pair fed 0.05 0.001 NS 0.05 —
WEEK 8 PR > T
50 -
160 NS -
280 0.01 NS —
400, ad lib 0.01 NS NS -
400, pair fed 0.05 NS NS NS
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Table 51. Summary of the statistical model for weight gain
in Experiment 1, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 4 13147.25 0.0021
Week 1 63833.68 0.0001
Diet*Week 4 3421.98 0.2520
Error 29 17459.42
Mg Diet 
(ug/gm)
MAIN EFFECT
50 
PR > T
160 280
400 400 
ad lib pair fed
50
160 0.05 -
280 0.01 NS -
400, ad lib 0.001 NS NS -
400, pair fed NS NS 0.05 0.01
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Table 52. Summary of the statistical model 
efficiency in Experiment 1, and the least 
probabilities for the diet main effect.
for feed 
square mean
Source DF SS PR > F
Diet 4 0.01 0.0401
Week 1 0.03 0.0001
Diet*Week 4 0.01 0.0772
Error 29 0.04
Mg Diet 
(ug/gm) 50 160 280
400 
ad lib
400 
pair fed
MAIN EFFECT PR > T
50
160 NS -
280 NS NS -
400, ad lib 0.01 0.05 NS -
400, pair fed NS NS NS NS
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Table 53. Summary of the statistical model for bone 
magnesium in Experiment 1, and the least square mean 
probabilities for the diet main effect and for the diet*week 
interaction.
Source DF SS PR > F
Diet 4 32.45 0.0001
Week 1 0.62 0.0013
Diet*Week 4 1.20 0.0011
Error 29 1.42
Mg Diet 
(ug/gm) 50 160 280
400 
ad lib
400 
pair fed
MAIN EFFECT PR > T
50
160
280
400, ad lib 
400, pair fed
0.001
0.001
0.001
0.001
0.01
0.001
0.001
0.05
NS NS
WEEK 3 PR > T
50 -
160 0.001 -
280 0.001 NS -
400, ad lib 0.001 0.01 0.05 -
400, pair fed 0.001 0.01 NS NS —
WEEK 8 PR > T
50 -
160 0.001 -
280 0.001 0.001 -
400, ad lib 0.001 0.001 NS -
400, pair fed 0.001 0.001 NS NS
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Table 54. Summary of the statistical model for spleen weight
in Experiment 1, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 4 0.06 0.0001
Week 1 0.01 0.0034
Diet*Week 4 0.01 0.1870
Error 29 0.02
Mg Diet 400 400
(ug/gm) 50 160 280 ad lib pair fed
MAIN EFFECT PR > T
50
160 0.001 -
280 0.001 NS -
400, ad lib 0.001 NS NS -
400, pair fed 0.001 NS NS NS
Table 55. Summary of the statistical model for thymus weight
in Experiment 1 .
Source DF SS PR > F
Diet
Week
Diet*Week
Error
4
1
4
29
0.002
0.045
0.004
0.044
0.8710 
0.0001 
0.5877
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Table 56. Summary of the statistical model for total white
blood cell count in Experiment 1, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet 4 196.92 0.0372
Week 1 55.66 0.0782
Diet#Week 4 64.57 0.4399
Covariate 1 43.27 0.1182
Error 28 466.40
Mg Diet 
(ug/gm) 50 160 280
400 
ad lib
400 
pair fed
MAIN EFFECT PR > T
50
160 0.05 -
280 NS NS -
400, ad lib 0.05 NS NS -
400, pair fed 0.01 NS NS NS
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Table 57. Summary of the statistical model for eosinophils
in Experiment 1, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 4 70.60 0.0028
Week 1 84.04 0.0001
Diet*Week 4 77.76 0.0016
Covariate 1 0.00 0.9784
Error 28 94.25
Mg Diet 400 400
(ug/gm)
MAIN EFFECT
50 
PR > T
160 280 ad lib pair fed
50
160 NS -
280 0.001 NS -
400, ad lib 0.01 NS NS -
400, pair fed 0.001 NS NS NS —
WEEK 3 PR > T
50 -
160 0.05 -
280 0.001 0.05 -
400, ad lib 0.01 0.001 NS -
400, pair fed 0.001 0.01 NS NS
WEEK 8 PR > T
50 -
160 NS -
280 NS NS -
400, ad lib NS NS NS -
400, pair fed NS NS NS NS
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Table 58. Summary of the statistical model for lymphocytes
in Experiment 1, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 4 826.97 0.0360
Week 1 12.34 0.6763
Diet*Week 4 641.65 0.0821
Covariate 1 2.10 0.8631
Error 28 1941.07
Mg Diet 
(ug/gm) 50 160 280
400 
ad lib
400 
pair fed
MAIN EFFECT PR > T
50
160 NS -
280 NS NS -
400, ad lib 0.05 NS 0.05 -
400, pair fed 0.05 NS 0.01 NS
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Table 59. Summary of the statistical models for basophils, 
neutrophils and monocytes in Experiment 1.
basophils:
Source DF SS PR > F
Diet 4 0.48 0.5940
Week 1 0.03 0.6953
Diet*Week 4 1.04 0.2176
Covariate 1 0.03 0.6587
Error 28 4.72
neutrophils:
Source DF SS PR > F
Diet 4 534.36 0.0755
Week 1 83.87 0.2316
Diet*Week 4 575.62 0.0601
Covariate 1 31.67 0.4587
Error 28 1570.58
monocytes:
Source DF SS PR > F
Diet 4
Week 1
Diet*Week 4
Covariate 1
Error 28
6.85 0.4635
0.00 0.9848
2.84 0.8183
0.06 0.8595
51.86
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Table 60. Summary of the statistical models for T cells and
B cells in Experiment 1.
T cells:
Source DF SS PR > F
Block: Day 3 226.75 0.4317
Diet 4 105.48 0.8546
Week 1 18.21 0.6367
Diet*Week 4 58.90 0.9442
Error 26 2071.92
B cells:
Source DF SS PR > F
Block: Day 3 81.92 0.7013
Diet 4 217.33 0.4520
Week 1 146.95 0.1213
Diet*Week 4 101.57 0.7762
Error 26 1489.50
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Table 61. 
per minute
CPM:
Summary of the statistical 
and the stimulation index
models for PHA counts 
in Experiment 1.
Source DF SS PR > F
Block: Day 3 12488365 0.9800
Diet 4 70846967 0.9019
Week 1 96714 0.9703
Diet*Week 4 272156575 0.4291
Error 26 1782223447
SI:
Source DF SS PR > F
Block: Day 3 41. 74 0.9880
Diet 4 191.64 0.9627
Week 1 56.66 0.6801
Diet*Week 4 862.38 0.6242
Error 26 8471.32
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Table 62. Summary of the statistical models for Con A counts 
per minute and the stimulation index in Experiment 1.
CPM:
Source DF SS PR > F
Block: Day 3 24715086354 0.0278
Diet 4 1502673843 0.9555
Week 1 7111655964 0.0913
Diet*Week 4 3844102775 0.7960
Error 26 60155288862
S I :
Source DF SS PR > F
Block: Day 3 81832 0.0280
Diet 4 33336 0.3839
Week 1 26847 0.0727
Diet*Week 4 19377 0.6446
Error 26 199512
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Table 63. Summary of the statistical models for PWM counts 
per minute and the stimulation index in Experiment 1.
CPM:
Source DF SS PR > F
Block: Day 3 943268211 0.1307
Diet 4 241499696 0.8105
Week 1 1526717974 0.0040
Diet*Week 4 310308310 0.7308
Error 26 3976791084
SI:
Source DF SS PR > F
Block: Day
Diet
Week
Diet*Week
Error
3
4 
1 
4
26
4464
2225
6601
1428
12310
0.0422
0.3449
0.0009
0.5646
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Table 64. Summary of the statistical model for total plasma
proteins in Experiment 1, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet 4 16.40 0.0148
Week 1 33.12 0.0001
Diet*Week 4 9.45 0.1007
Covariate 1 1.66 0.2288
Error 28 30.74
Mg Diet 
(ug/gm)
MAIN EFFECT
50 
PR > T
160 280
400 400 
ad lib pair fed
50
160 0.001 -
280 NS 0.05 -
400, ad lib 0.05 NS NS -
400, pair fed 0.05 NS NS NS
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Table 65. Summary of the statistical model for albumin in
Experiment 1, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 4 4.93 0.0142
Week 1 9.27 0.0001
Diet*Week 4 4.83 0.0155
Covariate 1 0.10 0.5773
Error 28 9.15
Mg Diet 400 400
(ug/gm)
MAIN EFFECT
50 
PR > T
160 280 ad lib pair fed
50
160 0.01 -
280 0.01 NS -
400, ad lib 0.05 NS NS -
400, pair fed 0.01 NS NS NS
WEEK 3 PR > T
50 -
160 NS -
280 NS NS -
400, ad lib NS NS NS -
400, pair fed 0.01 0.05 NS 0.05 —
WEEK 8 PR > T
50 -
160 0.001 -
280 0.01 NS -
400, ad lib 0.05 NS NS -
400, pair fed NS 0.01 NS NS
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Table 66. Summary of the statistical model for alpha 1
globulin in Experiment 1, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet 4 2.11 0.0012
Week 1 0.56 0.0176
Diet*Week 4 0.49 0.2565
Covariate 1 0.06 0.4242
Error 28 2.45
Mg Diet 
(ug/gm)
MAIN EFFECT
50 
PR > T
160 280
400 400 
ad lib pair fed
50
160 0.001 -
280 NS 0.01 -
400, ad lib 0.01 NS NS -
400, pair fed NS 0.01 NS NS
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Table 67. Summary of the statistical models for the alpha 2
and beta globulins in Experiment 1.
alpha 2:
Source DF SS PR > F
Diet 4 0.11 0.3699
Week 1 0.20 0.0093
Diet*Week 4 0.04 0.8131
Covariate 1 0.00 0.7738
Error 28 0.72
beta:
Source DF SS PR > F
Diet 4
Week 1
Diet*Week 4
Covariate 1
Error 28
0.65 0.2790
1.70 0.0008
0.35 0.5776
0.09 0.3861
3.36
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Table 68. Summary of the statistical model for gamma
globulin in Experiment 1, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet 4 0.08 0.0330
Week 1 0.06 0.0054
Diet*Week 4 0.04 0.2405
Covariate 1 0.01 0.3003
Error 28 0.18
Mg Diet 
(ug/gm) 50 160 280
400 
ad lib
400 
pair fed
MAIN EFFECT PR > T
50
160 NS -
280 0.01 NS -
400, ad lib 0.05 NS NS -
400, pair fed 0.01 NS NS NS
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Table 69. Summary of the statistical model for the
albumin/globulin ratio in Experiment 1, and the least square
mean probabilities for the diet main effect.
Source DF SS PR > F
Diet 4 0.34 0.0151
Week 1 0.01 0.5229
Diet*Week 4 0.15 0.1892
Covariate 1 0.07 0.0859
Error 28 0.64
Mg Diet 
(ug/gm)
MAIN EFFECT
50 
PR > T
160 280
400 
ad lib
400 
pair fed
50
160 NS -
280 0.05 NS -
400, ad lib NS NS NS -
400, pair fed 0.01 NS NS 0.01 -
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Table 70. Summary of the statistical model for IgM in
Experiment 1, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 4 1.39 0.0416
Week 1 0.13 0.3039
Diet*Week 4 0.36 0.5670
Covariate 1 0.41 0.0754
Error 28 3.40
Mg Diet 
(ug/gm) 50 160 280
400 
ad lib
400 
pair fed
MAIN EFFECT PR > T
50
160 0.05 -
280 0.01 NS -
400, ad lib 0.01 NS NS -
400, pair fed 0.01 NS NS NS
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Table 71. Summary of the statistical model for IgG in
Experiment 1, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 4 277.36 0.0039
Week 1 58.24 0.0515
Diet#Week 4 65.26 0.3499
Covariate 1 249.92 0.0002
Error 28 394.10
Mg Diet 
(ug/gm)
MAIN EFFECT
50 
PR > T
160 280
400 400 
ad lib pair fed
50
160 NS -
280 0.01 NS —
400, ad lib 0.01 0.05 NS -
400, pair fed 0.001 0.01 NS NS
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Table 72. Summary of the statistical models for antibody 
titer and log titer in Experiment 1.
antibody titer:
Source DF SS PR > F
Diet 4 70932.45 0. 3459
Week 1 22481.57 0.2338
Diet*Week 4 36628.33 0.6634
Covariate 1 8260.84 0.4668
Error 28 424993.83
log titer:
Source DF SS PR > F
Diet 4 461.67 0.2591
Week 1 186.54 0.1435
Diet*Week 4 52.62 0.9569
Covariate 1 0.09 0.9734
Error 28 2305.91
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Table 73. Summary of the statistical models for neutrophil 
phagocytosis and killing in Experiment 1.
without bacteria:
Source DF SS PR > F
Block: Day 3 498.90 0.1089
Diet 4 216.00 0.5841
Week 1 1.26 0.8978
Diet*Week 4 365.41 0.3252
Error 26 1941.89
with bacteria, not killed:
Source DF SS PR > F
Block: Day 3 8.80 0.3204
Diet 4 4.78 0.7368
Week 1 0.01 0.9384
Diet*Week 4 4.04 0.7915
Error 26 62.24
with bacteria, killed:
Source DF SS PR > F
DayBlock 
Diet 
Week
Diet*Week 
Error
3
4 
1 
4
26
504.31
213.33
0.85
375.36
1865.55
0.0963
0.5712
0.9143
0.2931
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Table 74. Summary of the statistical model for plasma copper
in Experiment 2, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 4 8.40 0.0001
R a t (Diet) 45 4.75
Week 3 3.37 0.0001
Diet*Week 12 6.16 0.0001
Error 105 5.42
Cu Diet 5.0 5.0
(ug/gm)
MAIN EFFECT
0.5 
PR > T
2.0 3.5 ad lib pair fed
0.5
2.0 0.01 -
3.5 0.001 0.01 -
5.0, ad lib 0.001 0.001 NS -
5.0, pair fed 0.001 0.001 NS NS —
WEEK Initial PR > T
0.5 -
2.0 NS -
3.5 NS NS -
5.0, ad lib NS NS NS -
5.0, pair fed NS NS NS NS —
WEEK 2 PR > T
0.5 -
2.0 0.01 -
3.5 0.001 0.01 -
5.0, ad lib 0.001 0.001 NS -
5.0, pair fed 0.001 0.001 0.05 NS
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Table 74. (continued)
Cu Diet 
(ug/gm)
WEEK 4
0.5 
PR > T
2.0 3.5
5.0 
ad lib
5.0 
pair fed
0.5
2.0
3.5
5.0, ad lib
0.001
0.001
0.001
0.001
0.001 0.05
5.0, pair fed 0.001 0.001 NS NS —
WEEK 8 PR > T
0.5 -
2.0 0.05 -
3.5 0.001 0.01 -
5.0, ad lib 0.001 0.001 NS -
5.0, pair fed 0.001 0.001 NS NS
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Table 75. Summary of the statistical model for ceruloplasmin
in Experiment 2, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 4 10275.47 0.0001
Rat(Diet) 45 4865.33
Week 3 2042.51 0.0003
Diet*Week 12 5825.29 0.0001
Error 80 7635.38
Cu Diet 5.0 5.0
(ug/gm)
MAIN EFFECT
0.5 
PR > T
2.0 3.5 ad lib pair fed
0.5
2.0 NS -
3.5 0.001 0.001 -
5.0, ad lib 0.001 0.001 0.05 -
5.0, pair fed 0.001 0.001 0.01 NS —
WEEK Initial PR > T
0.5 -
2.0 NS -
3.5 NS NS -
5.0, ad lib NS ' NS NS -
5.0, pair fed NS NS NS NS
WEEK 2 PR > T
0.5 -
2.0 NS -
3.5 0.001 0.01 -
5.0, ad lib 0.001 0.001 0.05 -
5.0, pair fed 0.001 0.001 0.001 NS
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Table 75. (continued)
Cu Diet 
(ug/gm) 0.5 2.0 3.5
5.0 5.0 
ad lib pair fed
WEEK 4 PR > T
0.5
2.0
3.5
5.0, ad lib
5.0, pair fed
NS
NS
0.001
0.01
NS
0.001 0.01 
0.05 NS NS
WEEK 8 PR > T
0.5
2.0
3.5
5.0, ad lib
5.0, pair fed
NS
0.01
0.01
0.001
0.001
0.001 NS 
0.001 NS NS
Table 76. Summary of the 
Experiment 2.
statistical model for catalase in
Source DF SS PR > F
Diet
R at(Diet) 
Week
Diet*Week
Error
4
44
1
4
15
967.39 
19918.49 
232.95 
1922. 19 
5634.69
0.7112
0.4433
0.3217
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Table 77. Summary of the statistical model for hemoglobin in
Experiment 2, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 4 114.30 0.0001
Rat(Diet) 45 78. 17
Week 3 152.69 0.0001
Diet*Week 12 66.25 0.0001
Error 105 145.20
Cu Diet 5.0 5.0
(ug/gm)
MAIN EFFECT
0.5 
PR > T
2.0 3.5 ad lib pair fed
0.5
2.0 0.001 -
3.5 0.001 NS -
5.0, ad lib 0.001 NS NS -
5.0, pair fed 0.001 0.01 0.01 NS —
WEEK Initial PR > T
0.5 -
2.0 NS -
3.5 NS NS -
5.0, ad lib NS NS NS -
5.0, pair fed NS NS NS NS —
WEEK 2 PR > T
0.5 -
2.0 0.01 -
3.5 0.001 NS -
5.0, ad lib 0.001 NS NS -
5.0, pair fed 0.001 0.001 0.01
o
•
o
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Table 77. (continued)
Cu Diet 
(ug/gm)
WEEK 4
0.5 
PR > T
to • o
inCO
5.0 
ad lib
5.0 
pair fed
0.5
2.0 0.001 -
3.5 0.001 NS -
5.0, ad lib 0.001 NS NS -
5.0, pair fed 0.001 NS NS NS
WEEK 8 PR > T
0.5 -
2.0 0.05 -
3.5 NS NS -
5.0, ad lib 0.01 NS 0.05 -
5.0, pair fed 0.001 NS 0.01 NS
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Table 78. Summary of the statistical model for hematocrit in
Experiment 2, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 4 669.76 0.0001
R a t (Diet) 45 414.96
Week 3 596.87 0.0001
Diet*Week 12 464.90 0.0001
Error 105 745.93
Cu Diet 5.0 5.0
(ug/gm)
MAIN EFFECT
0. 5 
PR > T
2.0 3.5 ad lib pair fed
0.5
2.0 0.01 -
3.5 0.001 0.05 -
5.0, ad lib 0.001 0.001 NS -
5.0, pair fed 0.001 0.001 0.01 NS —
WEEK Initial PR > T
0.5 -
2.0 NS -
3.5 NS NS -
5.0, ad lib NS NS NS -
5.0, pair fed NS NS NS NS —
WEEK 2 PR > T
0.5 -
2.0 0.001 -
3.5 0.001 NS -
5.0, ad lib 0.001 NS NS -
5.0, pair fed 0.001 0.01 NS
oo
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Table 78. (continued)
Cu Diet 
(ug/gm)
WEEK 4
0.5 
PR > T
oCM 3.5
5.0 
ad lib
5.0 
pair fed
0.5
2.0
3.5
5.0, ad lib
0.001
0.001
0.001
0.01
0.001 NS
5.0, pair fed 0.001 0.001 NS NS —
WEEK 8 PR > T
0.5 -
2.0 NS -
3.5 NS NS -
5.0, ad lib 0.01 0.01 0.05 -
5.0, pair fed 0.001 0.01 0.05 NS
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Table 79. Summary of the statistical model for weight gain
in Experiment 2, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet
Week
Diet*Week
Error
4
1
4
36
27773.38
63785.67
8846.18
20384.41
0.0001
0.0001
0.0098
Cu Diet 5.0 5.0
(ug/gm) 0.5 2.0 3.5 ad lib pair fed
MAIN EFFECT PR > T
0.5 -
2.0 0.01 -
3.5 0.001 0.05 -
5.0, ad lib 0.001 NS NS -
5.0, pair fed NS 0.01 0.001 0.001 —
WEEK 4 PR > T
0.5 -
2.0 NS -
3.5 NS NS -
5.0, ad lib NS NS NS -
5.0, pair fed NS NS NS NS
WEEK 8 PR > T
0.5 ...
2.0 0.001 -
3.5 0.001 0.05 -
5.0, ad lib 0.001 NS NS -
5.0, pair fed NS 0.001 0.001
o
•
o
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Table 80. Summary of the statistical model for feed 
efficiency in Experiment 2, and the least square mean 
probabilities for the diet main effect.
Source DF SS PR > F
Diet 4 0.01 0.0205
Week 1 0.10 0.0001
Diet*Week 4 0.00 0.6314
Error 36 0.02
Cu Diet 
(ug/gm)
MAIN EFFECT
0.5 
PR > T
o
•
CM 3.5
5.0 
ad lib
5.0 
pair fed
0.5
2.0 NS -
3.5 0.01 NS -
5.0, ad lib 0.05 NS NS -
5.0, pair fed NS NS 0.01 NS -
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Table 81. Summary of the statistical model for liver weight
in Experiment 2, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 4 4.50 0.0261
Week 1 0.89 0.0276
Diet*Week 4 0.67 0.7601
Error 36 12.93
Cu Diet 
(ug/gm)
MAIN EFFECT
0.5 
PR > T
2.0 3.5
5.0 
ad lib
5.0 
pair fed
0.5
2.0 0.05 -
3.5 0.01 NS -
5.0, ad lib 0.01 NS NS -
5.0, pair fed 0.01 NS NS NS -
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Table 82. Summary of the statistical model for liver copper
in Experiment 2, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 4 43.23 0.0001
Week 1 0.30 0.3039
Diet*Week 4 0.31 0.8901
Error 36 10.00
Cu Diet 
(ug/gm)
MAIN EFFECT
0.5 
PR > T
2.0 3.5
5.0 5.0 
ad lib pair fed
0.5
2.0 0.001 -
3.5 0.001 0.001 -
5.0, ad lib 0.001 0.001 NS -
5.0, pair fed 0.001 0.01 NS 0.05
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Table 83. Summary of the statistical model for spleen weight 
in Experiment 2.
Source DF SS PR > F
Diet 4 0.002 0.6993
Week 1 0.006 0.0179
Diet*Week 4 0.004 0.4108
Error 36 0.036
Table 84. Summary of 
in Experiment 2, and 
the diet main effect.
the
the
statistical model 
least square mean
for thymus weight 
probabilities for
Source DF SS PR > F
Diet 4 0.03 0.0059
Week 1 0.03 0.0002
Diet*Week 4 0.00 0.8430
Error 36 0.06
Cu Diet 
(ug/gm)
MAIN EFFECT
0.5 
PR > T
o
•
CSI 3.5
5.0 
ad lib
5.0 
pair fed
0.5
2.0 0.01 -
3.5 0.001 NS -
5.0, ad lib 0.01 NS NS -
5.0, pair fed 0.05 NS NS NS -
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Table 85. Summary of the statistical models for the total 
white blood cell count and the differential counts in 
Experiment 2.
total white blood cells:
Source DF SS PR > F
Diet 4 4.63 0.9233
Week 1 0.18 0.8526
Diet*Week 4 4.69 0.9219
Covariate 1 0.07 0.9088
Error 34 176.12
basophils:
Source DF SS PR > F
Diet 4 1.30 0.1167
Week 1 0.79 0.0346
Diet*Week 4 1.59 0.0647
Covariate 1 0.08 0.4946
Error 34 5.52
eosinophils:
Source DF SS PR > F
Diet 4 0.26 0.9952
Week 1 8.10 0.0175
Diet*Week 4 0.14 0.9984
Covariate 1 0.36 0.6033
Error 34 44.14
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Table 85. (continued)
neutrophils:
Source DF SS PR > F
Diet 4 90.66 0.5933
Week 1 72.84 0. 1412
Diet*Week 4 53.41 0.7959
Covariate 1 3.36 0.7484
Error 34 1091.34
lymphocytes:
Source DF SS PR > F
Diet 4 74.55 0.7407
Week 1 233.63 0.0180
Diet*Week 4 87.16 0.6815
Covariate 1 4.48 0.7327
Error 34 1284.87
monocytes:
Source DF SS PR > F
Diet 4 0.58 0.9925
Week 1 13.20 0.0227
Diet*Week 4 10.25 0.3697
Covariate 1 0.49 0.6472
Error 34 78.81
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Table 86. Summary of the statistical models for T cells and 
B cells in Experiment 2.
T cells:
Source DF SS PR > F
Block: Day 4 288.41 0.5899
Diet 4 465.93 0.3515
Week 1 44.49 0.5123
Diet*Week 4 445.80 0.3737
Error 31 3138.69
B cells:
Source DF SS PR > F
Block: Day 4 62.43 0.8754
Diet 4 102.08 0.7421
Week 1 46.02 0.3539
Diet*Week 4 34.06 0.9551
Error 31 1610.42
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Table 87. Summary of the statistical models for PHA counts
per minute and the stimulation index in Experiment 2.
CPM:
Source DF SS PR > F
Block: Day 4 22970048 0.5122
Diet 4 50924465 0.1433
Week 1 13017250 0.1782
Diet*Week 4 17851279 0.6308
Error 31 212661910
SI:
Source DF SS PR > F
Block: Day 4 228.09 0.6113
Diet 4 449.68 0.2773
Week 1 278.36 0.0782
Diet*Week 4 175.33 0.7199
Error 31 2600.91
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Table 88. Summary of the statistical models for Con A counts
per minute and the stimulation index in Experiment 2.
CPM:
Source DF SS PR > F
Block: Day 4 1158925921 0.0921
Diet 4 705233024 0.2778
Week 1 1626364233 0.0014
Diet*Week 4 772753304 0.2361
Error 31 4082847406
SI:
Source DF SS PR > F
Block: Day 4 32568.54 0.0812
Diet 4 15827.95 0.3664
Week 1 46758.76 0.0010
Diet*Week 4 18154.71 0.2987
Error 31 109844.01
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Table 89. 
per minute
CPM:
Summary of the statistical 
and the stimulation index
models for PWM counts 
in Experiment 2.
Source DF SS PR > F
Block: Day 4 66957893 0.0101
Diet 4 27140030 0.1950
Week 1 13606216 0.0815
Diet*Week 4 6715423 0.8071
Error 31 130110498
SI:
Source DF SS PR > F
Block: Day 4 1082.86 0.0017
Diet 4 201.98 0.4041
Week 1 502.79 0.0031
Diet*Week 4 130.17 0.6190
Error 31 1510.09
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Table 90. Summary of the statistical models for the total
plasma proteins, albumin and the globulins in Experiment 2.
total protein:
Source DF SS PR > F
Diet 4 15.49 0.6050
Week 1 20.96 0.0619
Diet*Week 4 30.10 0.2760
Covariate 1 2.69 0.4942
Error 34 191.24
albumin:
Source DF SS PR > F
Diet 4 2.07 0.9056
Week 1 6.42 0.0850
Diet*Week 4 7.97 0.4334
Covariate 1 1.47 0.4015
Error 34 69.41
alpha 1:
Source DF SS PR > F
Diet 4 0.71 0.4238
Week 1 0.03 0.7029
Diet*Week 4 1.72 0.0688
Covariate 1 0.02 0.7241
Error 34 6.08
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Table 90. (continued)
alpha 2:
Source DF SS PR > F
Diet 4 0.26 0.4169
Week 1 0.14 0.1420
Diet*Week 4 0.26 0.4001
Covariate 1 0.00 0.8226
Error 34 2.16
beta:
Source DF SS PR > F
Diet 4 2.10 0.2788
Week 1 2.00 0.0307
Diet*Week 4 0. 79 0.7331
Covariate 1 0.16 0.5342
Error 34 13.40
gamma:
Source DF SS PR > F
Diet 4 0.02 0.7385
Week 1 0.12 0.0036
Diet*Week 4 0.07 0.279.3
Covariate 1 0.03 0.1222
Error 34 0.42
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Table 91. Summary of the statistical model for IgM in
Experiment 2, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 4 5.12 0.0012
Week 1 1.31 0.0205
Diet*Week 4 0.65 0.5788
Covariate 1 1.85 0.0068
Error 34 7.55
Cu Diet 
(ug/gm)
MAIN EFFECT
0.5 
PR > T
2.0
5.0 5.0 
3.5 ad lib pair fed
0.5
2.0 0.01 -
3.5 0.001 NS -
5.0, ad lib 0.001 NS NS
5.0, pair fed 0.001 NS NS NS
Table 92. Summary of the 
Experiment 2.
statistical model for IgG in
Source DF SS PR > F
Diet 4 184.74 0.0756
Week 1 145.90 0.0104
Diet#Week 4 50.89 0.6361
Covariate 1 19.89 0.3234
Error 34 673.50
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Table 93. Summary of the statistical models for antibody 
titer and log titer in Experiment 2.
antibody titer:
Source DF SS PR > F
Diet 4 1282.27 0.3580
Week 1 8.40 0.8643
Diet*Week 4 756.96 0.6186
Covariate 1 2110.24 0.0100
Error 34 9631.16
log titer:
Source DF SS PR > F
Diet 4 134.43 0.2193
Week 1 1.71 0.7828
Diet*Week 4 155.89 0.1601
Covariate 1 176.68 0.0079
Error 34 753.47 0.7828
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Table 94. Summary of the statistical models for neutrophil
phagocytosis and killing in Experiment 2.
without bacteria:
Source DF SS PR > F
Block: Day 4 3101.38 0.0105
Diet 4 1397.21 0.1580
Week 1 3.73 0.8913
Diet*Week 4 913.63 0.3456
Error 31 6082.48
with bacteria, not killed:
Source DF SS PR > F
Block: Day 4 235.18 0.2331
Diet 4 110.28 0.6028
Week 1 2685.06 0.0001
Diet*Week 4 105.97 0.6208
Error 31 1234.18
with bacteria, killed:
Source DF SS PR > F
Block: Day 4 4412.46 0.0014
Diet 4 1456.16 0.1371
Week 1 2938.85 0.0005
Diet*Week 4 1090.33 0.2521
Error 31 5970.00
245
Table 95. Summary of the statistical models for
myeloperoxidase (MPO) and superoxide dismutase (SOD) in
Experiment 2.
MPO:
Source DF SS PR > F
Diet 4 1.09 0.6733
Week 1 8.25 0.0002
Diet*Week 4 1.55 0.5093
Error 35 16.19
SOD:
Source DF SS PR > F
Diet
Week
Diet*Week 
Error
4
1
4
35
23136.90
5.30
12541.57
158112.93
0.2963
0.9729
0.6011
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Table 96. Summary of the statistical model for plasma 
magnesium in Experiment 3, and the least square mean 
probabilities for the diet main effect and for the diet*week 
interaction.
Source DF SS PR > F
Diet 5 12.85 0.0001
R a t (Diet) 54 1.50
Week 3 10. 53 0.0001
Diet*Week 15 9.43 0.0001
Error 98 3.04
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu 
160 Mg 2.0 Cu 
280 Mg 2.0 Cu 
160 Mg 3.5 Cu 
280 Mg 3.5 Cu
0.001
0.001
0.001
0.001
0.001
NS
0.001
0.01
NS 0.001
400 Mg 5.0 Cu 0.001 0.001 NS 0.001 NS
WEEK Initial PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.05 -
280 Mg 2.0 Cu NS 0.001 -
160 Mg 3.5 Cu 0.05 0.001 NS -
280 Mg 3.5 Cu NS 0.001 NS NS -
400 Mg 5.0 Cu NS 0.001 NS NS NS —
WEEK 2 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 0.001 -
160 Mg 3.5 Cu 0.001 0.05 0.05 -
280 Mg 3 . 5 Cu 0.001 0.001 NS 0.01 -
400 Mg 5.0 Cu 0.001 0.001 NS 0.01 NS
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Table 96. (continued)
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 0.001 -
160 Mg 3.5 Cu 0.001 0.01 NS -
280 Mg 3.5 Cu 0.001 0.001 NS NS -
400 Mg 5.0 Cu 0.001 0.01 NS NS NS
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 0.01 -
160 Mg 3.5 Cu 0.001 NS 0.05 -
280 Mg 3.5 Cu 0.001 0.001 NS 0.01 -
400 Mg 5.0 Cu 0.001 0.001 NS 0.01 NS
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Table 97. Summary of the statistical model for bone
magnesium in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet
Week
Diet*Week
Error
5
1
5
44
47.98
0.11
2.00
9.37
0.0001 
0.4751 
0.1179
Diet
(ug/gm)
50 Mg 
0.5 Cu
160
2.0
Mg
Cu
280 Mg 
2.0 Cu
160
3.5
Mg
Cu
280 Mg 
3.5 Cu
400
5.0
Mg
Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 0.001 -
160 Mg 3.5 Cu 0.001 NS 0.001 -
280 Mg 3.5 Cu 0.001 0.01 NS 0.05 -
400 Mg 5.0 Cu 0.001 0.001 NS 0.01 NS
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Table 98. Summary of the statistical model for plasma copper
in Experiment 3, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 5 12.82 0.0001
Rat(Diet) 54 3.48
Week 3 8.69 0.0001
Diet*Week 15 5.77 0.0001
Error 98 3.81
Diet
(ug/gm)
MAIN EFFECT
50 Mg 
0.5 Cu
PR > T
160 Mg 
2.0 Cu
280 Mg 
2.0 Cu
160 Mg 
3.5 Cu
280 Mg 
3.5 Cu
400
5.0
Mg
Cu
50 Mg 0.5 Cu
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.01 NS -
160 Mg 3.5 Cu 0.001 0.001 0.001 -
280 Mg 3.5 Cu 0.001 0.001 0.001 NS -
400 Mg 5.0 Cu 0.001 0.001 0.001 0.01 0.001
WEEK Initial PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu NS NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS
WEEK 2 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu 0.001 0.001 0.001 -
280 Mg 3.5 Cu 0.001 0.001 0.001 NS
400 Mg 5.0 Cu 0.001 0.001 0.001 0.01 0.0
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Table 98. (continued)
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu 0.05 NS —
160 Mg 3.5 Cu 0.001 0.001 0.001 —
280 Mg 3.5 Cu 0.001 0.001 0.001 NS
400 Mg 5.0 Cu 0.001 0.001 0.001 0.05 0.01
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.01 NS -
160 Mg 3.5 Cu 0.001 0.001 0.001 -
280 Mg 3.5 Cu 0.001 0.001 0.001 NS -
400 Mg 5.0 Cu 0.001 0.001 0.001 NS
o
•
o
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Table 99. Summary of the statistical model for plasma 
ceruloplasmin in Experiment 3, and the least square mean 
probabilities for the diet main effect and for the diet*week 
interaction.
Source DF SS PR > F
Diet 5 26439.12 0.0001
R at(Diet) 54 7885.34
Week 3 4341.09 0.0001
Diet*Week 15 8194.71 0.0001
Error 98 9368.70
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu 0.001 0.001 0.001 -
280 Mg 3.5 Cu 0.001 0.001 0.001 NS -
400 Mg 5.0 Cu 0.001 0.001 0.001 0.01 NS —
WEEK Initial PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.01 NS NS -
280 Mg 3.5 Cu NS 0.001 0.001 0.01 -
400 Mg 5.0 Cu NS 0.001 0.001 0.001 NS
WEEK 2 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu 0.001 0.001 0.001 -
280 Mg 3.5 Cu 0.001 0.001 0.001 NS -
400 Mg 5.0 Cu 0.001 0.001 0.001 NS o • o
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Table 99. (continued)
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu 0.01 0.05 0.05 -
280 Mg 3.5 Cu 0.001 0.001 0.001 0.05 -
400 Mg 5.0 Cu 0.001 0.001 0.001 0.01 NS —
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.05 -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu 0.001 0.001 0.001 -
280 Mg 3.5 Cu 0.001 0.001 0.001 NS -
400 Mg 5.0 Cu 0.001 0.001 0.001 NS NS
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Table 100. Summary of the statistical model for liver weight
in Experiment 3, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 5 14.62 0.0001
Week 1 0.40 0.0148
Diet*Week 5 5.48 0.0010
Error 44 9.54
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu 0.05 NS NS NS -
400 Mg 5.0 Cu 0.01 NS NS NS NS
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 101. Summary of the statistical model for liver copper
in Experiment 3, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet
Week
Diet*Week
Error
5
1
5
44
58.85
0.65
0.96
14.34
0.0001 
0.1640 
0.7070
Diet
(ug/gm)
50 Mg 
0.5 Cu
160
2.0
Mg
Cu
280 Mg 
2.0 Cu
160
3.5
Mg
Cu
280 Mg 
3.5 Cu
400
5.0
Mg
Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 0.01 0.001 -
280 Mg 3.5 Cu 0.001 0.001 0.001 NS
400 Mg 5.0 Cu 0.001 0.001 0.001 0.01 0.05
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Table 102. Summary of the statistical model for hemoglobin
in Experiment 3, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 5 136.63 0.0001
Rat(Diet) 54 163.44
Week 3 73.94 0.0001
Diet*Week 15 86.78 0.0039
Error 98 228.42
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0. 5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
WEEK Initial PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu NS NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS —
WEEK 2 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu 0.05 NS NS NS «
400 Mg 5.0 Cu 0.05 NS NS NS NS
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Table 102. (continued)
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.05 -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu 0.05 NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS —
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS --
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 103. Summary of the statistical model for hematocrit
in Experiment 3, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 5 795.98 0.0001
Rat(Diet) 54 814.44
Week 3 933.67 0.0001
Diet*Week 15 756.44 0.0001
Error 98 1254.36
Diet 
(ug/gm)
MAIN EFFECT
50 Mg 160 Mg 
0.5 Cu 2.0 Cu
PR > T
280 Mg 
2.0 Cu
160 Mg 
3.5 Cu
280 Mg 
3.5 Cu
400
5.0
Mg
Cu
50 Mg 0.5 Cu
160 Mg 2.0 Cu 0.001
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
WEEK Initial PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu NS NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS —
WEEK 2 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.05 -
280 Mg 2.0 Cu 0.05 NS -
160 Mg 3.5 Cu 0.05 NS NS -
280 Mg 3.5 Cu 0.05 NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS
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Table 103. (continued)
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.01 -
280 Mg 2.0 Cu 0.05 NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu 0.05 NS NS NS -
400 Mg 5.0 Cu 0.01 NS NS NS NS
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 104. Summary of the statistical model for weight gain
in Experiment 3, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 5 45666.66 0.0001
Week 1 105342.30 0.0001
Diet*Week 5 3516.25 0.5908
Error 44 41280.31
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 105. Summary of the statistical model for feed
efficiency in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet
Week
Diet*Week 
Error
5
1
5
44
0.04
0.01
0.00
0.04
0.0001
0.0001
0.8712
Diet
(ug/gm)
50 Mg 
0.5 Cu
160
2.0
Mg
Cu
280 Mg 
2.0 Cu
160
3.5
Mg
Cu
280 Mg 
3.5 Cu
400
5.0
Mg
Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 106. Summary of the statistical model for spleen 
weight in Experiment 3, and the least square mean 
probabilities for the diet main effect and for the diet*week 
interaction.
Source DF SS PR > F
Diet 5 0.14 0.0001
Week 1 0.03 0.0001
Diet*Week 5 0.02 0.0326
Error 44 0.05
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 0.05 -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 107. Summary of the statistical model for thymus
weight in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet
Week
Diet*Week
Error
5
1
5
44
0.02 
0.10 
0.00 
0.04
0.0086
0.0001
0.9874
Diet
(ug/gm)
50 Mg 
0.5 Cu
160
2.0
Mg
Cu
280 Mg 
2.0 Cu
160
3.5
Mg
Cu
280 Mg 
3.5 Cu
400
5.0
Mg
Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu 0.01 NS NS -
280 Mg 3.5 Cu 0.01 NS NS NS -
400 Mg 5.0 Cu 0.01 NS NS NS NS
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Table 108. Summary of the statistical model for total white 
blood cell count in Experiment 3, and the least square mean 
probabilities for the diet main effect and for the diet*week 
interaction.
Source DF SS PR > F
Diet 5 92.53 0.0031
Week 1 0.03 0.9394
Diet*Week 5 110.95 0.0009
Covariate 1 79.96 0.0001
Error 43 186.44
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 0.05 NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.01 NS NS NS NS
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu NS NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS
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Table 109. Summary of the statistical model for basophils in
Experiment 3, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 5 9.27 0.0260
Week 1 12.13 0.0001
Diet*Week 5 9.38 0.0247
Covariate 1 2.61 0.0515
Error 43 27.94
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS 0.01 -
280 Mg 3.5 Cu NS NS NS NS -
400 Mg 5.0 Cu 0.05 0.05 0.01 NS
o
•
o
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu NS NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu 0.05 0.05 0.01 -
280 Mg 3.5 Cu NS NS NS 0.05 -
400 Mg 5.0 Cu 0.001 0.001 0.001 NS 0.01
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Table 110. Summary of the statistical model for eosinophils
in Experiment 3, and the least square mean probabilities for
the diet*week interaction.
Source DF SS PR > F
Diet 5 20.85 0.0745
Week 1 4.41 0.1367
Diet*Week 5 28.45 0.0218
Covariate 1 0.88 0.5012
Error 43 82.42
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu NS NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS —
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.01 -
280 Mg 2.0 Cu 0.01 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.05 NS NS NS NS
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Table 111. Summary of the statistical model for neutrophils
in Experiment 3, and the least square mean probabilities for
the diet main effect and for the diet*week interaction.
Source DF SS PR > F
Diet 5 1180.84 0.0002
Week 1 28.11 0.3877
Diet*Week 5 474.52 0.0403
Covariate 1 3.41 0.7627
Error 43 1587.19
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu NS NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS
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Table 112. Summary of the statistical model for lymphocytes
in Experiment 3, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 5 1461.52 0.0007
Week 1 16.39 0.5892
Diet*Week 5 334.24 0.3220
Covariate 1 0.23 0.9492
Error 43 2380.77
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.01 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 113. Summary of the statistical model for monocytes in
Experiment 3, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 5 28.45 0.0548
Week 1 12.06 0.0301
Diet*Week 5 4.73 0.8501
Covariate 1 7 .06 0.0934
Error 43 103.09
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.01 -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu 0.05 NS NS -
280 Mg 3.5 Cu NS 0.05 NS NS -
400 Mg 5.0 Cu NS 0.05 NS NS NS
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Table 114. Summary of the statistical model for T cells in
Experiment 3, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Block: Day 4 859.82 0.0850
Diet 5 1469.55 0.0209
Week 1 2079.55 0.0001
Diet*Week 5 507.44 0.4055
Error 40 3888.38
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu 0.01 NS -
160 Mg 3.5 Cu 0.05 NS NS -
280 Mg 3.5 Cu 0.01 NS NS NS -
400 Mg 5.0 Cu 0.01 0.05 NS NS NS
Table 115. Summary of the statistical model for B cells in 
Experiment 3.
Source DF SS PR > F
Block: Day
Diet
Week
Diet*Week 
Error
4
5 
1 
5
40
1155,
619
574,
412,
2842,
19
49
54
34
76
0.0074 
0.1470 
0.0070 
0.3454
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Table 116. Summary of the statistical models for PHA counts
per minute and the stimulation index in Experiment 3.
CPM:
Source DF SS PR > F
Block: Day 4 87712680 0.0696
Diet 5 29392437 0.6246
Error 17 140896022
SI:
Source DF SS PR > F
Block: Day 4 872.66 0.0068
Diet 5 75.58 0.8721
Error 17 724.43
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Table 117. 
counts per
CPM:
Summary of 
minute and
the
the
statistical
stimulation
models for Con A 
index in Experiment 3.
Source DF SS PR > F
Block: Day 4 6208931567 0.0012
Diet 5 771874498 0.6052
Error 17 3554979024
S I :
Source DF SS PR > F
Block: Day 4 78489.92 0.0137
Diet 5 4851.88 0.9521
Error 17 77349.75
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Table 118. Summary of the statistical model for PWM counts
per minute in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Block: Day 4 1133994972 0.0033
Diet 5 922945778 0.0150
Error 17 798449757
Diet
(ug/gm)
50 Mg 
0.5 Cu
160 Mg 
2.0 Cu
280 Mg 
2.0 Cu
160 Mg 
3.5 Cu
280 Mg 
3.5 Cu
400 Mg 
5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu 0.05 0.05 0.05 -
280 Mg 3.5 Cu NS NS NS 0.05
400 Mg 5.0 Cu 0.01 0.01 0.01 NS 0.05
Table 119. Summary of the statistical model for the PWM 
stimulation index in Experiment 3.
Source DF SS PR > F
Block: Day 4 15291.67 0.0019
Diet 5 2346.69 0.5431
Error 17 9561.50
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Table 120. Summary of the statistical model for total plasma
proteins in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet 5 14.55 0.0158
Week 1 3.96 0.0436
Diet*Week 5 1.08 0.9447
Covariate 1 1.07 0.2853
Error 43 39.40
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu 0.01 NS -
160 Mg 3.5 Cu 0.05 NS NS -
280 Mg 3.5 Cu 0.05 NS NS NS -
400 Mg 5.0 Cu 0.001 0.05 NS NS NS
Table 121. Summary of the statistical model for the 
albumin/globulin ratio in Experiment 3.
Source DF SS PR > F
Diet 5 0.26 0.2263
Week 1 0.05 0.2479
Diet*Week 5 0.23 0.2938
Covariate 1 0.13 0.0597
Error 43 1.54
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Table 122. Summary of the statistical model for albumin in
Experiment 3, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 5 6.13 0.0178
Week 1 2.16 0.0242
Diet#Week 5 0.28 0.9814
Covariate 1 0.06 0.6943
Error 43 17.02
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu 0.05 NS -
160 Mg 3.5 Cu 0.01 NS NS -
280 Mg 3.5 Cu 0.05 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 123. Summary of the statistical model for alpha 1
globulin in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet 5 1.96 0.0001
Week 1 0.09 0.1162
Diet*Week 5 0.09 0.7732
Covariate 1 0.11 0.0792
Error 43 1.50
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 0.01 NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 0.05 NS NS NS
Table 124. Summary of the statistical model for alpha 2 
globulin in Experiment 3.
Source DF SS PR > F
Diet 5
Week 1
Diet*Week 5
Covariate 1
Error 43
0.18 0.0832
0.04 0.1365
0.07 0.5535
0.15 0.0044
0.72
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Table 125. Summary of the statistical model for beta
globulin in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet 5 1.80 0.0039
Week 1 0.33 0.0570
Diet*Week 5 0.23 0.7601
Covariate 1 0.03 0.5466
Errrr 43 3.77
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS 0.01 -
160 Mg 3.5 Cu 0.05 NS 0.001 -
280 Mg 3.5 Cu NS NS 0.001 NS -
400 Mg 5.0 Cu NS NS 0.05 NS NS
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Table 126. Summary of the statistical model for gamma 
globulin in Experiment 3, and the least square mean 
probabilities for the diet main effect and for the diet*week 
interaction.
Source DF SS PR > F
Diet 5 0.03 0.0312
Week 1 0.00 0.9325
Diet*Week 5 0.03 0.0368
Covariate 1 0.04 0.0001
Error 43 0.10
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.01 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu 0.05 NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS
WEEK 4 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu NS -
280 Mg 2.0 Cu NS NS -
160 Mg 3.5 Cu NS NS NS -
280 Mg 3.5 Cu NS NS NS NS -
400 Mg 5.0 Cu NS NS NS NS NS
WEEK 8 PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu NS 0.05 0.01 -
280 Mg 3.5 Cu 0.01 NS NS NS -
400 Mg 5.0 Cu 0.01 NS NS NS NS
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Table 127. Summary of the statistical model for IgM in
Experiment 3, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 5 26.97 0.0015
Week 1 0.71 0.4325
Diet*Week 5 1.61 0.9195
Covariate 1 20.70 0.0001
Error 43 48.82
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu NS 0.05 0.01 -
280 Mg 3.5 Cu NS NS 0.05 NS -
400 Mg 5.0 Cu 0.05 NS 0.05 NS NS
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Table 128. Summary of the statistical model for IgG in
Experiment 3, and the least square mean probabilities for
the diet main effect.
Source DF SS PR > F
Diet 5 230.28 0.0300
Week 1 48.53 0.0953
Diet*Week 5 84.62 0.4208
Covariate 1 83.70 0.0303
Error 43 717.12
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.05 NS -
160 Mg 3.5 Cu 0.05 NS NS -
280 Mg 3.5 Cu 0.01 NS NS NS -
400 Mg 5.0 Cu 0.05 NS NS NS NS
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Table 129. Summary of the statistical models for antibody
titer and log titer in Experiment 3.
antibody titer:
Source DF SS PR > F
Diet 5 97392.87 0.7349
Week 1 26130.45 0.3937
Diet*Week 5 151250.35 0.5161
Covariate 1 32429.45 0.3425
Error 43 1513723.15
log titer:
Source DF SS PR > F
Diet 5 777.51 0.1422
Week 1 80.85 0.3445
Diet*Week 5 213.06 0.7880
Covariate 1 157.01 0.1899
Error 43 3804.89
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Table 130. Summary of the statistical model for neutrophil
phagocytosis in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Block: Day 4 1921.59 0.4035
Diet 5 12309.25 0.0008
Week 1 2574.66 0.0238
Diet*Week 5 1455.23 0.6821
Error 40 18648.81
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.01 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 131. Summary of the statistical model for neutrophil
killing in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Block: Day 4 1933.66 0.4312
Diet 5 12519.93 0.0011
Week 1 2579.68 0.0278
Diet*Week 5 1655.06 0.6494
Error 40 19801.62
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.01 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
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Table 132. Summary of the statistical model for
myeloperoxidase in Experiment 3, and the least square mean
probabilities for the diet main effect.
Source DF SS PR > F
Diet
Week
Diet*Week
Error
5
1
5
44
11.99
0.00
0.69
18.40
0.0004
0.9479
0.5493
Diet 50 Mg 160 Mg 280 Mg 160 Mg 280 Mg 400 Mg
(ug/gm) 0.5 Cu 2.0 Cu 2.0 Cu 3.5 Cu 3.5 Cu 5.0 Cu
MAIN EFFECT PR > T
50 Mg 0.5 Cu -
160 Mg 2.0 Cu 0.001 -
280 Mg 2.0 Cu 0.001 NS -
160 Mg 3.5 Cu 0.001 NS NS -
280 Mg 3.5 Cu 0.001 NS NS NS -
400 Mg 5.0 Cu 0.001 NS NS NS NS
Table 133. Summary of the statistical model for superoxide 
dismutase in Experiment 3.
Source DF SS PR > F
Diet 5 52115.75 0.4150
Week 1 42386.42 0.0474
Diet*Week 5 43959.01 0.5126
Error 43 437253.26
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Table 134. Correlation coefficients (r) and probabilities 
(P) for plasma magnesium, spleen and thymus weights, and 
white blood cell count (WBC) in Experiment 1 at three weeks 
and eight weeks.
three weeks:
plasma
Mg
spleen
wt
thymus
wt
WBC
plasma Mg r=
P=
-
spleen wt r=
P=
-0.61
0.01
-
thymus wt r=
P=
-0.02
NS
0.08
NS
-
WBC r=
P=
-0.69
0.001
0.35
NS
0.14 
NS
-
eight weeks:
plasma
Mg
spleen
wt
thymus
wt
WBC
plasma Mg r= -
P=
spleen wt r= -0.78 _
P= 0.001
thymus wt r= 0.08 -0.15
P= NS NS
WBC r= -0.30 0.32 -0.17
P= NS NS NS
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Table 135. Correlation coefficients (r) and probabilities 
(P) for plasma magnesium, IgM, IgG, and antibody titer in 
Experiment 1 at three weeks and eight weeks.
three weeks:
plasma IgM IgG antibody
Mg titer
plasma Mg r= -
P=
IgM r = 0.63 —
P= 0.01
IgG r= 0.58 0.25 _
P= 0.01 NS
antibody r = 0. 29 0.49 0.06
titer P= NS 0.05 NS
eight weeks:
plasma IgM IgG antibody
Mg titer
plasma Mg r = -
P=
IgM r= 0.57 —
P= 0.01
IgG r= 0.04 0.34 —
P= NS NS
antibody r= 0.15 0.45 0.23
titer P= NS 0.05 NS
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Table 136. Correlation coefficients (r) and probabilities 
(P) for plasma copper, spleen and thymus weights, and white 
blood cell count (WBC) in Experiment 2 at four weeks and 
eight weeks.
four weeks:
plasma
Cu
spleen
wt
thymus
wt
WBC
plasma Cu r=
P=
-
spleen wt r = 
P=
0.13
NS
-
thymus wt r = 
P=
0.35
NS
0.46
0.05
-
WBC r = 
P=
0.27
NS
0.39
NS
0.47
0.05
-
eight weeks:
plasma
Cu
spleen
wt
thymus
wt
WBC
plasma Cu r= -
P=
spleen wt r= -0.18
P= NS
thymus wt r = 0.20 -0.24 —
P= NS NS
WBC r= -0.17 -0.46 0.27
P= NS 0.05 NS
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Table 137. Correlation coefficients (r) and probabilities 
(P) for plasma copper, IgM, IgG, and antibody titer in 
Experiment 2 at four weeks and eight weeks.
four weeks:
plasma IgM IgG antibody
Cu titer
plasma Cu r = 
P= '
IgM r=
P=
0.50
0.01
-
IgG r= -0.23 -0.10
P= NS NS
antibody r = -0.001 -0.09
titer P= NS NS
eight weeks:
plasma
Cu
IgM IgG antibody
titer
plasma Cu r= -
P=
IgM r = 0.32 —
P= NS
IgG r= -0.46 0.19 —
P= 0.05 NS
antibody r= -0.16 -0.42 -0.29
titer P= NS NS NS
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Table 138. Correlation coefficients (r) and probabilities 
(P) for plasma copper, ceruloplasmin (Cp), neutrophil 
killing, superoxide dismutase (SOD), and myeloperoxidase 
(MPO) in Experiment 2 at four weeks and eight weeks.
four weeks:
plasma
Cu
Cp neutrophil
killing
SOD MPO
plasma Cu r= 
P=
-
Cp r = 
P=
0.71
0.001
-
neutrophil r = 
killing P=
-0.17
NS
-0.24
NS
-
SOD r = 
P=
0. 36 
NS
0.24
NS
-0.11
NS
-
MPO r = 
P=
0.09
NS
0.11
NS
0.52
0.01
-0.04
NS
-
eight weeks:
plasma
Cu
Cp neutrophil
killing
SOD MPO
plasma Cu r= -
P=
Cp r= 0.64 —
P= 0.01
neutrophil r=
1—
1
o1 oCOo1 —
killing P= NS NS
SOD r= 0.17 0.05 0.44
P= NS NS 0.05
MPO r= 0.07 0.04 0.40
P= NS NS NS
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Table 139. Correlation coefficients (r) and probabilities 
(P) for plasma copper, ceruloplasmin (Cp), liver weight and 
copper concentration, and catalase in Experiment 2 at four 
weeks and eight weeks.
four weeks:
plasma
Cu
Cp liver
wt
liver
Cu
catalase
plasma Cu r = 
P=
-
Cp r=
P=
0.71
0.001
-
liver wt r = 
P=
-0.43
0.05
-0.11
NS
-
liver Cu r = 
P=
0. 76 
0.001
0.66
0.001
-0.55
0.01
-
catalase r = 
P=
-0.18
NS
-0.33
NS
-0.49
0.01
-0.11
NS
-
eight weeks:
plasma
Cu
Cp liver
wt
liver
Cu
catalase
plasma Cu r=
P=
-
Cp r-
P=
0.64
0.01
-
liver wt r = 
P=
-0.74
0.001
-0.40
NS
-
liver Cu r = 
P=
0.87
0.001
0.62
0.01
-0.72
0.001
-
catalase r= 0.27 0. 30 -0.01 0.31 —
P= NS NS NS NS
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Table 140. Correlation coefficients (r) and probabilities 
(P) for plasma magnesium and copper, spleen and thymus 
weights, and total white blood cell counts (WBC) in 
Experiment 3 at four weeks and eight weeks.
four weeks:
plasma
Mg
plasma
Cu
spleen
wt
thymus
wt
WBC
plasma Mg r = 
P=
-
plasma Cu r = 
P=
0.65
0.001
-
spleen wt r = 
P=
-0.73
0.001
-0.45
0.01
-
thymus wt r = 
P=
0.32
NS
0.18
NS
-0.29
NS
-
WBC r=
P=
-0.66
0.001
-0.57
0.001
0.75
0.001
0.08
NS
-
eight weeks:
plasma
Mg
plasma
Cu
spleen
wt
thymus
wt
WBC
plasma Mg r = 
P=
-
plasma Cu r=
P=
0.63
0.001
-
spleen wt r = 
P=
-0.59
0.001
-0.35
NS
-
thymus wt r = 
P=
0.37
NS
0.34
NS
-0.17
NS
-
WBC r=
P=
0.05
NS
-0.11
NS
0.01
NS
0.50
0.01
-
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Table 141. Correlation coefficients 
(P) for plasma magnesium and copper 
titer in Experiment 3 at four weeks
(r) and probabilities 
, IgM, IgG, and antibody 
and eight weeks.
four weeks :
plasma
Mg
plasma
Cu
IgM IgG antibody 
titer
plasma Mg r = 
P=
-
plasma Cu r=
P=
0.65
0.001
-
IgM r = 
P=
0.15
NS
-0.11
NS
-
IgG r = 
P=
0.18
NS
-0.15 
NS
0.63
0.001
-
antibody
titer
r=
P=
0.32
NS
0.43
0.05
-0.01
NS
-0.03
NS
eight weeks:
plasma
Mg
plasma
Cu
IgM IgG antibody 
titer
plasma Mg r = 
P=
-
plasma Cu r = 
P=
0.63
0.001
-
IgM r = 
P=
0.25
NS
-0.07
NS
-
IgG r = 
P=
0.47
0.01
0.41
0.05
0.46
0.05
-
antibody
titer
r = 
P=
0.22
NS
0.26
NS
0. 39 
0.05
0.18
NS
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Table 142. Correlation coefficients (r) and probabilities 
(P) for plasma magnesium and copper, ceruloplasmin (Cp), 
neutrophil killing, superoxide dismutase (SOD), and 
myeloperoxidase (MPO) in Experiment 3 at four weeks and 
eight weeks.
four weeks:
plasma
Mg
plasma
Cu
Cp neutrophil
killing
SOD MPO
plasma Cu r-
P=
0.65
0.001
-
Cp r=
P=
0.50
0.01
0.86
0.001
-
neutrophil
killing
r=
P=
-0.36
NS
-0.25
NS
-0.36
NS
-
SOD r=
P=
0.12
NS
0.06
NS
-0.10
NS
0.18
NS
-
MPO r=
P=
-0.29
NS
-0. 16 
NS
-0.13
NS
0.64
0.001
0.09
NS
-
eight weeks •
plasma
Mg
plasma
Cu
Cp neutrophil
killing
SOD MPO
plasma Cu r=
P=
0.63
0.001
-
Cp r=
P=
0.60
0.001
0.94
0.001
-
neutrophil
killing
r = 
P=
-0.55
0.01
-0.46
0.01
-0.43
0.05
-
SOD r=
P=
-0.09
NS
-0.17
NS
-0.11
NS
0.11
NS
-
MPO r = 
P=
-0.60
0.001
-0.41
0.05
-0.35
NS
0.62
0.001
0.36
NS
-
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Table 143. Correlation coefficients (r) and probabilities 
(P) for plasma magnesium and copper, ceruloplasmin (CP), 
liver weight and copper concentration, and catalase (Cat) in 
Experiment 3 at four weeks and eight weeks.
four weeks:
plasma
Mg
plasma
Cu
Cp liver
wt
liver
Cu
Cat
plasma Cu r=
P=
0.65
0.001
-
Cp r = 
P=
0.50
0.01
0.86
0.001
-
liver wt r = 
P=
-0.61
0.001
-0.55
0.01
-0.42
0.05
-
liver Cu r=
P=
0.78
0.001
0.93
0.001
0.80
0.001
-0.60
0.001
-
catalase r=
P=
0.23
NS
0.34
NS
0.29
NS
-0.23
NS
0.40
0.05
-
eight weeks:
plasma
Mg
plasma
Cu
Cp liver
wt
liver
Cu
Cat
plasma Cu r=
P=
0.63
0.001
-
Cp r=
P=
0.60
0.001
0.94
0.001
-
liver wt r = 
P=
-0.70
0.001
-0.59
0.001
-0.53
0.01
-
liver Cu r=
P=
0.73
0.001
0.90
0.001
0.82
0.001
-0. 76 
0.001
-
catalase r = 
P=
0. 36 
NS
0.41
0.05
0.53
0.01
-0.54
0.01
0.44
0.05
-
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Table 144. Summary of the regression analyses* parameter 
estimates in Experiment 1 using plasma magnesium as the 
independent variable at three weeks and eight weeks.
three weeks:
variable intercept bi PR > T b2 PR > T
PHA CPMa 3148.81 5167.41 0.7888 -1768.93 . 0.8083
PHA SI* 1.21 14.45 0.6887 -3.78 0.7814
Con A CPM 88480.71 -77441.27 0.6098 32090.29 0.5761
Con A SI 91.59 4.79 0.9864 5.43 0.9591
PWM CPM 42751.74 -46124.99 0.2738 17183.72 0.2805
PWM SI 33.89 4.37 0.9584 -2.20 0.9446
antibody
titer 47.30 -61.37 0.7693 40.35 0.6108
log titer 4.52 5. 54 0.8134 -0.17 0.9850
eight weeks:
variable intercept bi PR > T b2 PR > T
PHA CPM 16924.89 -17059.34 0. 3043 5425.17 0.3071
PHA SI 32.39 -38.92 0.3048 13.34 0.2834
Con A CPM 93895.78 -85369.33 0.2989 22936.59 0.3806
Con A SI 236.04 -285.50 0.0947 89.35 0.1015
PWM CPM 15412.93 -12760.29 0.3095 3210.68 0.4212
PWM SI 32.94 -37.12 0.1267 11.11 0.1513
antibody
titer -159.51 382.44 0.2166 -113.74 0.2491
log titer 0.13 21. 13 0.2017 -5.71 0.2772
a, counts per minute
b, stimulation index
295
Table 145. Summary of the regression analyses’ parameter 
estimates in Experiment 2 using plasma copper as the 
independent variable at four weeks and eight weeks.
four weeks:
variable intercept bi PR > T b2 PR > T
PHA CPMa 164.22 2897.01 0.0298 -1731.64 0.0317
PHA SI»> 1.40 8.16 0.0515 -5.08 0.0459
Con A CPM 1900.67 15964.00 0.1055 -10560.50 0.0785
Con A SI 10. 72 50.37 0.1605 -34.52 0.1142
PWM CPM 1680.93 2827.67 0.2941 -2209.48 0.1791
PWM SI 5.60 10.82 0.2145 -8.03 0.1311
antibody
titer 15.36 9.99 0.7372 -6.34 0.7246
log titer 5.61 3.48 0.6629 -2.26 0.6402
eight weeks •
variable intercept bi PR > T b2 PR > T
PHA CPM 237.08 4719.81 0.4912 -2278.57 0.5626
PHA SI 6.04 6.80 0.7708 -2.87 0.8303
Con A CPM 20283.46 -5503.58 0.8512 4065.33 0.8097
Con A SI 138.34 -125.97 0.4275 70.49 0.4399
PWM CPM 1790.34 2815.65 0.5340 -989.26 0.7031
PWM SI 12. 73 1.07 0.9509 1.16 0.9074
antibody
titer 38.80 -74.87 0.0012 41.85 0.0016
log titer 5.61 3.48 0.6629 -2.26 0.6402
a, counts per minute
b, stimulation index
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Table 146. Summary of the regression analyses’ parameter 
estimates in Experiment 3 using plasma magnesium as the 
independent variable at four weeks and eight weeks.
four weeks:
variable intercept b, PR > T b2 PR > T
antibody
titer 52.88 -138.70 0.6932 118.50 0.4000
log titer 4.79 10.27 0.4620 -1.33 0.8099
eight weeks :
variable intercept b, PR > T b2 PR > T
PHA CPMa 145.79 2104.56 0.7792 -114.48 0.9725
PHA SI»> 2.31 6.21 0.7528 -1.83 0.8338
Con A CPM 12854.60 25361.36 0.6114 -9622.54 0.6627
Con A SI 115.17 -6.57 0.9732 -8.99 0.9171
PWM CPM -2716.36 30952.71 0.2242 -13119.97 0.2436
PWM SI 39.95 13.24 0.8690 -10.33 0.7713
antibody
titer -124.14 347.71 0.1116 -135.88 0.1574
log titer -17.65 57.65 0.0080 -23.11 0.0150
a, counts per minute
b, stimulation index
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Table 147. Summary of the regression analyses’ parameter 
estimates in Experiment 3 using plasma copper as the 
independent variable at four weeks and eight weeks.
four weeks:
variable intercept bi PR > T b2 PR > T
antibody
titer 108.88 -328.36 0.3381 297.37 0.1136
log titer 9.34 2.93 0.8211 4.38 0.5328
eight weeks:
variable intercept bi PR > T b2 PR > T
PHA CPMa 76.65 6942.82 0.2028 -3282.15 0.2457
PHA SI» 0.85 18.11 0.1950 -9.18 0.2061
Con A CPM 11567.37 38253.76 0.2768 -17046.69 0.3499
Con A SI 67.47 103.80 0.4555 -63.70 0.3797
PWM CPM 2996.05 18890.35 0.2860 -7150.63 0.4349
PWM SI 25.48 29.36 0.6121 -13.74 0.6480
antibody
titer 48.77 -21.30 0.8921 33.58 0.6815
log titer 6.90 11.27 0.4943 -3.52 0.6809
a, counts per minute
b, stimulation index
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